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Abstract
Proteins of the GW182 family have recently emerged as key players in miRNA-
mediated gene silencing. They have been shown to interact with Argonaute
proteins, components of the RISC and are assumed to mediate the repression in
metazoa. Three paralogues are encoded in the human genome, TNRC6A (GW182),
TNRC6B and TNRC6C and only one in fly. Results in Drosophila melanogaster
demonstrated that GW182 has the potential to both repress translation and induce
mRNA deadenylation and decay.
In this work, we investigate the role of GW182 proteins in miRNA-mediated
repression. We demonstrate that the repression mediated by TNRC6C is due to
a combination of effects on the mRNA level and mRNA translation. Through
deletion analysis, we could identify the C-terminal part of TNRC6C as a key
effector domain mediating repression of protein synthesis. Furthermore, we show
that two unstructured regions located within the C-terminal part are responsible
for the effect. We give evidence for a direct interaction of TNRC6C with PABP and
CNOT1. Both interactions are mediated by the C-terminal effector domain, however
by different sub-fragments. While repression of protein synthesis is independent
of the interaction with PABP, it relies on the interaction with the CCR4–NOT
complex. The interaction is mediated by GW-repeats which are located in the two
regions flanking the RRM. Finally, we show that the C-terminal effector domain is
able to induce repression upon tethering not only of poly(A)+ but also of poly(A)–
reporters.
Our results characterize the role of GW182 proteins in gene silencing and clarify
some of the recent contradictions about the diverse proposals for the mode of action
of miRNAs. The identified effector motifs function as important mediators of
miRNA-induced silencing and reveal the recruitment of the CCR4–NOT machinery
to the RNA-induced silencing complex. In addition to inducing mRNA decay, the
recruitment of GW182 also results in inhibition of mRNA translation independently
of deadenylation.
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1Introduction
1.1 Genetics and Epigenetics
The beginning of the field that we now call ‘classical genetics’ was set in the
eighteenth century by Gregor Johann Mendel. He monitored one specific trait at a
time in a single specimen over several generations [Carlson, 2004]. Mendel’s laws,
the fundamental outcome of his studies, set the basis for modern genetics. His
work was not yet accepted by the scientific community, however it started a search
for the material which carries genetic information.
Several important discoveries contributed to the foundation of genetic research:
In 1871, Friedrich Miescher published his discovery of a weak acid in the nuclei
of white blood cells, which we now know as DNA. He also proposed that it might
be the bearer of inheritance [Miescher, 1871]. More than fifty years later, in
1928, Frederic Griffith realized that genetic material from dead bacteria could be
functionally integrated in living cells. Oswald Avery proved Friedrich Miescher’s
hypothesis in 1944 by using specific enzymes to degrade DNA, RNA, or proteins –
showing that only DNA carries genetic information [Avery et al., 1944].
Meanwhile, the concept of chromosomes and their role in inheritance had been
discovered [Sutton, 1903], and in 1910, Thomas Hunt Morgan showed with his work
in Drosophila melanogaster that genes are located on chromosomes [Morgan, 1910].
However, a convincing idea for how genes encode proteins and how this information
is passed on to daughter cells was still lacking. The first insight into molecular
details came from X-ray diffraction images of DNA. The suggested helical structure
was finally confirmed by Francis Crick and James Watson [Watson and Crick, 1953].
The complementary structure of DNA also explained how the strands can be copied
before cell division since both strands carry the same information.
With the structure of DNA known, the field of molecular genetics developed
much faster. Soon, a central dogma was established, which defined the information
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flow in a cell: DNA acts as a template for messenger RNA and this information
is then translated into proteins. It also stated that this course of action was
unidirectional. The discovery of restriction enzymes by Smith and Wilcox [1970]
provided an indispensable tool for further investigations, and in 1977, the first
genome was sequenced by Frederick Sanger [Sanger et al., 1977]. The logical
consequence was the subsequent race for the sequence of the human genome,
which was fundamentally completed in 2001 simultaneously by the Human Genome
Project and Celera Genomics [Lander et al., 2001; Venter et al., 2001].
Having the whole genome sequenced, people expected an explanation for most
questions concerning diseases and inheritance. However, it soon became evident
that the DNA sequence alone cannot explain many observations: How can females
have two X chromosomes but the same amount of proteins as males? How can stem
cells of one organism with the same genotype differentiate into neurons, muscle
cells and blood vessels with distinct profiles of gene expression? Why are some
genetic elements in heterozygotes – and thereby the phenotype – influenced by the
parental generation as discovered in 1958 by Royal Alexander Brink [Brink, 1958]?
These questions could not be explained by mendelian genetics and gave birth to
the field of epigenetics.
1.1.1 A Short History of Epigenetics
Having understood that mendelian genetics is unable to explain the development
of an embryo, Conrad Hal Waddington proposed the word epigenetics to deal with
the correlation between phenotype and genotype [Waddington, 1942]. The word is
a portmanteau of the words ‘genetics’ and ‘epigenesis’ and should describe
„the branch of biology which studies the causal interactions between
genes and their products, which bring the phenotype into being“
[Waddington, 1942]. This definition has not changed since. Nowadays epigenetics
is considered as the study of any potentially stable and inheritable change in gene
expression or cellular phenotype that occurs without changing the underlying DNA
sequence [Goldberg et al., 2007]. Waddington described such phenomenon in his
‘epigenetic landscape’ as shown in Figure 1.1. The metaphor represents the process
of cellular decision-making and how this modulates development. A cell (here
represented by a ball) has to take several decisions during development. Each
permitted decision corresponds to a trajectory in the metaphor and thereby leads
to a different cell fate.
Today, scientists connect the term epigenetics with the combined modifications
of a DNA locus that alter its transcription pattern and thereby the phenotype of a
cell without changing the underlying genetic information (DNA sequence). Hence
the prefix -epi (Greek: ϵπι - over, above). Several distinct ways to alter the readout
2
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Figure 1.1: Waddington’s Epigenetic Landscape. The metaphorical
concept of an epigenetic landscape was proposed in 1957 by Conrad
Waddington. It illustrates cellular decision-making. The ball (a single
cell) can take concrete trajectories which lead to a different end point or
cell fate. Figure reprinted from Waddington [1957].
of a given locus have evolved, and much of today’s epigenetic research focuses on
the study of covalent and noncovalent modifications of DNA and histone proteins
[see Goldberg et al., 2007, and other articles in the same issue of Cell].
1.1.2 Mechanisms of Epigenetic Regulation
Each distinct tissue type has its own set of proteins expressed. This is necessary
to gain the crucial differentiation which helps cells to specialize. Typically, cell
identities are maintained for a lifetime even though the differentiation signal is
experienced only once [Bonasio et al., 2010]. Since all cells in one organism contain
the same genetic information, tools to switch genes on and off are crucial. Such
epigenetic mechanisms often include the covalent or non-covalent modification of
DNA (without altering the sequence) and/or histone modification. Both alterations
imply a change in chromatin structure and can thereby regulate the transcriptional
potential of the underlying genes. However, not only chromatin provides an
attractive way to change a cell’s epigenetic landscape. RNA, especially non-coding
RNA, acquires an increasingly important role in the field of epigenetics.
It seems legitimate to assume that all mechanisms contribute significantly to the
epigenetic reorganization of the genome. It is the joint effort of several pathways that
shapes the epigenetic landscape and these entities should be considered collectively.
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The individual mechanisms are described briefly in the following paragraphs.
1.1.2.1 DNA Methylation
The addition of a methyl group to DNA is probably the best characterized and
most widely studied epigenetic modification. However, since it is not essential to
this work, it will be discussed only shortly. The groundwork was accomplished by
two independent investigations published in 1975 [Holliday and Pugh, 1975; Riggs,
1975], which offered a role for DNA methylation in epigenetics. The possibility
that this modification can be inherited through cell division and that it does not
(at least not per se) alter the primary DNA sequence made it especially attractive.
Nowadays, at the age of the human methylome being analyzed at single nucleotide
(nt) resolution, the chemistry of DNA methylation is uncovered but its function is
still not fully understood.
In mammals, DNA methylation occurs almost exclusively in the context of
CpG dinucleotides. It involves the covalent attachment of a methyl group to the 5
position of the cytosine pyrimidine ring. This chemical modification does not directly
lead to a change in the underlying DNA sequence, however, methylcytosine can
spontaneously deaminate to thymine, resulting in the under representation of CpG
in the human genome (only 21% of the expected frequency) [Illingworth and Bird,
2009]. DNA methylation is carried out and maintained by DNA methyltransferases
[for a comprehensive review see Goll and Bestor, 2005].
Modified CpG pairs are distributed throughout the majority of the genome.
In spite of this, there exist areas with a high frequency of CpG dinucleotides, so
called CpG islands. These regions consist of an elevated G and C content and
the CpGs are not methylated [Illingworth and Bird, 2009]. Furthermore, most of
these CpG islands overlap with promoter sequences of 60-70% of all human genes.
The methylation of CpG is generally thought to be a strong repressive element in
epigenetics.
1.1.2.2 Chromatin Modification
The genetic material in a cell, DNA, is not present as a naked molecule. With the
help of DNA binding proteins, it is organized in a highly ordered and structured
way inside the nucleus. The combination of DNA and proteins, mainly histones, is
called chromatin. This condensed DNA scaffold does not only serve the purpose
of compressing the large amount of DNA, it can also regulate which genes are
accessible for transcription and which are not. In general, genes which are located
on loose chromatin (euchromatin) are actively transcribed, while genes on more
tightly packed chromatin (silent chromatin or heterochromatin) are considered to
be turned off. A primary component of chromatin that plays a key role in this
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regulation is the modification of histones [Bannister and Kouzarides, 2011].
Histone modifications have been investigated intensively [for a review see
Kouzarides, 2007, or more recent Bannister and Kouzarides, 2011]. Each of the
four histones that build the core nucleosome can be modified at specific amino acid
residues, which are generally enriched in the tails. The best known modifications
include lysine acetylation, lysine and arginine methylation, and serine and thre-
onine phosphorylation. There is no general rule stating whether a modification
alters chromatin structure to a more active way or if its a repressive alteration.
Furthermore, mono- or di-methylation at lysine residues can have opposing effects;
H3K9 mono-methylation is considered to be active (as is H3K4), while H3K9 di-
and tri-methylation are considered to be repressive. It has therefore been proposed
that the combinatorial nature of histone modifications reveals a ‘histone code’,
which extends the genetic code and represents a fundamental regulatory mechanism
[Jenuwein and Allis, 2001]. Although a lot about histone alterations is already
known, new sites and modifications are discovered every year [Tan et al., 2011].
The sheer complexity of covalent histone modification is multiplied by the existence
of histone variants that can change the overall composition of the nucleosome and
thereby its modifications.
The exact mechanistic details of how histone modifications influence chromatin
structure have not yet been determined. Charge-altering modifications of the
nucleosome can directly alter the physical properties of the chromatin fiber. Methy-
lation on the other hand has been shown to recruit or stabilize binding partners to
chromatin.
Taken together, DNA methylation and histone modification provide stable,
heritable, and crucial components of epigenetic regulation. They shape a cells
accessible genome, and aberrant placements of these marks or mutations in the
machinery are often connected with diseases [Portela and Esteller, 2010]. Both
epigenetic tools are tightly connected to each other; Histone deacetylases are
recruited by methylation marks on DNA as are nucleosome remodelling factors
[Fuks et al., 2000; Wysocka et al., 2006]. The complexity of the interplay between
those two machineries has recently been increased by a third player: non-coding
RNA.
1.1.2.3 Non-coding RNA
Any RNA molecule which is not translated into protein is considered non-coding
RNA (ncRNA). This includes highly abundant and functionally important RNAs
such as transfer RNA and ribosomal RNA. More recently, the family of ncRNAs
has been expanded by several short regulatory RNAs like microRNAs (miRNAs),
small interfering RNAs (siRNAs) and piwi-interacting RNAs (piRNAs).
NcRNAs have become a fundamental element in epigenetics. Although they
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are sometimes considered not to be ‘epigenetic’ in an exact way because they
are not directly connected to a specific DNA locus, they do meet the criteria by
carrying out a stable and inheritable change in gene expression without changing
the DNA sequence. It has become clear that small RNAs play an active role in
shaping the state of chromatin [Bernstein and Allis, 2005], and pioneering work in
yeast established a direct connection between small RNAs and epigenetic states
[reviewed in Moazed, 2009]. Clear examples of RNA involvement in epigenetics
range from dosage compensation mechanisms in D. melanogaster to the silencing of
genes by post-transcriptional and transcriptional gene silencing (PTGS and TGS,
respectively).
The discovery of RNA-interference pathways (RNAi) and the expanding world
of small RNAs [Grosshans and Filipowicz, 2008] point at the centrality of RNA
[Sharp, 2009] in epigenetics. miRNAs especially bring the RNA molecule to the
core of gene regulation. It is estimated that miRNAs regulate more than 50%
of all genes and are involved in nearly all cellular pathways and diseases. These
recent appraisals underline the considerable relevance of miRNAs and emphasize
the importance of further research in this field.
1.2 MicroRNA
MicroRNAs (miRNAs) are small, about 22 nt long RNAs that post-transcriptionally
regulate gene expression in eukaryotes. After their discovery (see 1.2.1 on page 7),
it soon became clear that miRNAs are of immense importance to most biological
processes, such as development, proliferation, differentiation, apoptosis, and stress
response. These small regulators of gene expression are highly conserved across
species and many are tissue or developmental-stage-specific. First estimations
made miRNAs responsible for regulating more than 30% of all genes in eukaryotes
[Bartel, 2004] while later algorithms suggested a number as high as 60% [Friedman
et al., 2009]. Since the number of regulated genes is significantly higher than the
numer of known miRNAs, one single miRNA can thereby, by direct or indirect
effects, influence protein synthesis from thousands of genes [Selbach et al., 2008].
Although miRNAs are generally thought to make only fine-scale adjustments to
protein output [Baek et al., 2008], their misregulation and aberrant expression
has been implicated in numerous diseases, including cancer, and miRNA-based
therapies are under investigation [Couzin, 2008]. MiRNAs comprise one of the more
abundant classes of gene regulatory molecules and are estimated by computational
approaches to represent 1% of the predicted genes in most vertebrate genomes
[Lim et al., 2003]. As mentioned before in section 1.1.2, they are also embedded
in and intertwined with other epigenetic mechanisms like DNA methylation and
chromatin formation [Iorio et al., 2010; Amaral et al., 2008].
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Overall, the abundance of miRNAs, their wide range of targets and their role
as regulators of many cellular processes and diseases (especially in stem cells [for a
review see Gangaraju and Lin, 2009]) make them an intriguing and crucial research
target.
1.2.1 MiRNA Discovery
The first miRNA was discovered only two decades ago by Ambros, Lee and Feinbaum
[Lee et al., 1993]. Their research on the role of the lin-4 and lin-14 genes in
Caenorhabditis elegans revealed that the lin-4 product is not a protein but instead
gives rise to a a pair of small RNAs. The 61 nucleotide long RNA was assumed
to fold into a hairpin and to eventually mature to a more abundant 22 nt long
transcript. Together with the Ruvkun laboratory [Wightman et al., 1993, in the
same issue of Cell], they realized that LIN-14 protein levels are inversely proportional
to those of lin-4 RNA. Further analysis revealed an antisense complementarity
between the lin-4 RNA and multiple sites in the 3’ end of the lin-14 mRNA. They
hypothesized that the lin-4 product can regulate the synthesis of LIN-14 protein
and together supported a model which revealed the first miRNA and mRNA target
interaction [Lee et al., 1993; Wightman et al., 1993].
This original discovery of a miRNA made no big impression on the field of RNA
research. In contrast, at that time it was thought to be a nematode idiosyncrasy
and no evidence of similar non-coding RNA was found in nematodes or any other
organism. Only seven years later, the discovery of a second miRNA brought the
deserved attention, leading to the now so prominent field of miRNA research. In
2000, Reinhart et al. [2000] reported that let-7, another gene in the C. elegans
heterochronic pathway, encoded a 22 nt long RNA. This RNA acts to promote the
transition from late-larval state to adult in the same way that lin-4 acts earlier
in development. Let-7 -RNA has subsequently been reported to repress the genes
lin-14, lin-41, lin-28 and others. The identification of homologs of the let-7 gene
in human and fly and the detection of the RNA itself [Pasquinelli et al., 2000]
stimulated a large cloning effort in the search for new miRNAs. Indeed, only one
year later, three labs have reported cloning of hundreds of additional small RNAs
from fly, worm and humans [Lagos-Quintana et al., 2001; Lau et al., 2001; Lee and
Ambros, 2001].
Evolutionary conservation of the let-7 gene indicated the existence of a wider
phenomenon. The cloning effort was intensified and a registry has been set up to
catalog and name newly identified genes [Griffiths-Jones, 2004]. The first correlation
between miRNAs and diseases were drawn soon after their discovery [Calin et al.,
2002], and in 2005, genetic evidence for the relevance of miRNAs in mammals came
from a study which described the deletion of a gene encoding Dicer, a key miRNA
processing molecule (see 1.2.2.2 on page 9) [Yang et al., 2005].
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Nowadays, more than 20.000 mature miRNAs in over 150 different species
are annotated (www.mirbase.org, [Kozomara and Griffiths-Jones, 2011]) and the
number is still growing. All kinds of cellular processes and diseases have been shown
to be regulated by miRNAs. First therapeutic trials are on the way and countless
algorithms have been developed to search for new miRNAs and targets [Huang
et al., 2011; Thomas et al., 2010]. However, despite all efforts and considerable
progress, many questions still remain unanswered in the young field of miRNA
research.
1.2.2 MiRNA Biogenesis
MiRNAs are genomically encoded. Most miRNA genes are found in intergenic
regions and usually contain their own promoter [for comprehensive reviews on
miRNA biogenesis see Kim et al., 2009; Carthew and Sontheimer, 2009]. Many
miRNA genes are clustered in polycistronic transcripts and share common regulatory
elements. MiRNA sequences are also found in introns of protein-coding and non-
coding transcription units (in the same orientation) and as such are usually regulated
together with their host gene [Rodriguez et al., 2004; Baskerville and Bartel, 2005].
Most of the genes are typically transcribed by RNA polymerase II [Lee et al.,
2004a], although some studies report an involvement of RNA polymerase III for
certain miRNAs [Borchert et al., 2006]. A typical monocistronic transcript is
composed of a ∼33 nt long stem loop with two flanking segments and can be
capped, polyadenylated, spliced and edited [Bracht et al., 2004; Cai et al., 2004].
The resulting primary or pri-miRNA transcript is processed in two steps into the
mature miRNA (compare Figure 1.2 on page 10).
1.2.2.1 Nuclear processing
The first processing step occurs in the nucleus. The cleavage process excises the
∼33 bp long stem loop from pri-miRNA resulting in formation of a ∼77 nt long
precursor or pre-miRNA with a 3’-hydroxyl and a 5’-phosphate group. The core
component of the enzymatic complex executing the cleavage is the RNase III enzyme
Drosha [Lee et al., 2003; for a review see Kim, 2005]. Drosha is a ∼160 kDa large
endoribonuclease and contains two RNase III domains and one double-stranded
RNA binding domain (dsRBD) [Han et al., 2004]. Drosha carries out the catalytic
cleavage but is dependent on a cofactor for efficient and accurate processing. This
cofactor is known as DiGeorge syndrome critical region 8 (DGCR8) protein in
mammals and Partner of Drosha (Pasha) in C. elegans and D. melanogaster.
DGCR8 contains two dsRBDs itself and is believed to determine the cleavage
site on the pri-miRNA [Landthaler et al., 2004]. Together, Drosha and DGCR8,
often in association with additional regulatory proteins, form a complex called the
8
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Microprocessor, which is required for proper miRNA processing [Gregory et al.,
2004; Denli et al., 2004].
Not all pri-miRNA transcripts are processed by Drosha. A group of miRNAs
are found in very small introns. In those cases, the pre-miRNA sequence matches
exactly the size of the intron. These ‘mirtrons’ are spliced out and can enter the
miRNA processing pathway directly, thereby bypassing the Microprocessor step
[Okamura et al., 2007; Ruby et al., 2007]. Although being uncommon, mirtrons
are found throughout the animal kingdom.
Chronology of splicing and processing is yet unclear. A recent study, using an
in vitro system with both splicing and pre-miRNA processing activities, concludes
that microprocessor and spliceosome activity are functionally linked [Kataoka
et al., 2009]. This may suggest that Drosha processing of pri-miRNAs and mRNA
splicing may occur at the same time. Mammalian Drosha contains a serine-arginine
rich region, a common protein-protein interaction domain for splicing factors.
However, such a domain is not found in the fly homologue. Another study argues
for a direct coupling of miRNA processing and transcription [Morlando et al.,
2008]. They show that „Drosha cleavage occurs during transcription acting on
both independently transcribed and intron-encoded miRNAs“. Morlando et al.
suggest that exonucleolytic degradation from Drosha cleavage sites may influence
the splicing and maturation process of numerous mRNAs.
Following the nuclear processing by the Microprocessor complex, pre-miRNAs
are exported to the cytoplasm. Export is mediated by one of the nuclear transport
receptors, Exportin-5 [Bohnsack et al., 2004; Yi et al., 2003]. Exportin-5 has
been known as a minor transport factor for tRNAs. However, since the affinity
of Exportin-5 for pre-miRNAs is much higher, pre-miRNAs seem to be the main
cargo. Exportin-5 binds cooperatively to pre-miRNA and GTP-Ran in the nucleus
and then releases its cargo in the cytoplasm upon hydrolysis of GTP.
1.2.2.2 Cytoplasmic processing
Once in the cytoplasm, pre-miRNAs undergo a second step of processing, which
produces the mature ∼22 nt long miRNA. The main player in this process is Dicer,
a cytoplasmic RNAse III protein of ∼200 kDa. Dicer is a highly conserved protein,
found in nearly all eukaryotes. Some organisms contain multiple homologues with
distinct roles like in D. melanogaster [Lee et al., 2004b]. Dicer typically consists of
an N-terminal DEXH-box RNA helicase domain, a domain of unknown function
(DUF283), a PAZ domain, two catalytic RNase III domains and a dsRBD [see
Carmell and Hannon, 2004 and Jaskiewicz and Filipowicz, 2008 for reviews]. The
PAZ domain is also found in the Argonaute protein family (see 1.3.1 on page 14),
and is in fact named after the three founding proteins, Piwi, Argonaute, and Zwille.
Dicer was first discovered to play a role in generating siRNAs, but it was soon
9
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Figure 1.2: MicroRNA biogenesis. MicroRNAs are transcribed by RNA
polymerase II. The primary miRNA is processed in the nucleus by the
microprocessor, a protein complex with Drosha and DGCR8 being the
most important components. This step can be bypassed if the pre-miRNA
is produced directly from short introns (mirtrons) as a result of splicing
and debranching. The pre-miRNA is exported to the cytoplasm where
it is further cleaved by Dicer to yield the mature miRNA duplex. The
miRNA guide strand is subsequently loaded into the RNA induced silencing
complex (RISC). Figure modified and reprinted from Krol et al. [2010b].
proven that it also participates in processing pre-miRNAs [Knight and Bass, 2001].
The enzyme functions as a monomer, with a single processing center formed by
intramolecular dimerization of both RNase III domains. This model resembles the
catalytic center of bacterial RNase III [Zhang et al., 2004]. The PAZ domain and
the dsRBD stimulate the interaction with pre-miRNAs. The cleavage results in
formation of the siRNA-like duplex of two complementary strands, a guide strand
and a passenger strand. One of these strands, corresponding to guide or mature
miRNA, is then incorporated into the RNA induced silencing complex (RISC, see
chapter 1.3 on page 13).
Human Dicer interacts with two closely related proteins, TRBP (TAR RNA
binding protein) [Haase et al., 2005] and PACT [Lee et al., 2006]. While these
cofactors are seemingly not necessary for cleavage [Zhang et al., 2002], they clearly
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facilitate it. Depletion of either TRBP or PACT results in a diminished efficiency
of post-transcriptional gene silencing. Although their exact biochemical function
remains to be determined, they are proposed to have roles in pre-miRNA cleavage,
miRNA stability, and probably contribute to the formation of the RISC (see chapter
1.3).
Latest research revealed a miRNA biogenesis pathway independent of Dicer
[Cheloufi et al., 2010; Cifuentes et al., 2010]. The two independent reports identified
an alternative biogenesis for pre-miR-451, which uses Argonaute2 (Ago2, see 1.3.1
on page 14) slicer catalytic activity. This miRNA is processed by Drosha and then
loaded into Ago where it is cleaved, generating a miRNA intermediate containing
an extended 3’ end. Ago2 has been previously shown to play a role in miRNA
biogenesis: MiRNAs that display a high degree in complementarity along the
hairpin can be cleaved by Ago2 to generate Ago2-cleaved pre-miRNAs or ac-pre-
miRNAs [Diederichs and Haber, 2007](see Figure 1.2), which are then further
processed by Dicer.
1.2.3 Regulation of Biogenesis and Decay of MiRNAs
Due to their strong and general impact on protein synthesis, levels of miRNAs in a
cell have to be controlled very tightly. Therefore, regulation of miRNA metabolism
including miRNA decay is crucial for a cell. This topic has emerged into a field of
its own and will be discussed only briefly in the scope of this work [for extensive
reviews on miRNA regulation and decay see Garneau et al., 2007; Winter et al.,
2009; Krol et al., 2010b].
MiRNA biogenesis is regulated at all possible levels; transcription, processing
in the nucleus, and maturation in the cytoplasm. Furthermore, recent discoveries
of maturation steps specific for individual miRNAs have increased regulatory
possibilities after transcription. Multiple proteins have been shown to effectively
regulate miRNA processing.
Regulation at the level of transcription. MiRNA generation can be con-
trolled and regulated in the same way as the generation of protein-coding mRNAs.
This is thought to be a major level of control for tissue-specific or temporal ex-
pression of miRNAs. RNA polymerase II, responsible for miRNA transcription,
recognizes specific promoters and is regulated by transcription factors. For ex-
ample, the temporal expression pattern of let-7 is dependent on a transcriptional
enhancer element, known as temporal regulatory element (TRE) [Johnson et al.,
2003]. Expression of a specific miRNA also depends on the methylation status of
the promoter [Brueckner et al., 2007].
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MiRNA transcripts can be edited. Post-transcriptional editing by adenosine
deaminases acting on RNA (ADARs) modifies adenosine into inosine, which alters
the base-pairing and structural properties of the transcript. Several miRNA
transcripts have been reported to be edited this way [Blow et al., 2006; Yang et al.,
2006]. Despite multiple examples, the exact function of miRNA editing is not
yet known. Modifications might even have different effects on specific miRNAs,
since editing has been reported to have both inhibititory and stimulatory effect on
miRNA processing.
At the level of Drosha cleavage, processing is regulated mainly by protein-
protein interactions. The RNA helicases p68 and p72 are known components of the
Microprocessor complex and are thought to positively influence miRNA expression
[Fukuda et al., 2007]. Furthermore, transforming growth factor-β (TGFβ) and
bone morphogenetic protein (BMP) induce expression of miR-21 by regulating
Microprocessor activity. They recruit the ligand-specific signal transducers (SMAD
proteins) to pri-miR-21 in a complex with p68. How SMAD proteins exactly
modulate miRNA biogenesis is still unclear. Above all, the two main components
of the Microprocessor complex, Drosha and DGCR8 mutually regulate each other.
DGCR8 stabilizes Drosha through a protein-protein interaction; Drosha cleaves
two hairpin structures of the DGCR8 mRNA, resulting in a negative feedback loop
[Han et al., 2009].
Dicer processing in the cytoplasm is regulated similarly to the previous cleavage
step by the Microprocessor in the nucleus. The two main proteins interacting
with Dicer are TRBP and PACT. These two proteins are not essential for miRNA
processing, but clearly facilitate it (see 1.2.2.2 on page 9). Furthermore, a well
known negative regulator of let-7 miRNA, LIN-28, can influence cleavage by
Drosha and/or Dicer by interacting with the terminal loop of pri-let-7 or pre-let-7
[Viswanathan and Daley, 2010; Nam et al., 2011]. A recent report revealed the
full complexity of this process by showing that LIN28A and LIN28B regulate let-7
biogenesis by two distinct ways [Piskounova et al., 2011].
MiRNA decay. Research of miRNA turnover has long been neglected despite
being a crucial step in regulating miRNA levels. Therefore, not much is known yet
about miRNA decay. Experiments using RNA polymerase II inhibitors suggested
that miRNAs in general have a long half life [Gatfield et al., 2009]. However, a
recent report showed that turnover happens very fast in neurons and is regulated
by neuronal activity [Krol et al., 2010a]. Which enzymes degrade miRNAs? In C.
elegans, Chatterjee and Grosshans [2009] showed that the 5’ to 3’ exoribonuclease
XRN-2 is responsible for miRNA degradation. In plants, a family of 3’ to 5’
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exoribonucleases encoded by the small RNA degrading nuclease (SDN) genes
degrades mature miRNAs to limit their accumulation [Ramachandran and Chen,
2008]. Since the enzymes in plants and C. elegans have opposing polarity, not much
can be concluded about mechanisms of degradation in other organisms.
1.3 The RNA-induced Silencing Complex
After being processed into its mature form, the miRNA is incorporated into a
multiprotein complex called the RNA-induced silencing complex (RISC). From
here on, the pathway seems to be biochemically indistinguishable from the central
steps of RNA interference (RNAi). RNAi was discovered by Fire and Mello in
1998 [Fire et al., 1998]. Even though miRNAs have been discovered five years
earlier, the connection between the two mechanisms was not yet clear at that
time. Only later did it become apparent that the mechanisms of most small RNAs
(especially siRNAs and miRNAs) share a high similarity. The main difference
between siRNA and miRNA function is the degree of complementarity to a target
and thus the ensuing resulting way of reducing RNA activity. SiRNAs typically
base-pair perfectly and induce endonucleolytic mRNA cleavage only in a single
specific site. MiRNA binding to a target usually involves mismatches and one
miRNA can have multiple diverse targets (for more details on miRNA mechanism
see chapter 1.4 on page 19).
In D. melanogaster and C. elegans, function of miRNA and siRNA is mediated
by distinct Dicer enzymes and Argonaute proteins [Lee et al., 2004b; Okamura
et al., 2004]. The RISC for miRNA is also known as a microRNA ribonucleoprotein
complex (miRNP), however, for simplicity, it will be referred to as RISC.
The RISC is loaded with a miRNA strand which guides it to its corresponding
target RNA. As processing by Dicer produces a double stranded miRNA duplex, the
two strands have to be separated and only one of them is eventually incorporated
in the RISC. The strand which becomes loaded is called guide strand, the other
is referred to as passenger strand. The guide strand is chosen on the basis of
thermodynamic stability of the duplex miRNA ends. In general, the strand with
the more unstable base pairs at the 5’-end is selected as miRNA [Schwarz et al.,
2003]. The passenger strand is assumed to be degraded [Gregory et al., 2005].
However, in rare cases, both strands of the duplex are functional and may target
different mRNAs.
The detailed molecular mechanism of miRISC loading is still under debate. Dicer,
together with TRBP and Ago, forms a RISC loading complex (RLC) [Chendrimada
et al., 2005; Maniataki and Mourelatos, 2005]. After Dicer releases the miRNA
duplex, it is presumed that the more stable duplex end interacts with TRBP
while the other is bound by Ago [Tomari et al., 2004]. In D. melanogaster, strand
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selection is supported by R2D2, which interacts with Dicer2 and binds to the more
stable end of the duplex [Liu et al., 2003]. The removal of the passenger strand is
facilitated by the slicer activity of Ago2 [Matranga et al., 2005]. However, in case
of duplexes with mismatches (common for miRNAs) or in case of Ago proteins
with no endonucleolytic activity (Ago 1, 3 and 4 in humans), the unwinding of the
duplex is thought to be assisted by a helicase.
Since Ago proteins are essential for a functional RISC and different Ago proteins
determine its function, much research has been undertaken to better understand
them.
1.3.1 Argonaute Proteins
The most intensely studied proteins and key components of the RISC are members
of the Argonaute (Ago) protein family [for comprehensive reviews see Hutvagner
and Simard, 2008 and Cenik and Zamore, 2011]. The discovery and the subsequent
understanding of these highly conserved proteins is closely linked to the study of
RNAi and miRNAs pathways. Ago proteins were first described in Arabidopsis
thaliana as being important for development [Moussian et al., 1998], and in D.
melanogaster as important for germ-line stem cell division [Lin and Spradling, 1997].
But only since the association of Ago proteins with RNAi did the research on these
central components increase significantly.
The Argonaute protein family members can be divided into two classes, Ago
and Piwi (P-element induced wimpy testis) proteins. Sometimes a third class is also
discussed, consisting of the worm-specific group 3 of Argonaute proteins [Yigit et al.,
2006; Hutvagner and Simard, 2008]. The two main groups can be distinguished by
the small RNA they are binding to. Members of the Ago group bind to siRNAs
and miRNAs while Piwi family proteins interact with piRNAs (Piwi-interacting
RNAs). PiRNAs are 26-31 nt long and are expressed in spermatogenic cells in the
germ line of many animal species. They are thought to silence transposons, thereby
protecting the integrity of the genome [Kim, 2006; Siomi et al., 2011].
The Ago group includes four ubiquitously expressed proteins in mammals
(Ago1-4) and two proteins in D. melanogaster, Ago1 and Ago2. In D. melanogaster,
Ago1 functions primarily in the miRNA pathway while Ago2 is involved in siRNA
function [Okamura et al., 2004]. In humans, no preferences of Ago proteins for
either miRNAs or siRNAs have been revealed. However, Ago2 is the only one with
slicing activity and can therefore act in siRNA mediated cleavage of the target
mRNA (see section 1.3.1.2 on page 15).
All eukaryotic Ago proteins that function in gene silencing consist of three
distinct domains: PAZ, MID and PIWI. To date, there exists no three-dimensional
structure of an entire eukaryotic Ago protein. However, due to research on eubac-
terial and archaeal Ago proteins and structures of individual domains of eukaryotic
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Ago proteins, we have a broad understanding of how these proteins work [Jinek
and Doudna, 2009].
1.3.1.1 Functional Domains of Argonautes
The PAZ domain is shared with Dicer and is responsible for binding the 3’-end
of the small RNA. It is able to specifically recognize the 3’-overhang of a miRNA
duplex which is left after sequential cleavage by Drosha and Dicer. The 2 nt long
overhang is inserted into a pocket of conserved aromatic and hydrophobic residues
[Ma et al., 2004].
The PIWI domain is the catalytic center of some of the Ago proteins. Surpris-
ingly, crystal structures of prokaryotic Ago-like proteins revealed that the PIWI
domain folds similar to the catalytic domain of RNase H [Song et al., 2004; Parker
et al., 2004]. RNase H is known to cleave RNA using DNA as a template. It soon
became evident that Ago proteins also harbor an endonucleolytic activity which
requires Mg2+ to cleave a target RNA. Related to the catalytic center of RNase H,
the PIWI domain contains three negatively charged and evolutionary conserved
amino acids, Asp-Asp-His (DDH), which have all been shown to be essential for
cleavage [Liu et al., 2004; Rivas et al., 2005]. Rivas et al. could also prove that Ago
contains the catalytic center by reconstituting the RISC from bacterially expressed
human Ago2 and single-stranded siRNA.
Interestingly, not all Ago proteins are able to cleave a target RNA. In some
Ago proteins (for example human Ago1, 3, and 4), the catalytic center of the PIWI
domain has diverged to an extent that its endonucleolytic activity is impaired.
However, despite the missing enzymatic activity, all Ago proteins have been shown
to function in miRNA-dependent mRNA silencing [Pillai et al., 2004].
The MID domain anchors the 5’-monophosphate of the small RNA. It is proposed
that it nucleates the alignment of the small RNA on the surface of Ago [Parker
et al., 2004]. Being responsible for binding the 5’-phosphate, the MID domain
might also play a role in sorting small RNAs to the various Ago paralogues [Frank
et al., 2010].
1.3.1.2 Argonaute function
It is now clear that Argonaute proteins function as the core component of the
RISC [for a review see Peters and Meister, 2007]. Similar to RNase H, the catalytic
activity requires divalent metal ions and produces a 3’-hydroxyl end and a 5’-
phosphate group. The cleavage is very precise and occurs always between the
target nucleotides paired to the tenth and eleventh nucleotides of the guide RNA.
In analogy to Dicer, Ago proteins which cleave their target are also called „Slicer“.
Cleavage of a target RNA requires a perfect match between the guide small RNA
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and its target, and therefore usually occurs only for siRNAs. In D. melanogaster,
the distinction between the two small RNA silencing pathways is made by using
different Ago proteins for different mechanisms. While specific small RNA classes
are not restricted to associate with Ago1 or Ago2, only Ago1 is able to repress
an mRNA with central mismatches in its miRNA binding sites. On the other
hand, miRNA-loaded Ago2-RISC only mediates RNA cleavage [Forstemann et al.,
2007]. However, more recent reports showed that the separation of both pathways
is not that clear and both Drosophila Ago proteins can regulate translation without
cleavage (although by different mechanisms) [Iwasaki et al., 2009]. In humans, only
Ago2 has the capability of cleaving its mRNA target and is therefore the only Ago
protein mediating siRNA cleavage [Meister et al., 2004; Liu et al., 2004].
To inhibit mRNA function, the RISC is not obliged to cleave the target mRNA.
A cleavage-independent silencing mechanism is especially important when the
involved Ago protein has no endonucleolytic activity (as shown for human Ago 1, 3,
and 4), or when miRNAs only have restricted complementarity with their targets.
In contrast to plants, this is true for most miRNA-mediated gene repression in
animals. When there is no cleavage involved, the silencing mechanism is thought to
be mediated mainly by Ago interacting with proteins which impair translation and
induce mRNA deadenylation. Indeed, comprehensive lists of interacting proteins
have been reported for human Ago1 and Ago2 [Hock et al., 2007]. Fore more details
on miRNA mechanism see chapter 1.4 on page 19.
1.3.2 mRNA Targeting
Once the RISC is assembled, it is directed to its target mRNA by the sequence of the
incorporated guide strand. Target recognition of miRNAs is a widely discussed field
of research and most of our comprehension comes from bioinformatic studies. The
first hint that miRNAs bind to their regulatory target by partial complementarity
came from the early paper on lin-4 RNAs [Lee et al., 1993, see chapter 1.2.1 on
page 7]. Since then, hundreds of miRNA genes have been identified by cloning and
computational methods for target identification quickly evolved. In plants, where
miRNAs bind their targets with extensive complementarity, many targets have
been identified by searching for RNAs with sequences complementary to miRNA
binding sites [Rhoades et al., 2002; Sun et al., 2011]. In mammals, perfect binding
between miRNA and target occasionally happens but is rather the exception [Yekta
et al., 2004]. Therefore, the search for regulatory targets is more complicated and
prone to generate false positives.
To date, several independent algorithms have been implemented to identify
mammalian miRNA targets, the most prominent being TargetScan (http://
targetscan.org, [Friedman et al., 2009]) and PicTar (http://pictar.mdc-berlin.
de, [Lall et al., 2006]). For a more detailed overview of miRNA target recognition
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and available prediction tools see Bartel [2009]. Since predicting targets purely
based on partial complementarity with a 22 nt long miRNA leads to an immense
number of false positives, all computational approaches use some additional features
for predicting miRNA binding sites.
First, miRNA sites are generally located in the 3’-UTR (untranslated region)
of target mRNAs [Gu et al., 2009]. Considering that the 3’-UTR of mRNAs is
a well known site for other types of regulation, this restriction makes sense. If
miRNA sites were located in the ORF, they would interfere with the translational
machinery [Gu et al., 2009]. By being located in the 3’-UTR, the RISC can bind
to the mRNA without completely impairing translation so that miRNAs are able
to fine tune gene expression. A further reason why miRNA binding sites are much
more common in the 3’-UTR is that they are far more effective than sites in the
5’-UTR or in the ORF [Moretti et al., 2010]. In the case of miRNA binding sites
in the 5’-UTR or ORF, Moretti et al. conclude that these sites work by causing
a steric hindrance to the scanning or translating ribosome. Taken together, sites
in the 3’-UTR are under selective biological pressure and therefore evolutionary
conserved. The embedding of this information in search algorithms leads to a better
discrimination between true and false miRNA target sites [Lewis et al., 2003].
A further factor which significantly reduced the number of false positives is
the so called ‘seed’ sequence [Lewis et al., 2005]. The initial observation by Lai
[2002] concluded that „the 5’-ends of many miRNAs are perfectly complementary
to 3’-UTR sequence motifs that mediate negative post-transcriptional regulation“.
The 6-8 nt long seed region of a miRNA forms a perfect and consecutive stretch
of Watson-Crick base-pairing with the mRNA. This perfect complementarity is
crucial for miRNA mediated silencing, and mutating the seed sequence has become
a standard practice for target site validation.
Despite the diversity of computational approaches and recent experimental
progress, there is still room for improvement. Some of the principles are being
challenged by biochemical studies like the finding and exploration of functional
miRNA target sites located in the ORF [Moretti et al., 2010] or miRNAs with a
non-perfect complementarity in the seed region [reviewed in Brodersen and Voinnet,
2009]. More recently, two proteomic studies extended the search for miRNA
targets [Baek et al., 2008; Selbach et al., 2008]. Both reports label proteins during
translation using a method called SILAC (stable-isotope labeling by amino acids
in cultured cells). With subsequent mass spectrometry, whole proteomes of cells
grown in the presence of different labels can be compared side by side. Searching
whole proteomes for miRNA targets and other advancements as well as fine tuning
of computational methods will certainly increase and refine the ranks of miRNA
targets. However, biochemical confirmation of the miRNA-mRNA interaction is
still necessary.
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1.3.3 RISC Localization and P-bodies
It is not yet understood how the active RISC complex finds complementary mRNAs
in the cytoplasm. But there is evidence that part of the RISC mediated repression
takes place in distinct foci within the cell, so called P-bodies. The first observation of
P-bodies occurred in 1997, when Bashkirov et al. reported that XRN1 was „highly
enriched in discrete, prominent foci“. Several other names have been suggested,
including GW-bodies, referring to the protein GW182 that was discovered early on
as a component of P-bodies [Eystathioy et al., 2003], but the name P-bodies was
accepted as a more general term.
P-bodies have been demonstrated to play fundamental roles in general mRNA
decay, nonsense-mediated mRNA decay, AU-rich element mediated mRNA decay,
and microRNA induced mRNA silencing, and the number of proteins detected
in P-bodies has increased considerably. This work only emphasizes the miRNA
related mechanism but the following reviews provide a detailed overview of other
processes and proteins: Kulkarni et al. [2010]; Eulalio et al. [2007a]; Parker and
Sheth [2007]; Balagopal and Parker [2009].
In general, P-bodies are sites of mRNA decay. However, it is important to note
that not all mRNAs which enter P-bodies are degraded, as it has been demonstrated
that some mRNAs can exit P-bodies and re-initiate translation [Brengues et al.,
2005; Bhattacharyya et al., 2006]. The connection to miRNA repression was
established when Ago was shown to localize to P-bodies [Sen and Blau, 2005; Liu
et al., 2005b; Pillai et al., 2005]. Using transfected reporters, researchers could
show that miRNAs localize to P-bodies in a complex with their target mRNAs [Liu
et al., 2005b; Pillai et al., 2005]. Bhattacharyya et al. showed that the endogenous
CAT-1 (cationic amino acid transporter-1) localizes to P-bodies when repressed by
miR-122. This reporter is released from P-bodies and reenters translation if cells
are subjected to stress.
There is more evidence for P-bodies being important for RNAi processes: The
disruption of P-bodies decreases the efficiency of RNAi [Jakymiw et al., 2005] and
the human protein RCK/p54, an important component of P-bodies, is required
for miRNA mediated silencing [Chu and Rana, 2006]. However, the same report
could also show that P-body integrity is not necessary for silencing by siRNAs.
Importantly, recent reports gave evidence that P-bodies are rather a consequence
of RNA interference than the cause [Pauley et al., 2006; Eulalio et al., 2007b].
Despite the well established link between P-bodies and RNA silencing, the exact
role of the distinct foci and the accompanying spatial restriction in a cell is not yet
clear. Some reports even challenge the idea of a connection to P-bodies by reporting
rather a congregation of GW182 and Ago2 with endosomes and multivesicular
bodies (MVBs) [Gibbings et al., 2009]. Indeed, active RISCs have been reported to
be physically and functionally coupled to MVBs [Lee et al., 2009] and miRNAs
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have been found in exosomes [Valadi et al., 2007]. Further research will clarify
the role of spatial distribution and cellular compartments in miRNA and siRNA
mediated processes.
1.4 Mechanisms of MiRNA-Mediated Repression
MiRNAs and siRNAs both repress their targets genes. In plants, miRNAs gen-
erally have a perfect complementary binding site and their target is cleaved and
subsequently degraded [reviewed in Jones-Rhoades et al., 2006]. This mechanism
is similar to siRNA mediated cleavage in mammals. The downregulation of gene
expression by miRNAs in vertebrates on the other hand, is a highly sophisticated
process and probably involves multiple mechanisms and regulation steps. The exact
molecular details of how miRNAs repress gene expression are not yet determined
and the mechanism of translational repression remains controversial. Many reviews
have been written on the complex puzzle of miRNA mediated repression, the most
recent being Chekulaeva and Filipowicz [2009], Huntzinger and Izaurralde [2010]
and Fabian et al. [2010].
Over the last decade, several different and often contradictory mechanisms
have been proposed (compare Figure 1.3 on page 21). Three ideas have been
predominantly suggested:
• Deadenylation and subsequent degradation of the mRNA
• Block of translation initiation
• Slowed elongation or ribosome drop-off
To better understand the diverse possibilities of miRNA mediated repression, one
needs an insight into the complex mechanism of eukaryotic translation. And
although it is now clear that the repressive effect of miRNAs on protein synthesis is
due to both mRNA destabilization and translational repression, the order of events
and the exact step of translation being regulated remain to be elucidated.
1.4.1 An Insight into Eukaryotic Translation
Eukaryotic translation is divided into three distinct steps: initiation, elongation
and termination [refer to Jackson et al., 2010, Van Der Kelen et al., 2009 and
Fabian et al., 2010 for reviews]. At the initiation step, the whole complex necessary
for translation is assembled at the translation start site of the mRNA. During
elongation, the peptide chain is extended with the help of tRNAs. Termination
releases the newly synthesized protein and is followed by a disassembly of the
ribosomal subunits from the mRNA.
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Initiation involves at least 10 different eukaryotic initiation factors (eIFs).
It is considered as the rate-limiting step in translation and therefore the most
common target for regulation. Most eukaryotic mRNAs contain a 5’-cap structure,
a m7GpppN group and a 3’-poly(A) tail. The cap structure serves as docking
point for the eIF4F complex, which contains three main proteins: eIF4A, eIF4E
and eIF4G. eIF4A comprises a DEAD-box ATPase and an ATP-dependent RNA
helicase and is thought to unwind the mRNA 5’ secondary structure. eIF4E is a
small protein which specifically interacts with the cap, while eIF4G mainly serves
as an assembly scaffold. It is necessary for the coordinated attachment of the
translation initiation machinery to the mRNA and facilitates the recruitment of the
40S subunit to the mRNA by binding to eIF3. It also binds to the poly(A)-binding
protein (PABP), leading to a potential circularization of the mRNA. Once the
40S subunit of the ribosome is assembled, it scans the mRNA for the start codon
AUG [Kapp and Lorsch, 2004]. The subsequent joining of the 60S unit initiates
elongation.
Although most mRNAs use the described initiation and scanning mechanism,
initiation on some specific RNAs can also be mediated by internal ribosome entry
sites (IRESs). This circumvents the necessity of some eIFs and makes the process
independent of the 5’-cap [Jackson, 2005].
1.4.2 Repression after Initiation
Several post-initiation mechanisms of repression including inhibition of ribosome
elongation or inducing ribosome drop-off have been proposed (see Figure 1.3).
Evidence for elongation being blocked by miRNAs comes from studies with polysome
sedimentation analysis. However one has to keep in mind that these experiments
look at a steady-state which might not reflect the situation in vivo. Early studies in
C. elegans showed that lin-14 mRNA remains associated with polysomes even while
the corresponding protein is severely downregulated [Olsen and Ambros, 1999],
suggesting that repression occured after translation initiation. Similar results were
obtained in mammalian cells [Petersen et al., 2006; Maroney et al., 2006; Nelson
et al., 2004]. Moreover, Petersen et al. found that IRES mediated translation is
also sensitive to miRNAs and presented additional data that miRNAs promote
premature termination and ribosome drop-off. A similar conclusion, that repression
works at a post-initiation step, was drawn by Maroney et al., observing that
endogenous miRNAs and their target cosediment with polysomes.
The idea that protein accumulation is inhibited due to the degradation of the
nascent peptide chain [Olsen and Ambros, 1999] has been experimentally adressed
by Nottrott et al. [2006]. Since they were unable to immunoprecipitate growing
polypeptides from repressed mRNA reporters, they concluded that miRNAs recruit
proteases to inhibit protein accumulation. In contrast, repression is not prevented
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when reporter proteins are targeted to the endoplasmatic reticulum (ER) [Pillai
et al., 2005], which makes a degradation in the cytosol unlikely and argues against
the ‘proteolytic’ mechanism.
One has to keep in mind that repression by miRNAs is generally only partial and
binding of a single miRNP to mRNA often has no significant effect on translation
[Pillai et al., 2005]. It is therefore conceivable that miRNPs can bind to actively
translated mRNAs and cosediment with polysomes. This is in agreement with the
RISC binding mainly to the 3’-UTR in order not to completely abrogate translation.
Also, in contrast to earlier studies in C. elegans, shifts in polysome gradients have
been observed by Ding and Grosshans [2009]. The debate about this mode of
action is still ongoing, but despite the evidence of miRNAs being associated with
polysomes, a molecular mechanism for repression at a post-initiation step has not
yet been proposed.
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Figure 1.3: Possible mechanisms for miRNA-mediated gene silenc-
ing. Four partial contradictory mechanisms have been proposed about
how the RNA-induced silencing complex mediates repression. Proposals
for a repression at the level of translation initiation (upper left) include the
prevention of 60S subunit joining and an interference with cap-recognition
via eIF4E. Degradation of nascent protein and ribosome drop-off work at
the elongation step. Finally, protein synthesis can be downregulated by
deadenylation and subsequent degradation of the mRNA.
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1.4.3 Repression of Translation Initiation
In contrast to above mentioned studies, experiments carried out in other laborato-
ries strongly support the idea of repression at translation initiation [Pillai et al.,
2005; Ding and Grosshans, 2009; Humphreys et al., 2005; Bhattacharyya et al.,
2006]. Data from Humphreys et al. with IRES driven reporters implicate the cap
recognition step of eIF4E as a molecular target. Investigations using an IRES by
Pillai et al. reinforced the conclusion that the m7G-cap is essential for translational
repression. According to these experiments, cap-dependent cistrons are subject
to miRNA mediated repression, while cistrons under the control of an artificially
tethered eIF4E or eIF4G are not. Many of the above mentioned studies use artifi-
cial reporters with miRNA binding sites in the 3’-UTR. However, a more recent
approach by Ding and Grosshans [2009] looks at endogenous targets in C. elegans,
comparing wild-type worms with worms with mutated miRNA genes. Their data
indicate that lin-14 and lin-28 repression is accompanied by a decreased association
with polysomes and partial mRNA degradation and thus support repression at
translation initiation.
Subsequent studies in cell-free extracts of diverse origin have supported the
mechanism of repression at translation initiation [Wang et al., 2006; Thermann
and Hentze, 2007; Mathonnet et al., 2007; Wakiyama et al., 2007; Zdanowicz et al.,
2009]. In all in vitro systems, the m7G-cap was required for efficient repression by
miRNAs; mRNAs containing an artificial ApppN-cap structure or an IRES were
not inhibited. Zdanowicz et al. demonstrated a crucial role for the m7GpppN-cap
structure and suggested that miRNAs may target cap-dependent translation through
a mechanism related to the eIF4E binding proteins. Importantly, supporting the
above observations, silencing was suppressed if the extract was supplemented with
purified eIF4F (including the cap binding unit eIF4E, see section 1.4.1 on page 19)
[Mathonnet et al., 2007].
One has to consider that current in vitro models are not very robust and show
only a repression of about three to four times in contrast to other experimental
setups like tethering where a repression up to ten times can be observed. Although
this minor repression could quite possibly reflect physiological conditions, further
requirements like preannealing of the synthetic miRNA [Wang et al., 2006] or
overexpression of RISC components [Wakiyama et al., 2007] make these results
difficult to interpret.
The discrepancies about the mechanism of repression at translation initiation
are clearly reflected in the amount of different possibilities suggested. Wang et al.
showed that in a rabbit reticulocyte extract, mRNAs being repressed by an artificial
miRNA are enriched in 40S but not 60S ribosomal subunits. They proposed that
joining of the 60S ribosomal subunit is impaired by miRNAs. A similar conclusion
is drawn by Chendrimada et al. [2007]. The authors reported that eIF6 – together
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with the 60S subunit – co-immunoprecipitates with the RISC. eIF6 is required for
60S biogenesis in Saccharomyces cerevisiae and is known to regulate translation by
preventing 60S joining [Ceci et al., 2003]. Depletion of eIF6 in either human or C.
elegans cells partially alleviated the repression by miRNAs. They concluded that
the RISC associates with eIF6 and disrupts polysome formation.
A completely different step of translation initiation being regulated by miRNAs
was suggested by Kiriakidou et al. [2007]. They identified a limited sequence
homology of the Ago2 MID domain to the cap-binding factor eIF4E. They observed
that Ago2 binds directly to the cap structure; an interaction which is lost upon
mutating two conserved aromatic amino acids to valines. However, the appealing
conclusion that Ago2 prevents the cap-eIF4E interaction and thereby inhibits
translation initiation was soon challenged by later reports. A recent bioinformatic
study could show that the two aromatic residues are too far apart to form a sandwich
like structure with the cap [Kinch and Grishin, 2009]. Moreover, data from Elisa
Izaurraldes lab [Eulalio et al., 2008a] demonstrated that the mutation of the two
aromatic amino acids interferes with Ago2 binding to GW182, a crucial element
in gene silencing downstream of Ago2 (see chapter 1.5 on page 26). In the same
report, they also knock down eIF6 without seeing an effect on miRNA-mediated
repression, questioning the work of Chendrimada et al., see above.
Several possibilities could explain the above mentioned contradictions. The most
obvious are differences in the experimental settings used by various laboratories.
Effects on repression might vary depending on transfection reagents, if endogenous
or artificial miRNAs were analyzed, the number of binding sites in the reporter,
if measurements are carried out in vitro or in vivo, and, in general, which step of
translation is investigated. Distinct modifications, like using cap-analogues can
change the rate-limiting step in translation initiation which in turn can influence
the result of repression [Nissan and Parker, 2008]. In addition, conditions and
especially confluency of tissue culture can influence miRNA levels as shown by
Hwang et al. [2009].
Another possibility is that miRNAs inhibit protein synthesis via multiple
mechanisms. Depending on the experimental setup, one might observe only one
of the mechanisms. One example is that different promoters of reporter genes
might lead to distinct mechanisms of miRNA-mediated repression [Kong et al.,
2008]. Another more controversial example is the observation of upregulation of
protein synthesis by miRNAs [Vasudevan et al., 2007; Orom et al., 2008]. Here
too, the results strongly depend on the conditions of the experiment. In particular,
Vasudevan et al. could observe the activation of translation only in quiescent cells
arrested in G0/G1. They further found that Ago2 associates with fragile X mental
retardation syndrome-related protein 1 (FXR1) in ‘activating’ RISCs. A special case
is the observation by Orom et al. [2008], who reported an upregulation of mRNAs
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bearing a 5’-TOP motif. Such motifs are common in mRNAs encoding proteins
involved in translation and generally serve as regulatory elements. Surprisingly,
binding of miR-10a to the 5’-UTR downstream of the 5’-TOP motif was observed
and it led to an upregulation of translation of the target mRNAs.
The diversity of approaches makes it difficult to compare the proposed mech-
anisms. To date, there is no irrefutable proof for any of the above listed models.
In addition to the disputes about initiation versus post-initiation, leading lab-
oratories still do not agree about the contribution of mRNA destabilization to
miRNA-mediated repression.
1.4.4 Deadenylation and Degradation
Degradation of mRNA is a fundamental process in a cell and serves three main
functions. First, it is a part of RNA surveillance which ensures the quality of
mRNA molecules. Non-functional transcripts are recognized and targeted to
degradation, mainly by either nonsense-mediated decay (NMD) [Fasken and Corbett,
2005; Amrani et al., 2006] or non-stop-mediated mRNA decay (NSD). NMD is
responsible for degrading mRNA molecules with a premature termination codon,
while NSD degrades any that lack translation termination codons. The second
important aspect of RNA degradation is antiviral defense [Ding, 2010]. In plants,
it includes components of the basic RNA decay machinery as well as elements from
more specialized systems like RNAi. Finally, mRNA turnover plays a key role in
eukaryotic cells by setting the basal level of gene expression and as a regulatory
response [Parker and Song, 2004]. We know now that this regulatory response is
mainly triggered by RNA binding proteins and miRNAs.
Despite the diversity of control and stability-regulation mechanisms, all mRNA
transcripts eventually get degraded. The pathway of mRNA turnover is best
studied in yeast and includes three main steps. First, the poly(A) tail at the end
of the 3’-UTR is shortened, a mechanism referred to as deadenylation. Following
deadenylation, the 5’-cap structure is removed by a decapping complex consisting
of Dcp1 and Dcp2. This step fully exposes the mRNA to 5’→3’ digestion by the
exonuclease Xrn1. Alternatively, transcripts can be degraded in a 3’→5’ direction
by the cytoplasmic exosome complex [Wang and Kiledjian, 2001]. The final step of
degradation is thought to occur in P-bodies (see chapter 1.3.3 on page 18).
Multiple eukaryotic mRNA deadenylases are known, including the CCR4–NOT
complex and the PAN2–PAN3 complex [see Garneau et al., 2007, for a review].
While most of the research has been accomplished in S. cerevisiae, these complexes
are highly conserves across eukaryotic organisms including yeast, fly and vertebrates.
The PAN2–PAN3 complex is a PABP-dependent poly(A) nuclease and consists
of PAN2 and PAN3 with PAN3 containing the 3’→5’ exonuclease domain. This
complex is mainly involved in the first phase of trimming the poly(A) tail to
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∼80 nt in mammals [Yamashita et al., 2005]. The CCR4–NOT complex is a much
bigger machinery, consisting of several core subunits and is involved in various
cellular functions [see Collart and Panasenko, 2011 for the S. cerevisiae complex
and Lau et al., 2009 for CCR4–NOT composition in human]. It is the main
deadenylase in S. cerevisiae, with the CCR4 subunit being the 3’→5’ exonuclease.
In higher eukaryotes, CCR4 and CAF1 provide the exonucleolytic activity. The
complex furthermore contains a E3 ligase, CNOT4, which provides ubiquitination
activity. The CNOT1 subunit, consisting of 2108 amino acids in S. cerevisiae,
is the largest component of the complex and servers mainly as a scaffold for the
other subunits. In S. cerevisiae, it is the only subunit essential for viability, and
most interactions seem to be mediated via the C-terminal region [Collart and
Panasenko, 2011]. Despite the abundant knowledge about the single components,
there is little structural information available about the whole complex due to its
heterogeneous composition. In contrast to PAN2–PAN3 activity, PABP blocks the
nuclease activity of the CCR4–NOT complex [Tucker et al., 2002].
It has been debated for a long time if mRNA decay plays a role in miRNA-
mediated silencing. It is now widely accepted that miRNAs have an effect on both
translation and mRNA stability, but many factors still remain in the dark: Which
comes first, translational repression or mRNA destabilization? Which mechanism
predominates? Are all targets regulated by the same mechanisms to the same
extent?
Although first studies on miRNA did not show degradation of target mRNAs,
recent reports in different organisms could clearly show a correlation between
repression of protein synthesis and mRNA levels [Bagga et al., 2005; Wu and Belasco,
2005; Krutzfeldt et al., 2005; Giraldez et al., 2006]. Most of the studies investigated
one miRNA-target pair and observed a frequent correlation between repression
and destabilization of the target. Microarray studies of whole transcriptomes also
provide evidence for a role of miRNAs in mRNA destabilization [Lim et al., 2005;
Rehwinkel et al., 2006].
Looking at single miRNA-mRNA pairs or even whole transcriptomes, one might
miss targets which are regulated more at the translational level. To directly compare
the level of mRNA decay with the level of protein repression, two groups used a
proteomic approach [Selbach et al., 2008; Baek et al., 2008]. While Baek et al.
observe a strong correlation between decrease in mRNA and protein abundance,
Selbach et al. argued that for certain genes, the protein levels were significantly
more reduced than the levels of corresponding mRNAs. Another recent approach
looked at the ribosome association of targets regulated by miRNAs [Guo et al.,
2010]. Using profiling of ribosome protected fragments, Guo et al. show that
„changes in mRNA levels closely reflect the impact of miRNAs on gene expression
and indicate that destabilization of target mRNAs is the predominant reason for
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reduced protein output“. However, despite arguing for a predominant role of mRNA
decay, these global studies also demonstrate a regulation of target mRNAs that
cannot be accounted for by mRNA decay and is therefore likely to happen at the
level of translation [Djuranovic et al., 2011].
Notwithstanding the fact that mRNA decay is a crucial element of miRNA-
mediated repression, the temporal course of events during repression is not yet clear.
There is a certain evidence that mRNA decay may be happening after translational
repression [Djuranovic et al., 2011]: First, at earlier timepoints in the proteomic
study, mRNA does not seem to be downregulated as strongly as at later time points
[Selbach et al., 2008]. Second, kinetic studies on deadenylation in vitro showed
that deadenylation happens after translational repression [Fabian et al., 2009].
Upon realizing the connection between miRNA translational repression and
mRNA degradation, its molecular basis has been investigated more closely. Genetic
and biochemical studies tried to understand which components of the various
mRNA decay machineries are responsible for mRNA destabilization. Depletion of
the CCR4–NOT complex as well as of the decapping enzymes DCP1 and DCP2
prevented miRNA-mediated degradation [Rehwinkel et al., 2005; Behm-Ansmant
et al., 2006; Eulalio et al., 2007c; Piao et al., 2010]. Surprisingly, these studies
revealed the importance of a new class of proteins in miRNA-mediated silencing:
the GW182 proteins.
1.5 TNRC6 Proteins in Gene Silencing
GW182 proteins have recently emerged as key players in miRNA-mediated silencing.
The first member of this family, a protein of 182 kDa, was discovered as the antigen
recognized by a serum from a patient suffering from motor and sensory neuropathy
[Eystathioy et al., 2002]. The discrete cytoplasmic speckles stained by the serum
were termed GW-bodies, which are similar to P-bodies [Eystathioy et al., 2003].
Importantly, the report already proposed „that the GW ribonucleoprotein complex
is involved in the posttranscriptional regulation of gene expression“.
Members of the GW182 protein family are characterized by the presence of
multiple Gly-Trp (GW) repeats. There exist three paralogues in vertebrates,
TNRC6A/GW182 (Trinucleotide repeat-containing gene 6A protein), TNRC6B and
TNRC6C, with two, three and one isoforms each, respectively, and one orthologue
in insects (GW182 or Gawky [Schneider et al., 2006]). All members of the GW182
protein family share a common domain organization (Figure 1.4). Two distinct
structural domains are annotated, a central ubiquitin associated (UBA) domain
and a C-terminal RNA recognition motif (RRM) [Ding and Han, 2007]. The RRM
is flanked by regions predicted to be unstructured, called M2 and Cterm. In
vertebrates, both unstructured regions contain GW repeats, in D. melanogaster
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only the M2 region contains GW motifs. At its N-terminal side, the M2 region
is adjacent to a conserved motif called PAM2. A glutamine-rich (Q-rich) region
is located between the UBA domain and the PAM2. The highest number of GW
repeats (GW or WG) occurs in the N-terminal region of the protein and their
numbers vary between different family members.
1690
GW-rich UBA
933 1091
Q-rich
15151385750
RRMPAM2
Hs
TNRC6C
1384Dm
dGW182
605 830 1215940490
M2 Cterm
Figure 1.4: Domain organization of GW proteins. All members of the
GW182 protein family share a similar domain composition. GW repeats
are mainly situated in the N-terminus of the protein. Positions of Q-rich
region, UBA (ubiquitin-associated) domain, PAM2 motif, and RRM are
indicated.
Two GW-like proteins are found in C. elegans, AIN-1 and AIN-2. They share
the common N-terminal GW-rich region but lack the UBA domain, the PAM2
motif, and the RRM. Therefore, they are sometimes considered not to belong to the
GW protein family, even though they share the GW repeats, bind to Ago proteins
and are essential for repression of protein synthesis [Zhang et al., 2007; Ding and
Grosshans, 2009].
In studies following their discovery, GW182 proteins were shown to interact
with Ago proteins [Meister et al., 2005; Behm-Ansmant et al., 2006]. Interactions of
Ago proteins have also been investigated in Schizosaccharomyces pombe with Ago1
and Tas3. Till et al. found a amino acid sequence in Tas3 which binds to the PIWI
domain of Ago. This conserved motif has been termed „Argonaute hook“ and it
includes several GW repeats. They reported a similar short linear peptide motif
in human TNRC6B which is sufficient for an in vitro Ago association [Till et al.,
2007]. In a broader approach in plants, El-Shami et al. [2007] noted that „reiterated
WG/GW motifs form evolutionarily and functionally conserved Argonaute-binding
platforms in RNA interference-related components“.
As mentioned before, GW182 proteins are part of and localize to P-bodies
in both mammals and D. melanogaster [Eystathioy et al., 2003; Schneider et al.,
2006]. P-bodies have been connected with mRNA decay but are also known as
storage sites for repressed mRNAs (see Chapter 1.3.3 on page 18). Knocking
down GW182 proteins using RNAi severely impairs the formation of P-bodies
[Jakymiw et al., 2005], however, microscopically visible P-bodies are not required
for miRNA-mediated gene silencing [Eulalio et al., 2007b].
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GW182 proteins have been connected to miRNA function and have been shown
to be crucial components for miRNA-mediated gene silencing [Rehwinkel et al.,
2005; Liu et al., 2005a; Behm-Ansmant et al., 2006]. Depletion of GW182 in D.
melanogaster cells relieves repression of miRNA targets [Rehwinkel et al., 2005], and,
more importantly, tethering GW182 proteins to an mRNA silenced the reporter
independently of Ago protein [Behm-Ansmant et al., 2006]. The bypassing of Ago
requirement in miRNA-mediated silencing suggested that GW182 proteins function
downstream of Ago and are the effector proteins of the miRNA machinery.
1.6 Aim of this Study
miRNAs have been discovered only less than two decades ago and turned out
to be major players in the regulation of gene expression in nearly all cellular
processes. Since their discovery, an enormous effort by many laboratories shed
light on miRNA pathway and function. They are transcribed in the nucleus and
undergo two processing steps (one in the nucleus and one in the cytoplasm) until
the mature miRNA is incorporated into the RISC. Argonaute proteins are the key
components of the RISC and have been originally thought to mediate the effect of
repression. However, recent findings suggested that members of the GW182 protein
family function downstream of Ago proteins and are crucial for miRNA-mediated
gene silencing.
Functional studies on miRNA mechanism revealed many discrepancies about
their mode of repression. To date, multiple possibilities have been proposed, the
most prominent being repression at translation initiation, repression at translation
elongation or repression by target degradation. The aim of this study was to shed
light on the diverse modes of action by miRNAs.
Since GW182 proteins were suggested to mediate miRNA-induced repression, our
main objective was the elucidation of the role of GW182 family proteins in miRNA-
mediated gene silencing. To get a better understanding of how these proteins
mediate repression, we decided to perform deletion mutagenesis of the protein and
see which domains contribute to silencing. If miRNA-mediated repression works by
multiple mechanisms, we thought we might be able to uncouple deadenylation from
the effect on translation by analyzing separate domains of TNRC6C. At that time
we chose rather TNRC6C than TNRC6A or TNRC6B since most earlier studies
focused on TNRC6A and TNRC6C is the only paralogue with only one isoform.
To analyze the mechanistic details of different regions, we made extensive use of
the tethering assay which was introduced to miRNA studies in this laboratory.
Tethering a protein (or a protein fragment) to a reporter construct enabled us to
measure the effect on mRNA activity [Pillai et al., 2004].
We decided to use different assays such as immunoprecipitations, mass spec-
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trometry analysis, and yeast two-hybrid system to identify protein interactions with
TNRC6C. Furthermore, point mutations of conserved amino acids or sequences
should lead to a more detailed insight into the molecular mechanism. To differ-
entiate between the two most prominent mechanisms – target degradation and
translational repression – we planned to use reporters that are either polyadenylated
or poly(A)-free. Reporters without poly(A) tail do not undergo deadenylation.
Tethering fragments of TNRC6C to poly(A)– reporters should provide a measure
of the effect on translational repression.
This study characterizes the human GW family member TNRC6C and describes
its specific interaction partners. It further identifies two unstructured regions in
the C-terminal domain as the main effectors of repression. This work will lead to
a better understanding of the diverse modes of repression by miRNAs and will
provide novel molecular insights ons miRNA-mediated gene silencing.
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2Results
In this study, we investigated the role of the human TNRC6C protein in gene
silencing mediated by miRNAs. The first part of the result section is represented
by the attached paper published in RNA [Zipprich et al., 2009] (section 2.1). It is
mainly concerned with the general role of TNRC6 proteins in miRNA-mediated
repression and also identifies the C-terminal domain of TNRC6C as the main
mediator of repression.
In the second part, we further characterized the C-terminal domain of TNRC6C.
Surprisingly, exhaustive dissection of this domain led to the identification of
two unstructured protein regions which are responsible for mediating the effect.
Furthermore, we could identify two specific interaction partners of the C-terminal
domain, PABP and CNOT1. We were able to determine specific sequences in
the two C-terminal regions which are necessary to contact downstream factors
and thereby are crucial for repression. Finally, the importance of the poly(A)-tail
for TNRC6C mediated repression was investigated, using poly(A)+ and poly(A)–
reporters.
2.1 Identification of The C-terminal Domain of
TNRC6C
Jakob T. Zipprich, Sankar Bhattacharyya, Hansruedi Mathys and Witold Filipowicz
RNA 15, 781-793, 2009
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Importance of the C-terminal domain of the human
GW182 protein TNRC6C for translational repression
JAKOB T. ZIPPRICH, SANKAR BHATTACHARYYA, HANSRUEDI MATHYS, and WITOLD FILIPOWICZ
Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland
ABSTRACT
Proteins of the GW182 family play an important role in the execution of microRNA repression in metazoa. They interact
directly with Argonaute proteins, components of microRNPs, and also form part of P-bodies, structures implicated in
translational repression and mRNA degradation. Recent results demonstrated that Drosophila GW182 has the potential to both
repress translation and accelerate mRNA deadenylation and decay. In contrast to a single GW182 protein in Drosophila, the
three GW182 paralogs TNRC6A, TNRC6B, and TNRC6C are encoded in mammalian genomes. In this study, we provide
evidence that TNRC6C, like TNRC6A and TNRC6B, is important for efficient miRNA repression. We further demonstrate that
tethering of each of the human TNRC6 proteins to a reporter mRNA has a dramatic inhibitory effect on protein synthesis. The
repression is due to a combination of effects on the mRNA level and mRNA translation. Through deletion and mutagenesis, we
identified the C-terminal part of TNRC6C encompassing the RRM RNA-binding motif as a key effector domain mediating protein
synthesis repression by TNRC6C.
Keywords: GW182; miRNA; RNA stability; translation; polyadenylation
INTRODUCTION
MicroRNAs (miRNAs) are 20- to 22-nucleotide (nt)-long non-
coding RNAs regulating gene expression post-transcriptionally
by base-pairing to target mRNAs. In animals, most inves-
tigated miRNAs form imperfect hybrids with sequences in
the 39-untranslated region (39-UTR), with the miRNA 59-
proximal ‘‘seed’’ region (positions 2–8) providing most of
the pairing specificity (for review, see Bartel 2004; Bushati
and Cohen 2007; Filipowicz et al. 2008). Generally, the
miRNA association results in translational repression, fre-
quently accompanied by considerable degradation of mRNA
(Nilsen 2007; Standart and Jackson 2007; Eulalio et al. 2008a;
Filipowicz et al. 2008; Wu and Belasco 2008). More recently,
however, miRNAs were also found to have the potential to
activate translation (Vasudevan et al. 2007, 2008; Orom et al.
2008). For example, in nonproliferating cells or cells in the
G0 cell cycle phase, miRNAs were reported to stimulate
rather than inhibit protein synthesis (Vasudevan et al. 2007,
2008).
miRNAs function as components of ribonucleoprotein
(RNP) complexes, miRNPs. The best-characterized con-
stituents of miRNPs are proteins of the Argonaute (AGO)
family. Their function in miRNA-mediated repression is
well documented in many organisms (Peters and Meister
2007; Tolia and Joshua-Tor 2007). Mammals contain four
AGO proteins, AGO1-4, associating with similar sets of
miRNAs and participating in translational repression (Liu
et al. 2004; Meister et al. 2004). In Drosophila, Ago1 is
dedicated to the miRNA pathway while Ago2 mainly
functions in RNA interference (RNAi) (Peters and Meister
2007; Tolia and Joshua-Tor 2007). The Ago proteins
repress protein synthesis when artificially tethered to the
mRNA 39-UTR, indicating that they function as down-
stream effectors in the repression, with miRNAs mainly
acting as guides bringing the proteins to mRNA targets
(Pillai et al. 2004, 2005; Rehwinkel et al. 2005; Wu et al. 2008).
Argonautes are not the only proteins required for
the miRNA-mediated repression. Several components of
P-bodies (known also as GW-bodies), which are cytoplasmic
structures involved in the degradation and storage of trans-
lationally repressed mRNAs (Eulalio et al. 2007a; Parker and
Sheth 2007), also function in the miRNA pathway and,
consistently, repressed mRNAs, miRNAs, and Ago proteins
are enriched in P-bodies (Liu et al. 2005; Pillai et al. 2005; Sen
and Blau 2005; Huang et al. 2007; for review, see Jakymiw
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et al. 2007; Eulalio et al. 2008a; Filipowicz et al. 2008). Of the
P-body components, proteins of the GW182 family play a
particularly important role in the execution of miRNA
repression. GW182 proteins, characterized by the presence
of multiple Gly-Trp (GW) repeats (Eystathioy et al. 2002;
Ding et al. 2005; Rehwinkel et al. 2005; Schneider et al. 2006),
interact with Argonautes through their GW-rich domain
(Behm-Ansmant et al. 2006; Till et al. 2007; Eulalio et al.
2008b). Recent work carried out in the Drosophila system
demonstrated that this interaction is essential for the
repression (Till et al. 2007; Eulalio et al. 2008b). Importantly,
tethering of GW182 to the mRNA bypassed the Ago1
requirement for repression in Drosophila cells, demonstrat-
ing that GW182 functions in the same pathway but down-
stream from Ago1 (Behm-Ansmant et al. 2006).
Despite a considerable research effort, the mechanistic
details of miRNA function in repressing protein synthesis
are still poorly understood. Moreover, the results from
studies conducted in different systems and different labo-
ratories have often been contradictory, making it difficult
to obtain a lucid picture of the repression (Nilsen 2007;
Standart and Jackson 2007; Eulalio et al. 2008a; Filipowicz
et al. 2008; Wu and Belasco 2008). Although many experi-
ments investigating miRNA function in metazoan cells or
in vitro point to the initiation of translation as a target of
miRNA repression (Humphreys et al. 2005; Pillai et al.
2005; Bhattacharyya et al. 2006; Chendrimada et al. 2007;
Kiriakidou et al. 2007; Mathonnet et al. 2007; Wakiyama
et al. 2007), there is also considerable evidence that
miRNAs inhibit translation at post-initiation steps (Olsen
and Ambros 1999; Maroney et al. 2006; Nottrott et al. 2006;
Petersen et al. 2006; Lytle et al. 2007). Although reports
aimed at the reconciliation of some conflicting data have
appeared recently (Kong et al. 2008), the question of
whether the disparities represent artifacts of different
experimental approaches or whether miRNAs are indeed
able to repress protein synthesis by different mechanisms
remains one of the key problems to be resolved (Nilsen
2007; Eulalio et al. 2008a; Filipowicz et al. 2008).
Another important and unanswered issue is the relative
contribution of translational inhibition and mRNA degra-
dation to the final outcome of the repression. Most in-
vestigated mRNAs undergo moderate or substantial deg-
radation, which appears to be initiated by removal of the
poly(A) tail in response to miRNP association with the
mRNA 39-UTR (Bagga et al. 2005; Lim et al. 2005; Wu and
Belasco 2005; Behm-Ansmant et al. 2006; Giraldez et al.
2006; Rehwinkel et al. 2006; Schmitter et al. 2006; Eulalio
et al. 2007b). In Drosophila, the GW182 protein is impli-
cated in the recruitment of deadenylating enzymes to the
mRNA, although the protein also functions in translational
repression independently of its role in deadenylation (Behm-
Ansmant et al. 2006). However, many mRNAs repressed
by miRNAs are resistant to degradation (for a comprehensive
list, see Filipowicz et al. 2008). Which features of mRNA or of
the mRNA–miRNA interaction determine whether repres-
sion follows translational inhibition or mRNA decay? Is the
latter a consequence of translation being repressed, or does it
occur independently of the translational status of the mRNA?
In contrast to the single GW182 protein expressed in
Drosophila, three GW182 paralogs, TNRC6A, TNRC6B, and
TNRC6C,are encoded inmammaliangenomes (for review, see
Ding andHan 2007; Jakymiw et al. 2007). Evidence has already
been presented that the two human proteins TNRC6A and
TNRC6B function in the miRNA pathway and are important
for effective miRNA repression (Jakymiw et al. 2005; Liu et al.
2005; Meister et al. 2005; Till et al. 2007). However, mecha-
nistic details of the repression have not been investigated for
any of the mammalian proteins. In this study, we provide
evidence that TNRC6C, like TNRC6A and TNRC6B, is
essential for efficient miRNA repression and demonstrate that
tethering of each of the human GW182 proteins to reporter
mRNA has a dramatic effect on protein synthesis, with only a
moderate effect on mRNA stability. Finally, we identify the
C-terminal fragment of TNRC6C, encompassing the RNA-
bindingRRMmotif, as a regionmediating the repression. Two
other domains, GW-rich and Q-rich, also repress protein
synthesis upon tethering, but their effects are much less
pronounced than that of the C-terminal region.
RESULTS
Human GW182 protein TNRC6C is involved
in miRNA-mediated repression
The three GW182 protein paralogs encoded in mammalian
genomes, TNRC6A, TNRC6B, and TNRC6C, have a domain
organization similar to Drosophila GW182 (also known as
Gawky). At the N-proximal part, they contain a domain rich
in GW or WG repeats followed by a glutamine (Q)-rich
region of unknown function, hereafter referred to as DUF,
and an RNA-binding domain, RRM. TheDrosophilaGW182
and mammalian TNRC6C also contain a central ubiquitin-
associated (UBA) domain (Fig. 1A; for review, see Ding and
Han 2007). Two homologs of GW182 proteins, AIN-1 and
AIN-2, were characterized in Caenorhabditis elegans. While
AIN-1 and AIN-2 both contain GW- and Q-rich sequences,
they lack other domains present in mammalian proteins
(Ding et al. 2005; Zhang et al. 2007). Interestingly, through
database searches, we have identified a likely homolog of
TNRC6 and AIN proteins in the nematode Brugia malayi. In
addition to GW-containing and Q-rich sequences, this pro-
tein includes aDUFdomain (Fig. 1A,B). Hence, theB.malayi
protein likely represents an evolutionary link between
TNRC6 and AIN proteins.
The TNRC6A and TNRC6B proteins were demonstrated
previously to play a role in the miRNA pathway in
mammalian cells (Jakymiw et al. 2005; Liu et al. 2005;
Meister et al. 2005), but the expression and function of
TNRC6C have not been investigated. We raised polyclonal
Zipprich et al.
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antibodies (Abs) against peptides with sequence present in
TNRC6C but not two other mammalian GW182 proteins. In
Western analysis, the affinity-purified Ab recognized a pro-
tein of the expected size in lysates prepared from HEK293
and HeLa cells. The intensity of the recognized band was
weaker in lysates of cells in which TNRC6C was knocked
down by RNAi (Fig. 2A, lanes 7–10). Overexpression of the
HA-tagged version of the protein further confirmed that the
visualized band corresponds to TNRC6C (lane 6). The Ab
did not recognize overexpressed TNRC6A and TNRC6B
(Fig. 2A, lanes 4,5), consistent with it being specific for
TNRC6C. RT-PCR analysis with primers specific for indi-
vidual GW182 genes revealed that all three TNRC6 genes are
expressed in both HEK293 and HeLa cells (data not shown).
To find out whether TNRC6C, like TNRC6A and
TNRC6B (Jakymiw et al. 2005; Liu et al. 2005; Meister
et al. 2005), is required for miRNA-mediated repression, we
knocked it down using RNAi. As controls, TNRC6A and
TNRC6B were also individually depleted using gene-specific
siRNAs. The efficacy of the knockdowns was monitored by
following the levels of either ectopically expressed HA-
tagged TNRC6 proteins (Fig. 2B) or the endogenous
TNRC6C (Fig. 2A). For siRNAs directed
at TNRC6B and TNRC6C, we verified
that their effects were target-specific
(data not shown). As illustrated in Figure
2C, down-regulation of each TNRC6
protein partially rescued repression of
the Renilla luciferase (RL) reporter,
RL-3xBulgeB. RL-3xBulgeB harbors in
its 39-UTR three sites specific for let-7b
miRNA (Pillai et al. 2005; Schmitter et al.
2006), which is abundantly expressed in
HeLa cells. We conclude that TNRC6C
plays a role similar to those of TNRC6A
and TNRC6B, although the observation
that knockdown of each individual pro-
tein had a marked effect on miRNA
repression leaves open the possibility
that the functions of individual TNRC6
paralogs in mediating miRNA-mediated
inhibition do not entirely overlap.
Tethering of TNRC6 proteins
to mRNA causes repression
of protein synthesis
We used a tethering approach to inves-
tigate the effect of individual mamma-
lian TNRC6 paralogs on protein
synthesis. In this assay, which was used
successfully to study functions of AGO
proteins (Pillai et al. 2004; Rehwinkel
et al. 2005; Kiriakidou et al. 2007; Wu
et al. 2008) and the Drosophila GW182
(dGW182) (Behm-Ansmant et al. 2006), the proteins are
expressed as fusions with the HA-tag and the phage l N-
peptide, which specifically recognizes box B hairpins
inserted into the 39-UTR of RL-5BoxB reporter. The RL
expression was normalized to the activity of firefly lucifer-
ase (FL) expressed from the co-transfected plasmid bearing
no 5BoxB hairpins (FL-Con). As shown in Figure 3,
expression of the NHA version of each of the three TNRC6
proteins strongly repressed activity of the RL-5BoxB
reporter when compared to control TNRC6 proteins
containing the HA-tag but lacking the N peptide. Tethering
of NHA-LacZ, used as another control, yielded RL activity
similar to that measured in the presence of HA-TNRC6C
(see also Figs. 6A and 8, below; data not shown). Together
with Western analysis, which revealed similar expression
levels of NHA- and HA-tagged proteins (Fig. 3A), the data
demonstrate that the repression of protein synthesis is a
result of the TNRC6 proteins tethering to mRNA.
To find out whether the tethered TNRC6 proteins repress
RL activity by inhibiting translation or destabilizing the
mRNA, we quantified RL-5BoxB mRNA levels and, as a
reference, the levels of GFP mRNA coexpressed in transfected
FIGURE 1. Domain structure of selected GW-182-like proteins. (A) Schematic representation
of human (Hs) TNRC6A, TNRC6B, and TNRC6C proteins, the Drosophila (Dm) GW182
(dGW182), C. elegans (Ce) AIN-1 and AIN-2, and a candidate GW182 ortholog of Brugia
malayi (Bm). Positions of GW-rich, Q-rich, UBA (ubiquitin-associated), DUF (domain of
unknown function), and RRM domains are indicated. The percentage of amino acid identity
between highlighted regions of Drosophila, C. elegans, and B. malayi proteins is indicated. (B)
Amino acid alignments of DUF domains of selected GW proteins. Positions of amino acids
that have been mutated to alanines, either singly (T1410) or in the combination of two
(EF1388/1389 and WK1395/1396), are indicated. (Blue) Amino acids identical in more than
50% of proteins; (green) conservative substitutions by related amino acids.
Human GW182 proteins and translational repression
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cells. Comparison of RL activity (Fig. 3A) and Northern blot
data (Fig. 3B) revealed that tethering of TNRC6 proteins to
RL-5BoxB mRNA had a much stronger effect on protein
expression (10- to 20-fold) than on mRNA levels (approxi-
mately threefold), indicating that all three TNRC6 proteins
not only trigger marked mRNA destabilization but also
directly affect the translation process itself.
Identification of repressive domains of TNRC6C
by deletion analysis
To gain insight into the mechanism of TNRC6C-mediated
repression, we generated a collection of deletion mutants of
the protein and tested their effects on protein synthesis using
the tethering assay. Progressive deletions from the N
terminus of the protein (Fig. 4A) revealed that a fragment
bearing only the C-proximal domains DUF and RRM
(mutant DN1370) retained the potential to inhibit RL
activity upon tethering to mRNA (Fig. 4B). Quantification
of the data derived from many experiments in which effects
of NHA-TNRC6C and NHA-DN1370 were compared indi-
cated that repression by NHA-DN1370 was actually stronger
that that by a full-length NHA-TNRC6C (for significance of
the difference, see Fig. 5C and its legend), raising a possibility
that the N-terminal portion of TNRC6C may modulate
inhibitory activity of the C-terminal DN1370. Further
truncation of NHA-DN1370, leading to the removal of
DUF (mutant DN1471), decreased the repressive activity,
but this mutant still inhibited protein synthesis approxi-
mately fourfold compared with the more than 10-fold
repression seen with DN1370 (Fig. 4B). In the analysis of
mutants with progressive N-terminal deletions and of most
of other mutants described below, care was taken to assess
mutant proteins expressed at similar levels (Fig. 4B). This
sometimes required the adjustment of amounts of mutant-
encoding plasmids transfected into cells (see Materials and
Methods). However, within the range of plasmid concen-
trations used for transfections, the extent of repression
caused by individual mutants was generally independent of
the amount of transfected plasmid.
In a further set of mutants, progressive deletions were
carried out from the C terminus (Fig. 4A). As expected,
deletion of the C-terminal portion of TNRC6C containing
the DUF and RRM domains strongly affected the repressive
potential of the protein. Interestingly, analysis of other
mutants revealed that the N-terminal half of the GW-rich
domain (Fig. 4A, mutant 1–405) and a fragment encom-
passing the entire GW-rich domain and the UBA domain
(Fig. 4A, mutant 1–1034) each had some repressive activity:
their tethering inhibited protein synthesis z40% (Fig. 4C).
Tethering of the Q-rich domain alone (Fig. 4A, mutant
1080–1245) also caused an z65% repression of RL activity.
The repressive activity of a fragment encompassing both
the GW- and Q-rich domains (Fig. 4A, mutant 1–1368)
was not stronger than the individual domains alone.
The integrity of the DN1370 fragment is important
for effective repression
Since deletion analysis revealed that the C-terminal frag-
ment of TNRC6C (Fig. 5C, mutant DN1370) repressed
FIGURE 2. Expression of TNRC6C protein in HEK293 and HeLa cells
and its importance for effective miRNA-mediated repression. (A) Anti-
TNRC6C Abs specifically recognize endogenous TNRC6C in HEK293
and HeLa cell extracts and do not cross-react with overexpressed
TNRC6A and TNRC6B proteins. (Lanes 1–6) Extracts prepared from
HEK293 cells overexpressing indicated HA-TNRC6 proteins; (lanes 7–
10) extracts of HEK293 or HeLa cells transfected with either control or
anti-TNRC6 siRNAs. Abs used for Western analysis and positions of
protein size markers are indicated. (*) Non-specific proteins cross-
reacting with anti-TNRC6C Ab. Note that overexpression of TNRC6A
or TNRC6B proteins slightly decreases the level of endogenous
HTNRC6C (cf. lanes 4,5 and lane 7). (B) Knockdown of individual
TNRC6 proteins by specific siRNAs. Cells were cotransfected with
constructs expressing indicated NHA-tagged TNRC6 proteins and
either gene-specific or control siRNAs. One siRNA was used in the
case of TNRC6A, and mixtures of two in the case of TNRC6B and
TNRC6C (Materials and Methods). Anti-HA Ab was used for Western
blot analysis. (C) TNRC6C, similarly to TNRC6A and TNRC6B, is
required for efficient repression of RL-3xBulgeB reporter by endoge-
nous let-7 in HeLa cells. Down-regulation of each protein partially
rescues repression of RL-3xBulgeB. RL-3xBulgeBmut, containing
mutations in the seed sequence of the let-7 binding that prevent the
repression (Pillai et al. 2005; Schmitter et al. 2006), was used as a
control reporter. SiRNAs used for knockdowns are indicated. The data
represent means from three independent experiments.
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protein synthesis even more effectively than the full-length
protein, we focused our attention on this region. Repressive
activity of GW- and Q-rich domains was relatively small
and was not further investigated. The integrity of the
DN1370 fragment appeared to be important since deletion
of either the N-proximal DUF domain or 80 C-terminal
amino acids resulted in a significant decrease of the
repression. In addition, isolated RRM domain (Fig. 5C,
fragment NHA-1505–1610) was devoid of repressive poten-
tial (Fig. 5C, left part).
RNP1 and RNP2 motifs present in the RRM domains of
many characterized RNA-binding proteins contain aro-
matic residues involved in stacking interactions with RNA
ligands (Clery et al. 2008). Similarly, the RRM domains of
GW182 proteins contain several conserved aromatic amino
acids, both within and outside of RNP1 and RNP2 motifs
(Fig. 5B). Residues W1515, H1537, F1543, Y1556, and
F1583 were individually mutated to alanine in the context
of the DN1370 fragment. In another mutant, residues
H1537 and Y1556 were simultaneously replaced with
alanine. Several of the RRM mutants had a significantly
lower activity in repressing protein synthesis than the wild-
type DN1370 fragment (Fig. 5C, right part).
We also generated single or double amino acid muta-
tions in some conserved residues of the DUF domain (for
the identities of the mutated amino acids, see Fig. 1B).
However, these mutations had no appreciable effect on the
ability of the DN1370 fragment to
repress protein synthesis in the tether-
ing assay (data not shown).
The DN1370 fragment acts mainly
as a translational repressor
To find out whether the DN1370 frag-
ment acts similarly to the full-length
TNRC6C and affects both mRNA trans-
lation and stability, we examined the
level of RL-5BoxB reporter repressed by
tethering of the DN1370 fragment or its
RRM domain mutants. Comparison of
Northern blotting and RL activity data
originating from the same transfection
experiments indicated that tethering of
DN1370 results in an approximately two-
fold decrease in mRNA level under con-
ditions leading to an approximately 20-
fold drop in RL activity (Fig. 6A). Hence,
the inhibitory effect of DN1370 on RL
expression is due mainly to repression of
translation. After correction for differ-
ences inmRNA levels, the net effect of the
tethering of DN1370 on translation was
10-fold (Fig. 6A). Tethering of the two
tested DN1370 RRM domain mutants
also decreased the RL-5BoxBmRNA level twofold but did not
inhibit protein synthesis as much as the wild-type DN1370.
The net effect of the F1543A and H1537A/Y1556A mutants
on translation was only approximately 2.5-fold, compared
with the 10-fold effect ofDN1370 (Fig. 6A). This suggests that
the RRM domain functions in translational repression rather
than in mRNA destabilization.
We investigated whether the repressive effect on trans-
lation seen upon tethering of TNRC6C and its DN1370
deletion mutants could be due to mRNA deadenylation.
Total RNA isolated from cells transfected with vectors
expressing different proteins was subjected to RNase H
treatment in the presence or the absence of oligo(dT).
Incubation in the presence of oligo(dT) should result in
removal of poly(A) from mRNA and, consequently, in its
faster mobility in an agarose gel. Where the mRNA
has been deadenylated already in the cell, no major
difference in its mobility would be expected upon RNase
H digestion. As shown in Figure 6B, control RL-Con RNA
isolated from cells co-transfected with NHA-TNRC6C or
RL-5BoxB RNA isolated from cells co-transfected with HA-
TNRC6C contained poly(A) tracts since their mobility
increased upon oligo(dT) addition. Likewise, the mobility
of b-actin mRNA, analyzed as an additional control,
increased upon removal of poly(A) in vitro. Importantly,
RL-5BoxB RNA preparations isolated from cells transfected
with either NHA-TNRC6C or NHA-DN1370 deletion
FIGURE 3. Tethering of TNRC6 proteins to mRNA causes strong repression of protein
synthesis and partial mRNA degradation. (A) Indicated HA- or NHA-tagged TNRC6 proteins
were coexpressed into HEK293 cells with RL-5BoxB, FL-Con, and (in some transfections) GFP
reporters. (Upper panel) RL expression was normalized to the activity of FL and is shown as the
percentage of activity seen in the presence of HA-TNRC6C. Tethering of NHA-LacZ protein,
frequently used as an additional control (see Figs. 6 and 8), did not repress protein synthesis.
(Lower panel) Representative Western analysis of expressed proteins, performed with anti-HA
Ab. (B) Northern blot analysis of RL-5BoxB and GFP mRNAs levels. (Upper panel)
PhosphorImaging quantification of RL-5BoxB mRNA, normalized to GFP mRNA. (Bottom
panels) Representative Northern blot analysis. Values in A and B are means from three
independent experiments. Values for cells expressing HA-tagged proteins were set to 100%.
Human GW182 proteins and translational repression
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mutants also changed their mobility after incubation with
oligo(dT), consistent with them retaining the poly(A) tail
(Fig. 6B). These data indicate that the inhibitory effect of
tethering TNRC6C or DN1370 on translation is not due to
elimination of a stimulatory role of the poly(A)-binding
protein PABP on translation initiation (Kahvejian et al.
2005) or due to disruption of mRNA ‘‘circularization’’
(Wells et al. 1998) potentially caused by mRNA dead-
enylation.
The DN1370 fragment does not
interact with endogenous AGO
or TNRC6C proteins
We considered the possibility that the
inhibitory effect of DN1370 on protein
synthesis is due to the interaction of this
fragment with endogenous TNRC6 or
AGO proteins. If this were the case, the
inhibition would not be due to the
downstream function of DN1370 in
miRNA-mediated repression but due to
recruitment of the endogenous miRNP
complex to the reporter mRNA. Using
immunoprecipitation (IP) assays, we
first determined whether NHA-DN1370
expressed in HEK293 cells interacts with
endogenous AGO proteins or TNRC6C.
Neither AGO proteins nor TNRC6C
were pulled down with the anti-HA Ab
but, as expected (Behm-Ansmant et al.
2006; Till et al. 2007), the full-length
NHA-TNRC6C and its N-terminal GW-
rich fragment NHA-1–1034 very effec-
tively coimmunoprecipitated the endog-
enous Argonautes (Fig. 7A). Since specific
Abs recognizing TNRC6A and TNRC6B
proteins are not available, we have coex-
pressed HA-tagged versions of these pro-
teins together with either Flag-HA-tagged
DN1370 or Flag-HA-tagged AGO2, the
latter protein used as a control. IP experi-
ments with anti-Flag Abs revealed that
AGO2 but not DN1370 is able to inter-
act with TNRC6A and TNRC6Bproteins
(Fig. 7B). We conclude that the DN1370
fragment functions as an autonomous
repressive domain, the inhibitory effect
of which is not caused by interaction
with Argonautes or full-length TNRC6
proteins.
Cross-species repressive activity of
GW proteins and their mutants
In the accompanying manuscript, Che-
kulaeva et al. (2009) have identified three nonoverlapping
regions of theDrosophilaGW182 (dGW182) protein that are
able to repress protein synthesis effectively (five- to sixfold)
upon tethering to mRNA: the N-terminal GW-rich domain,
the Q-rich domain, and the C-proximal fragment containing
DUF and RRM domains (for a scheme of dGW182, see Fig.
1A). We tested the potential of the full-length dGW182 and
its active subfragments to inhibit the activity of the RL-
5BoxB reporter in HEK293 cells. Tethering of a full-length
FIGURE 4. Characterization of the TNRC6C deletion mutants. (A) Schematic representation
of TNRC6C and its deletion mutants. Mutants with progressive deletions from the (upper part
of scheme) N terminus and (lower part of scheme) C terminus. Numbers correspond to amino
acid positions. (B) The C-terminal domain of TNRC6C is sufficient to effectively repress
protein synthesis when tethered to mRNA. (Upper panel) Repressive activity of TNRC6C and
its N-terminal deletion mutants. HEK293 cells were co-transfected with plasmids expressing
N-HA fusions of TNRC6C or its fragments and plasmids encoding RL-5BoxB and FL
reporters. HA-TNRC6C served as a negative control. Activity of RL was normalized for
expression of FL. Values represent relative RL activities normalized to FL, with translation in
the presence of HA-TNRC6C set as 100%. (Lower panel) Expression levels of HA-TNRC6C
and NHA-TNRC6C and its mutants as assessed by Western blotting using anti-HA Ab.
Positions of protein size markers are indicated. (C) Analysis of progressive deletion mutants
from the C terminus and the 1080–1245 mutant reveals only moderate repressive activity of
GW- and Q-rich domains. Details of experiments are identical to those given in the legend to
Figure 4B. The values in B and C are means (6SEM) from four to 12 independent experiments.
Expression of the Q-rich domain was reproducibly weaker than of other domains.
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NHA-dGW182 repressed RL activity as efficiently as the
mammalian NHA-TNRC6C; expression of HA-dGW182
had no inhibitory effect. Interestingly, the N-terminal GW-
rich domain (mutant 1–605) of dGW182 was the most active
repressor in human cells; its repressive
activity (approximately sevenfold) was
comparable to that seen in Drosophila S2
cells (approximately sixfold). In contrast,
three further dGW182 fragments tested
(Q-rich domain, mutant 605–803, and
two C-terminal fragments encompassing
DUF and RRM domains, mutants 940–
1385 and 940–1215) repressed RL activity
in HEK293 cells only approximately two-
fold (Fig. 8).
In a reciprocal cross-species experi-
ment, different domains of TNRC6C
characterized in this work were tested in
DrosophilaS2 cells. A full-lengthTNRC6C
inhibited activity of the tethering reporter
approximately sixfold, while the GW-rich
(1–1034), Q-rich (1080–1245), and the
C-terminal DN1370 fragment repressed
protein synthesis z1.5-fold, eightfold,
and 20-fold, respectively (Chekulaeva
et al. 2009). Hence, although the full-
length dGW182 and TNRC6C proteins
exerted a similar strong repressive effect
irrespective of whether they were tested in
the homologous or heterologous system,
the contribution of individual domains to
this effect differed between human and
Drosophila proteins and cells (see Discus-
sion).
DISCUSSION
Proteins of the GW182 family play an
important role in the miRNA-mediated
repression in metazoa. They directly
interact with AGO proteins and appear
to function as downstream effectors in
the miRNA pathway, responsible for
inhibition of translation and accelera-
tion of mRNA decay (Jakymiw et al.
2005; Liu et al. 2005; Meister et al. 2005;
Rehwinkel et al. 2005; Behm-Ansmant
et al. 2006; Till et al. 2007; Zhang et al.
2007). In contrast to a single GW182
protein expressed in Drosophila, three
paralogs, TNRC6A, TNRC6B, and
TNRC6C, are encoded in mammalian
genomes but little is known about their
functions. In this study, we provide
evidence that TNRC6C, like TNRC6A
and TNRC6B studied previously, is expressed in HEK293
and HeLa cells and is essential for the efficient repression of
a target mRNA reporter by endogenous let-7 miRNP. More
important, we demonstrate that tethering of each human
FIGURE 5. Detailed characterization of the C-terminal DN1370 fragment of TNRC6C. (A)
Schematic representation of deletion mutants of the C-terminal DN1370 fragment of TNRC6C.
(B) Sequence alignment of RRM domains of selected GW182 proteins. Aromatic amino acids
mutated to alanines, either singly or in combination (mutantH1537/Y1556), are indicated. RNP1
and RNP2 motifs are overlined. Positions of a-helices and b-sheets predicted for the TNRC6C
RRMusing Phyre (http://www.sbg.bio.ic.ac.uk/phyre/) are shown below the alignment. (C, upper
panel) Repressive activity of mutants of the DN1370 fragment shown in panel A. Cells were co-
transfected with plasmids expressing NHA fusions of TNRC6C or the DN1370 fragment and its
mutants, and the reporter plasmids. Values represent the percent of translation as measured by
normalized RL activity, with translation in the presence of HA-TNRC6C taken as 100%. Error
bars show standard error (n = 3–12). Statistical significance (NHA-TNRC6C versus NHA-
DN1370 and NHA-DN1370 versus other deletion and RRM amino acid mutants) was calculated
using the nonparametricMann–Whitney–Wilcoxon test (NHA-TNRC6C versusNHA-DN1370)
or paired two-tailed Student’s t-test (all other comparisons); (*) P < 0.05; (**) P < 0.01. (Lower
panels) Expression levels of HA-TNRC6C, NHA-TNRC6C, and the C-terminal DN1370
fragment and its mutants as assessed by Western blotting using anti-HA Ab.
Human GW182 proteins and translational repression
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TNRC6 protein to reporter mRNA strongly affects a pro-
cess of translation, with a more moderate effect on mRNA
stability. We show that the effect on translation is not due
to the remaining mRNA being deadenylated. We identify
DN1370, the C-terminal fragment of TNRC6C including
the RRM RNA-binding motif, as a key region mediating the
translational repression of TNRC6C. Two other domains,
GW-rich and Q-rich, also repress protein synthesis upon
tethering but only approximately twofold. The DN1370
fragment appears to function as an autonomous domain,
the inhibitory function of which does not involve interac-
tion with AGO or TNRC6 family proteins.
Human TNRC6A and TNRC6B were previously identi-
fied as AGO-interacting proteins, and their knockdown was
shown to affect the efficiency of miRNA-mediated repres-
sion (Jakymiw et al. 2005; Liu et al. 2005; Meister et al.
2005; Till et al. 2007). Results of knockdown and co-IP
experiments presented in this report extend these conclu-
sions to TNRC6C. Involvement of TNRC6C in miRNA
regulation is also supported by recent IP experiments of
Landthaler et al. (2008). Our demonstration that individual
tethering of each of the three TNRC6 proteins dramatically
inhibits mRNA translation adds further evidence to the
repressive functions of these proteins. It is intriguing that
individual knockdown of each of the three TNRC6 proteins
markedly interferes with miRNA repression despite their
similar domain organizations. It remains to be established
whether this is due to not entirely overlapping functions of
individual TNRC6 paralogs in miRNA repression or is a
consequence of the decreased total pool of TNRC6 proteins
in the cell. Following submission of our manuscript, Li
et al. (2008) reported that tethering of TNRC6A also
represses translation of FL reporter in HEK293 cells but
only by approximately threefold. In a total of 15 indepen-
dent transfection experiments performed by us in HEK293
cells, inhibition of RL reporter by tethering of TNRC6C
varied between 6.5-fold and 18-fold. In HeLa cells, the
effect varied between six- and 12-fold (H. Mathys and W.
Filipowicz, unpubl.).
Previous analyses of GW182 proteins identified domains
responsible for interaction with Argonautes or localization
to P-bodies (Behm-Ansmant et al. 2006; Till et al. 2007).
However, no information was available about domains
mediating the repression of protein synthesis. Deletion
analysis combined with tethering assays identified DN1370,
the C-terminal fragment of TNRC6C encompassing DUF
and RRM motifs, as a region with a dramatic, up to 20-fold,
repressive effect on the activity of an mRNA reporter.
Noteworthy, repression of protein synthesis by DN1370
was even stronger from that observed when a full-length
TNRC6C was tethered to mRNA, raising a possibility that
the N-terminal portion of TNRC6C may modulate inhibi-
tory activity of the C-terminal part. The integrity of DN1370
was essential to achieve maximal repression, since deletion of
either the DUF domain or 80 C-terminal amino acids
downstream from RRM decreased its inhibitory activity
severalfold. Likewise, mutation of evolutionarily conserved
aromatic residues of the RRM significantly lowered its
inhibitory potential.
Previous work has shown that the GW182 protein in
Drosophila S2 cells stimulates mRNA deadenylation and
decay, but also has a direct inhibitory effect on mRNA
translation (Behm-Ansmant et al. 2006; Eulalio et al.
2008b). We found that the inhibitory outcome of the
tethering of each human TNRC6C paralog is also a
combination of effects on mRNA translation and mRNA
level. More detailed analysis of TNRC6C and its DN1370
fragment showed that mRNA escaping the degradation
remained polyadenylated. Thus the inhibitory effect on
translation is not due to elimination of a stimulatory role of
the poly(A)-binding protein PABP on translation initiation
(Kahvejian et al. 2005) or mRNA ‘‘circularization’’ (Wells
FIGURE 6. (Legend on next page)
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et al. 1998), but rather results from a more direct
interference with the translation process. Interestingly,
comparison of the repressive effects of DN1370 and its
mutants bearing amino acid substitutions in the RRM
indicated that introduced mutations partially mitigate
translational repression but have no appreciable effect on
mRNA level. Hence, the RRM domain may play a more
important role in translational repression rather than in
mRNA destabilization. Our finding that DN1370 does not
interact with the endogenous TNRC6 or AGO proteins also
indicates that this fragment functions as an autonomous
inhibitory domain and not by recruiting the endogenous
miRNP complex to the reporter mRNA. This is consistent
with the findings of Behm-Ansmant et al. (2006) that
GW182 in Drosophila functions downstream from Ago1
and does not require Ago1 for inducing repression.
The DN1370 fragment contains two domains, DUF and
RRM, that are conserved in GW182-like proteins in many
but not all metazoan organisms. The DUF domain is
present in proteins of vertebrates, insects, and the worm
B. malayi (Fig. 1) but not in Caenorhabditis elegans (Zhang
et al. 2007). The function of the DUF domain is unknown,
and limited mutagenesis of the domain carried out within
the context of the DN1370 fragment failed to identify
amino acids important for the repression (Fig. 1B; data not
shown). The RRM domain is conserved in all GW182
proteins of vertebrates and insects but is absent from the
worm proteins. RRM domains are found in many RNA-
binding proteins and are directly involved in the recogni-
tion of specific RNA substrates, primarily via aromatic
amino acids of RNP1 and RNP2 motifs and via residues in
loops interconnecting structural elements of the RRM
(Clery et al. 2008). Several possible functions of the
GW182 RRM in translational repression could be envis-
aged. The RRM may interact with the mRNA target and
induce repression by contacting the cap or AUG regions of
mRNA. Alternatively, the RRM could contact other RNA
components participating in translation, such as initiator
tRNA or ribosomal RNA. However, RRM domains were
also shown to participate in protein–protein interactions
(Clery et al. 2008). Hence, it is possible that a primary role
of the GW182 RRM is to contact protein factors involved
in mRNA translation. In future, it will be interesting to
identify components of mRNA translation and/or decay
machineries that interact with DN1370.
FIGURE 7. DN1370 does not interact with endogenous Ago and
TNRC6C proteins. Cell extracts of HEK293 cells transiently expressing
the indicated fusion proteins were incubated with anti-HA Affinity
Matrix (Roche), and immunoprecipitated proteins (45% of the total
immunoprecipitate) were analyzed by Western blotting using the
indicated Abs. Note that anti-AGO mAb 2A8 recognizes all human
AGO proteins (Nelson et al. 2007). Inputs represent 1% (detection of
Ago) and 5% (detection of TNRC6C) of the cell extract used for IP.
Nontransfected cells served as a control. (B) DN1370 does not interact
with TNRC6A and TNRC6B proteins. Cell extracts of HEK293 cells
transiently expressing indicated epitope-tagged proteins were incu-
bated with anti-Flag M2-Agarose Affinity Gel (Sigma), and immuno-
precipitated proteins (45% of the total immunoprecipitate) were
analyzed by Western blotting using anti-HA 3F10 mAb. Inputs
represent 2% of the cell extract used for IP. Note that HA-TNRC6B
unspecifically binds to a-Flag beads and traces of it are present in IPs
from both DN1370-expressing and control cells. (*) The band most
probably represents the IgG heavy chain.
FIGURE 6. The DN1370 fragment acts mainly as a translational
repressor. (A) Tethering of DN1370 causes strong repression of
translation that is partially relieved by mutations in the RRM domain.
Indicated proteins were coexpressed with reporter plasmids in
HEK293 cells, and their effect on RL activity and RL-5BoxB mRNA
stability was analyzed using extracts originating from the same
transfections. (Upper panel) Effect of tethering on RL activity ([gray
bars] normalized to FL) and RL-5BoxB mRNA level ([black bars]
normalized to GFP mRNA). Values for transfection of HA-TNRC6C
were set to 100%. Calculated net repressive effects on translation are
shown below bars (n = 3, with exception of Northern analysis for
NHA-H1537A/Y1566A and NHA-LacZ performed only twice and
once, respectively). (Lower panels) Representative Northern analyses.
(B) Treatment with RNase H in the presence of oligo(dT) results in
faster mobility of both control mRNAs and mRNAs repressed by
tethering. RL-Con and RL-5BoxB mRNAs were coexpressed in
HEK293 cells with proteins indicated above the panels. RNA isolated
from transfected cells was incubated with RNase H in the absence or
presence of oligo(dT) and analyzed by Northern blotting. The same
blot was consecutively hybridized with probes specific for RL and b-
actin mRNAs. Note that RL-Con mRNA is 220 nt shorter than RL-
5BoxB. Hybridization signals (as measured by PhosphorImaging) in
lanes representing incubations without oligo(dT) were found to be
reproducibly weaker than those in the lanes with oligo(dT). This is
more pronounced for RL mRNAs than b-actin mRNA, and in the case
of RL mRNAs, it applies to the same extent to mRNAs that do and do
not undergo repression.
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In contrast to the C-terminal DN1370 fragment, which
repressed activity of the target mRNA 10- to 20-fold,
tethering of GW-rich and Q-rich domains had only an
approximately twofold inhibitory effect on protein synthesis.
This differs substantially from the situation in Drosophila
cells, where three nonoverlapping regions of dGW182, GW-
rich and Q-rich domains, and the C-terminal fragment
equivalent to DN1370 were identified as regions repress-
ing protein synthesis fivefold to sixfold upon tethering
(Chekulaeva et al. 2009). The results of cross-species experi-
ments indicated that tethering of a full-length dGW182
repressed protein synthesis in HEK293 cells as efficiently as
TNRC6C (Fig. 8). Likewise, repression by full-length
TNRC6C in Drosophila S2 cells was comparable to that of
dGW182 (Chekulaeva et al. 2009). However, the contribu-
tions of individual domains to repression differed substan-
tially between human and Drosophila proteins and cells. The
GW-rich domain of dGW182 was the strongest repressor in
human cells and was probably responsible for most of the
activity of intact dGW182; the effects of the remaining
domains were very limited. When different domains of
human TNRC6C were tested in Drosophila S2 cells, the Q-
rich domain and the C-terminal DN1370 fragment acted as
strong repressors, with the GW-domain having the least
effect (Chekulaeva et al. 2009). Hence, the N-terminal GW-
rich domain of dGW182 is a strong repressor in both S2 and
HEK293 cells, while the analogous domain of TNRC6C has
little effect in either cell type. In contrast, Q-rich domains
from both dGW182 and TNRC6C were strongly inhibitory
in Drosophila but not human cells, likely reflecting some
specific aspects of the repression pathway in fly cells.
Interestingly, the human DN1370 fragment was strongly
repressive in both systems, but its dGW182 counterpart had
a major effect only in homologous Drosophila cells. The
reasons for these protein-specific and cell-specific differences
remain to be established, but the observations are consistent
with a model proposed for Drosophila dGW182 according to
which individual repressive domains of dGW182 contribute
additivelyor cooperatively to the assemblyof a larger repressive
complex acting downstream from miRNPs (Chekulaeva et al.
2009). It will be interesting to dissect the repressive potential of
the two other TNRC6 paralogs TNRC6A and TNRC6B. The
relative contributions to the repression of individual domains
of these two proteins may be different to those established for
TNRC6C.
MATERIAL AND METHODS
Cell culture, transfection, and luciferase assays
Human HEK293T cells (hereafter referred to as HEK293) were
grown in Dulbecco’s modified Eagle’s medium (DMEM; GIBCO
BRL) supplemented with 2 mM L-glutamine and 10% heat-
inactivated fetal calf serum (FCS). Generally, transfections were
performed in triplicates in six-well plates with z60% confluent
cells using Nanofectin (PAA Laboratories), following the manu-
facturer’s instructions. Unless indicated otherwise, amounts of
transfected plasmids per well were 50 ng of indicated RL reporter,
300 ng of FL-Con, and 20-100 ng of plasmid expressing indicated
HA- or NHA-tagged proteins; when indicated, in transfections
simultaneously used for Northern analysis, 200 ng of peGFP-C1
(Clonetech) was also included. In some experiments, amounts of
plasmids expressing TNRC6C deletion mutants were adjusted to
obtain comparable levels of overexpressed proteins. Cells were
lyzed 24 h post-transfection in Passive Lysis Buffer (PLB;
Promega) to measure RL and FL activities by Dual-Luciferase
Assay (Promega).
HeLa S3 cells were grown under similar conditions, but their
transfection with siRNAs and reporter plasmids was performed in
24-well plates using Lipofectamine 2000 (Invitrogen) with pro-
portionally lower amounts of indicated plasmids. Cells were
trypsinized 24 h post-transfection and seeded into wells of a
6-well plate. After 48 h, cells were lyzed as described above.
For RNAi, 100 nM a single siRNA (GCCUAAUCUCCGUGCU
CAATT and UUGAGCACGGAGAUUAGGCTG; sense and antisense
FIGURE 8. Effect of tethering of dGW182 and its deletion mutants
on activity of RL-5BoxB reporter in human cells. (Upper panel)
Tethering of dGW182 and its deletion mutants represses activity of
RL-5boxB reporter in HEK293 cells. Indicated plasmids expressing
human TNRC6C or Drosophila dGW182, or their mutants, were
transfected to cells together with RL-5boxB and FL-Con. Normalized
RL activity is indicated as the percentage of activity in cells expressing
HA-TNRC6C set as 100%. (Lower panel) Expression of fusion
proteins analyzed by Western blotting using anti-HA Ab. (Inset at
the bottom) Shows stronger exposure of the two lanes at far right,
indicating that the Q-rich domain (mutant 605-830) is expressed at a
much lower level than the remaining proteins. However, this low level
of NHA-605-830 appears to be sufficient to achieve maximal
repression since transfection of higher amounts of the plasmid
encoding NHA-605-830 did not result in stronger repression (data
not shown). The data represent means from three independent
experiments. We note that transfection of control NHA-lacZ plasmid
occasionally results in RL expression that is stronger (although not
significantly) than that of another control reporter, HA-TNRC6C.
The data were always normalized to RL expression in the presence
HA-TNRC6C, which we consider as a more appropriate control than
NHA-lacZ.
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strands, respectively) were used in the case of TNRC6A, and mixtures
of two siRNAs, each 50 nM, were used for silencing of TNRC6B
(GGCCUUGUAUUGCCAGCAATT, UUGCUGGCAAUACAAGGC
CTT and GGAGUGCCAUGGAAAGGUATT, UACCUUUCCAUG
GCACUCCTT) and TNRC6C (GCAUUAAGUGCUAAACAAATT,
UUUGUUUAGCACUUAAUGCTT and CCAAGAGUUCUGUCU
AAUATT, UAUUAGACAGAACUCUUGGTT). All siRNAs were
obtained from Microsynth. Allstars Negative Control siRNA was
purchased from QIAGEN.
Plasmids
RL-5BoxB, RL-3xBulgeB, RL-3xBulgeBmut, RL-Con, and FL-Con
reporters (Pillai et al. 2005; Schmitter et al. 2006) and plasmid
expressing NHA-LacZ (Pillai et al. 2004) were previously
described. The plasmid encoding Flag/HA-Ago2 was a kind gift
of Gunter Meister (Max Planck Institute for Biochemistry)
(Meister et al. 2004).
Plasmids expressing HA- and NHA-tagged TNRC6A, TNRC6B,
and TNRC6C were prepared as follows. For TNRC6A, the XhoI–
NotI fragment excised from plasmid phrGFP/N1-GW182-A (kindly
provided by E. Chan, Department of Oral Biology, University of
Florida) (Eystathioy et al. 2002) was cloned into XhoI–NotI-
digested pCI-NHA or pCI-HA vector (pCI-NHA or pCI-HA
contain sequences encoding NHA or HA tags in pCIneo) (Pillai
et al. 2004) to yield pCI-NHA-TNRC6A and pCI-HA-TNRC6A,
respectively. The TNRC6A clones lack the N-terminal 312 amino
acids (Eystathioy et al. 2002). For TNRC6B, the SalI–NotI fragment
from the plasmid pDEST/Myc-GW182-B (kindly provided by G.
Meister, Max Planck Institute for Biochemistry) (Meister et al.
2005) was cloned into SalI–NotI-digested pCI-NHA or pCI-HA
vector to yield pCI-NHA-TNRC6B and pCI-HA-TNRC6B, respec-
tively. Plasmids expressing HA- and NHA-tagged TNRC6C, pHA-
TNRC6C, and pNHA-TNRC6C were prepared as follows: The EST
clone KIAA1582 (from Kazusa DNA Research Institute, Japan) was
digested with BstEII and NotI, and a 4.2-kb fragment correspond-
ing to the downstream ORF part was eluted from agarose gel.
The N-terminal ORF fragment was PCR-amplified using CGGAAT
TCATGGCTACAGGGAGTGCCCAGGG and TGACTGAACCCAG
AATTGCTATTTCC oligonucleotides as primers and digested with
EcoRI and BstEII. The two fragments were inserted into a pCI-
NHA vector pre-cut with EcoRI and NotI to yield pCI-NHA-
TNRC6C. pCI-NHA-TNRC6C has an XhoI site between sequences
encoding N and HA peptides, and two NheI sites: one upstream of
the N-peptide-encoding sequence and another in the ORF. The
plasmid was partially digested with NheI and the linearized DNA
eluted from a gel. The DNA was then digested with XhoI. The
desired 10.4-kb XhoI fragment was purified, the NheI and XhoI
overhang sequences filled in with Klenow polymerase, and the
plasmid religated.
Deletion mutants of TNRC6C were designed taking into account
structure propensity calculations (http://bioinf.cs.ucl.ac.uk/disopred/).
Mutants were obtained using the In-Fusion 2.0 Dry-Down PCR
Cloning Kit (Clontech) and pCI-NHA-TNRC6C as a template.
PCR products were cloned into linearized pCI-NHA. To prepare
pFLAG-NHA-DN1370, sequence encoding NHA-DN1370 was
PCR-amplified using pCl-NHA-DN1370 as a template and AGGCT
AGTCGACATGGACGCACAAACACGACG and AACCCTCACT
AAAGGGAAGC oligonucleotides as primers. Following digestion
with SalI andNotI, the fragment was inserted into SalI/NotI-digested
expression plasmid pCIneo1FLAG (kindly provided by Michael
Doyle of this laboratory).
Site-directed mutagenesis was performed by PCR using a pCI-
NHA-DN1370 plasmid and partially overlapping primers con-
taining desired mutations as described (Zheng et al. 2004). The
original template was digested by the methylation-dependent
enzyme DpnI and the PCR product was transformed into
competent cells.
To generate pCI-NHA-dGW182, the sequence encoding NHA-
dGW182 in a modified version of plasmid pAC5.1-lN-HA-
GW182 (Behm-Ansmant et al. 2006) was PCR-amplified and
cloned into pCIneo digested with NheI and NotI. Plasmids
encoding deletion mutants were generated in a similar way as
pCI-NHA-dGW182, using Drosophila plasmids expressing corre-
sponding dGW182 mutants as templates (Chekulaeva et al. 2009).
pCI-HA-dGW182 plasmid was generated from a pCI-NHA-
dGW182 plasmid by PCR amplification of the HA-dGW182
region, its digestion with SmaI and NotI, and cloning into pCIneo
digested with NheI and NotI.
Correctness of all plasmids was verified by sequencing.
Northern and RNase H analyses
Total RNA was isolated from cells 24 h post-transfection using
Trizol reagent (Invitrogen). Twelve micrograms of total RNA
from each transfection was resolved in a formaldehyde–1%
agarose gel and blotted to the Nylon membrane for 48 h using
103 SSC. The RL- GFP- and b-actin-specific DNA probes (0.9,
0.75, and 1.0 kb long, respectively) were 32P-labeled using
Random-primed DNA labeling Kit (Roche) and used for hybrid-
ization. Radioactivity was quantified with a PhosphorImager
(Storm 860; Molecular Dynamics).
To analyze the polyadenylation status of mRNA, 20 mg of total
RNA isolated from transfected cells was annealed in the presence
or absence of 2 mg of oligo(dT) for 15 min at room temperature
and then treated with RNase H (New England Biolabs) in the
presence of RNasin Plus (Promega; 1 mL per reaction) for 45 min
at 37°C, following the manufacturer’s recommendations. RNA
was purified with Trizol LS (Invitrogen), separated on a denatur-
ing 1% agarose gel, and analyzed by Northern blotting.
Antibodies, Western blotting,
and immunoprecipitations
Antibodies against human TNRC6C were raised in rabbits by Euro-
gentec, using a mixture of two peptides, TGSAQGNFTGHTKKT
and TTIQDVNRYLLKSGG. The Abs were affinity-purified using
individual peptides coupled to Sepharose. For Western analysis,
aliquots of cell lysates in PLB were subjected to SDS-PAGE using a
pre-cast 4%–12% gradient (Invitrogen) (Figs. 4 and 5) or 6% linear
polyacrylamide gels (Figs. 2, 3; 10% for Fig. 8). Note thatmigration of
investigated proteins in relation to protein size markers differs
between these two types of gels. Anti-HA mAb 3F10 (Roche; 1:1000
dilution) or a combinationof anti-TNRC6C rabbitAbs (1:1000)were
usedasprimary antibodies, andgoat anti-ratAb coupled toHRP(MP
Biochemicals; 1:8000) and anti-rabbit Ab (GE Healthcare, 1:10,000)
as secondary Abs. Proteinswere detected using ECL (GEHealthcare).
For HA epitope IP reactions, cells were lysed with 50 mM Tris-
HCl (pH 7.5) containing 150 mM KCl, 5 mM MgCl2, 1 mM
CaCl2, 0.5% Triton X-100, 2 mM DTT, 40 U/mL RNaseOUT
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Recombinant Ribonuclease Inhibitor (Invitrogen), and EDTA-free
Protease Inhibitor Cocktail (Roche). The cleared lysate was
incubated with anti-HA Affinity Matrix (Roche). After washing
with 10 mM Tris-HCl (pH 7.5) containing 200 mM KCl, 5 mM
MgCl2, 1 mM CaCl2, proteins associated with the beads were
analyzed by Western blotting using anti-TNRC6C Abs, anti-HA
mAb 42F13 (FMI Monoclonal Antibody Facility), and mAb 2A8
(Nelson et al. 2007) recognizing human AGO proteins (kindly
provided by Z. Mourelatos, University of Pennsylvania School of
Medicine). Flag IPs were performed using the Flag Tagged Protein
Immunoprecipitation Kit (Sigma) according to the manufac-
turer’s protocol. Immunoprecipitated proteins and input fractions
were analyzed by Western blotting using anti-HA 3F10 antibody
(Roche).
Statistical analysis
Data were tested for Normality using the Shapiro test. The null
hypothesis for the Shapiro test is Normal data. Statistical
significances were calculated on the Normally distributed data
sets using a two-tailed paired Student’s t-test. When the Shapiro
test reported a P-value close to or below 0.05 (data are non-
Normal), we performed the nonparametric Mann–Whitney–
Wilcoxon test. The error bars plotted throughout show the
standard error of the mean (SEM). It follows from the central
limit theorem that the distribution of sample means will be
Normal even if the underlying sample distribution is not. So even
for these cases, the error of the sample means will still be correct.
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2.2 M2 and Cterm are Sufficient for mRNA Re-
pression
The preceding dissection of the human protein TNRC6C strongly highlighted the
importance of the C-terminal effector domain (CED) in mRNA repression. The
most conserved region of the CED is the RRM (RNA Recognition Motif) domain.
However, the RRM alone has no function in repression, as shown in Figure 5 of
Zipprich et al. [2009], presented above in section 2.1. To establish which part of the
CED is responsible for the repression or if its sub-fragments function by distinct
mechanisms, we analyzed activity of smaller fragments of the CED (see Figure 2.1).
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Figure 2.1: Dissection of the CED. (A) Schematic representation of
human TNRC6C and fragments analyzed in the study. Individual domains
and regions of TNRC6C are indicated: N-GW, GW-repeat-rich region;
UBA, ubiquitin associated-like domain; RRM, RNA recognition motif; M2
and Cterm2, regions flanking RRM, constituting – together with PAM2
and RRM – the CED region. (B) M2 and Cterm regions of TNRC6C
mediate repression of tethered mRNA. HEK293T cells were co-transfected
with plasmids encoding NHA-CED or indicated fragments, RL-5BoxB,
and firefly luciferase (FL) reporters to control transfection efficiency. As
negative controls, untethered HA-CED and tethered NHA-RRM (where
„N“ stands for tethering λ peptide) were expressed. Values represent
percentage of Renilla luciferase (RL) activity (normalized to FL activity) in
the presence of nontethered HA-CED or HA-CED∆PAM2. Figure modified
from Chekulaeva et al. [2011], see appendix B.
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To get an insight into the activity of specific sub-fragments, we constructed
deletion constructs of the full CED (∆N1370) according to the four distinguishable
regions, PAM2, M2, RRM and Cterm. CED∆PAM2 (∆N1417) comprises the full
CED without the PAM2 motif. M2-RRM (1417-1610) and RRM-Cterm (∆N1510)
represent constructs comprising the RRM with the flanking M2 or Cterm region,
respectively. CED∆Cterm (1371-1610) includes the PAM2 motif, the M2 region
and the RRM. RRM alone (1505-1610) served as a negative control. We further
constructed an M2-Cterm fusion, which comprises the M2 and the Cterm region
without the RRM in between. Two different variants of the M2-Cterm fusion
were cloned, with five or seven amino acids between both regions. No difference
in activity was observed between the two constructs. The combination of our
constructs allowed us to perform a more detailed analysis of each of the four regions
in the CED. All constructs were cloned into the pCI-neo vector bearing an HA- or
NHA-tag (see section 4.2).
Like the full length construct, tethering the CED or CED∆PAM2 represses RL
expression by approximately ten times if compared to a non-tethered control or to
the RRM alone. Significantly, constructs lacking either M2 or Cterm region showed
reduced repression, hinting to an importance of both regions. Both, M2 and Cterm
show very little conservation and are predicted to be unstructured (analyzed with
http://dis.embl.de and http://bioinf.cs.ucl.ac.uk/disopred/), see Figure
Figure 2.2 (following page): Alignment of the CED of GW182 pro-
teins from different species. (A) Alignment was performed using the T-
Coffee tool (http://tcoffee.vital-it.ch/cgi-bin/Tcoffee/tcoffee_
cgi/index.cgi). The CED regions used throughout the work are delin-
eated with bent arrows. PAM2 and RRM motifs are highlighted in blue
and pink, respectively. Mutations in human M2 and Cterm region are
highlighted in gray with tryptophan residues marked in red. In Drosophila
GW182, red tryptophan residues correspond to mutations used in the
yeast two-hybrid system (compare page 51). Mutations in the RRM were
performed in Zipprich et al. (see section 2.1) and are highlighted in gray.
Amino acids were always mutated to alanines. The numbers correspond to
amino acid positions in full-length GW182 proteins. Numbers of TNRC6A
correspond to the protein described in Zipprich et al. (see section 2.1).
Asterisks mark residues identical in all sequences, colons mark conservative
substitutions, and dots mark semi-conservative substitutions. (B) Dis-
ordered profile plot of TNRC6C CED. Prediction was performed using
the DISOPRED2 prediction (http://bioinf.cs.ucl.ac.uk/disopred/).
PAM2 and RRM motifs are highlighted in blue and pink, respectively.
Amino acids with a probability higher than 0.05 (dotted line) are predicted
to be disoredered.
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2.2). Interestingly, the M2-Cterm fusion repressed almost as well as CED∆PAM2.
This result further strengthens the idea that neither the PAM2 motif nor the RRM
play a considerable role in mediating repression and that the combination of M2
and Cterm is sufficient for effective mRNA repression.
2.3 The CED interacts with PABP and CNOT1
The dissection of the CED region of the human protein TNRC6C surprisingly
indicates an important function for the two unstructured regions flanking the RRM.
We assumed that the most likely way for those regions to mediate repression is by
interacting with other proteins.
To identify interacting proteins, a GST-fusion construct of the CED was overex-
pressed in HEK293T cells and was pulled-down via the GST-tag. The protein was
then eluted from the beads and the pulled-down material was separated by SDS-
PAGE and analyzed by mass spectrometry. Mass spectrometry analysis identified
several promising candidates which co-purified with the CED of TNRC6C(Figure
2.3 A). The appearance of PABP and components of the CCR4–NOT complex was
especially intriguing since they both play important roles in mRNA translation
and mRNA regulation.
With subsequent pull-down experiments, we could confirm the interaction of
PABP and CNOT1 with TNRC6C and were able to map the interaction to different
regions within the CED (see Figure 2.3 B). In pull-down experiments, the RRM
alone did not pull down CNOT1 or CAF1, whereas a fusion of M2 and Cterm regions
pulled them down with an efficiency similar to that of CED∆PAM2. Deleting either
one of the two unstructured regions clearly reduced the interaction with CNOT1
or CAF, showing a strong correlation with the repressive activity of the fragments
(compare with Figure 2.1). The interaction with PABP, however, seems not to be
mediated by the two regions flanking the RRM but rather by the PAM2 motif.
This finding is consistent with data of Fabian et al. [2009], see Appendix A and
Jinek et al. [2010]. Importantly, the observed interactions were not mediated by
RNA as all pull-down experiments included treatment with micrococcal nuclease.
2.4 GW Repeats Play a Role in Repression
The M2 and the Cterm regions of the CED are predicted to be unstructured and
show relatively little conservation compared with the highly conserved RRM (see
Figure 2.2). However, they seem to be responsible for mediating the repression
via the interaction with the CCR4–NOT machinery. We wanted to test if M2
and Cterm execute different functions or if both regions take part in the same
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Figure 2.3: The CED interacts with PABP and the CCR4–NOT
complex. (A) Mass spec analysis of purified CED. CED fragment was
overexpressed in HEK293T cells and purified via GST-tag. The most promi-
nent bands include CNOT1, Clathrin, PABP and components of the adaptor
protein (AP) complex which links Clathrin to distinct receptors. (B) M2
and Cterm regions of the CED interact with components of the CCR4–NOT
complex but not with PABP. TNRC6C CED and its subfragments were
used for GST pull-down assays. Inputs (7%) and pull-down assays were
analyzed by western blotting. Extracts from nontransfected cells were used
as controls. Pull-down experimnets were performed by Hansruedi Mathys,
Figure modified from Chekulaeva et al. [2011], see appendix B.
mechanism. To analyze a single region (either M2 or Cterm), we duplicated the
sequence and fused it together, resulting in an M2-M2 and a Cterm-Cterm construct.
We could not test single regions since they did not express in HEK293T cells. Both
constructs were then cloned into pCi-neo vectors and compared to the M2-Cterm
fusion (Figure 2.4, panel A). Our analysis revealed considerable redundancy of
repressive sequences in both regions since a fusion of M2 (M2-M2) or Cterm
(Cterm-Cterm) is nearly as active as the M2-Cterm fusion. The strong redundancy
probably implies that both regions contain similar elements for contacting a single
distinct downstream factor. Since the deletion of either region strongly impairs
repression and interaction with CNOT1, we concluded that M2 and Cterm region
have an additive effect on repression.
To identify important amino acids in M2 and Cterm, we performed mutagenesis
of selected short amino acid stretches in the context of CED∆PAM2 sub-fragments,
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M2-RRM or RRM-Cterm. Mutagenesis of the same amino acids in the context of
full-length CED or CED∆PAM2 had a very limited effect on repression, likely due
to the redundancy of sequence elements present in M2 and Cterm regions (data
not shown). Amino acids to be mutated were chosen according to conservation,
even though there is very little general sequence conservation in both flanking
regions (see Figure 2.2). Furthermore, tryptophan residues in GW/WG repeats
were selected for mutation.
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Figure 2.4: GW repeats are important for repression. (A) Duplicated
M2 or Cterm regions retain the full repressive potential of the M2-Cterm
fusion. Analyzed constructs are indicated at the top. Values are normalized
to activity of HA-CED∆PAM2 which is taken as 100%. (B)Mutations of W
residues in M2 lead to alleviation of repression by M2-RRM. Tethering assay
with indicated M2-RRM mutants was performed as previously described.
(C) Point mutants of RRM-Cterm showed similar alleviation of repression
as M2-RRM constructs. WT, wild-typr control. Figure modified from
Chekulaeva et al. [2011], see appendix B.
Importantly, our results showed that all mutations significantly affecting repres-
sion were in elements containing tryptophan residues (Figure 2.4). In the Cterm
region, two stretches of amino acids mutated were mutated, LW1647 and SLW1657
(Figure 2.4 C, compare also Figure 2.2 on page 47) (mutations were always to
alanine; if several consecutive amino acids were mutated, the number corresponds
to the first residue in the mutated stretch). Both mutations had a significant effect
on repression, and both motifs include W residues in a context of GW or WG
dipeptides. Consequent mutations of only W residues alone had a similar effect
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and mutating W residues in both elements (mutant W1648W1659) resulted in a
stronger reduction in repression. Similar effects could be observed for mutants of
the M2-RRM fragment (Figure 2.4 B). Mutant STW1485 significantly released
repression, and single point mutations of tryptophans (W1487 and W1494) had a
similar effect. Combining both mutations (mutant W1487W1494) resulted in an
even stronger release of repression. As a control, mutations of N1467 or K1482, or
the combination of both, had no effect on repression. We observed that mutating
tryptophans also strongly affected the activity of specific fragments to pull down
CNOT1 and CAF1 (data of Hansruedi Mathys, shown in supplementary data of
Chekulaeva et al. [2011], see appendix B).
We conclude that the Ws in M2 and Cterm are important for both mRNA
repression and interaction with the CCR4–NOT complex. M2 and Cterm both
contain sequence elements which, when mutated, affect repression and interaction,
pointing towards a considerable redundancy. Furthermore, our data suggests a
critical role for W residues in repression in a manner that involves recruitment of
the CCR4–NOT complex.
2.5 The CED interacts with CNOT1 in yeast
two-hybrid system
Mass spectrometry and pull-down experiments showed that the CED region interacts
with several components of the CCR4–NOT complex. It could be expected that
only one of the components interacts directly while the others are pulled-down
indirectly. Since CNOT1 was the most effectively pulled down CCR4–NOT complex
component, we assumed it to interact directly with the CED.
To investigate this hypothesis, we made use of the yeast two-hybrid system.
In this system, the two proteins of interest are fused to the DNA-binding domain
and the activation domain of a transcription factor, respectively. Only if the two
proteins interact with each other, the close proximity of DNA-binding and activation
domains allows a transcription of the reporter gene expressing β-Galactosidase
(β-Gal). In this study, we used the yeast strain W303-1B with the reporter plasmid
pSH18-34 (see section 4.4). Different components of the CNOT–CCR4 complex
were fused to the LexA DNA binding domain and the CED was fused to the B42
activation domain. The CCR4–NOT complex is strongly conserved between many
species, including yeast, fly, and mammals. Therefore, an interaction between D.
melanogaster CED and human CNOT1 was also expected to occur. We could show
previously in cross-species experiments that human full length TNRC6C and CED
have an effect in D. melanogaster, and vice versa (compare Figure 8 of section 2.1
[Zipprich et al., 2009] and Chekulaeva et al. [2009]).
51
The CED interacts with CNOT1 in yeast two-hybrid system Results
500
450
400
350
300
250
200
150
100
50
0
β-
G
al
 a
ct
iv
ity
 (n
m
ol
 m
in
  m
g 
)
C
N
O
T1
C
N
O
T1
C
N
O
T6
C
N
O
T7
C
N
O
T1
C
N
O
T6
C
N
O
T7
-1
-1
C
N
O
T6
C
ED
C
ED
C
ED
em
pt
y
em
pt
y
em
pt
y
B42
LexA
500
0
1000
1500
2000
2500
3000
C
N
O
T1
C
N
O
T1
C
N
O
T1
C
N
O
T1
C
N
O
T2
C
N
O
T6
dC
ED
 W
T
dC
ED
 7
W
A B
Figure 2.5: The CED interacts with CNOT1 in yeast two-hybrid
system. (A) Indicated LexA- and B42-fusion expression plasmids (or
empty pJG4-5 vector) were transformed into yeast strain W303-1B together
with a LacZ reporter gene containing eight LexA operator sites. Empty
pJG4-5 vector and the CNOT1-CNOT6 combination served as as control
for lack of self-activation and as negative control. The graph shows a
representative experiment (of four experiments performed), values represent
mean ± SEM of β-Gal activity. (B) Same experimental setup as in (A),
CNOT1-CNOT2 and CNOT1-CNOT6 served as positive and negative
control, respectively. D. melanogaster CED (dCED) either wild type (WT)
or mutant with seven tryptophans mutated to alanines (7W) was tested for
interaction with CNOT1.
We observed a strong β-Gal activity for the CNOT1-CED pair while the negative
control (CNOT1-CNOT6) and the empty vector control (CNOT1-empty) did not
show any signal (panel A in Figure 2.5). This result strongly suggests a direct
interaction between CED and CNOT1. While an indirect interaction via endogenous
yeast components cannot be excluded, it is highly unlikely. No β-Gal activity could
be observed for CED-CNOT6 and CED-CNOT7. These negative results prove
that at least for those two components of the complex, there is neither a direct
nor an indirect interaction in the tested yeast two-hybrid system. The interaction
between CNOT1 and CED was also established for the D. melanogaster CED. This
is consistent with the known conservation of the complex between species. More
importantly, this interaction is completely abolished if all tryptophans in the CED
are mutated to alanines (Figure 2.5, B). This result reinforces the suggested direct
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interaction between CNOT1 and CED and the crucial role of tryptophan motifs.
2.6 Poly(A) Tail is not Required for Repression
by the CED
The identification of the CCR4–NOT deadenylase complex as a downstream factor
active in miRNA mediated repression could explain how miRNAs induce deadenyla-
tion and mRNA decay. However, the question remains if the CED can also induce
repression at the level of translation, in a PABP and poly(A) independent way. To
investigate this, we tested whether the TNRC6C CED or CED∆PAM2 can repress
mRNA expression if tethered to a reporter without a poly(A) tail. Repression of a
poly(A)– mRNA would indicate that the observed effect is not due to the removal
of the poly(A) tail and the subsequent inhibition of circularization.
To generate a poly(A) free reporter, we initially replaced the cleavage and
polyadenylation signal in the RL-5BoxB reporter with sequences comprising a
histone stem-loop and the histone downstream element (together referred to as
HSL). This feature is responsible for formation of the 3’ end of histone mRNAs,
which do not undergo polyadenylation. Since in transfected HEK293 cells only
about 50% of the transcript was cleaved at the HSL element (data not shown), we
additionally introduced a hammerhead ribozyme (HhR) in a region downstream of
HSL. The resulting reporter (RL-5BoxB-HSL+HhR, Figure 2.6) has been confirmed
to be completely poly(A) free (experiments performed by Hansruedi Mathys, data
shown in supplementary information of Chekulaeva et al. [2011], see appendix B).
Repression of poly(A)+ mRNA by tethered CED or CED∆PAM2 is approx-
imately ten times when compared to the CED lacking the N-peptide (Figure
2.6, see also Figure 2.1 and Figure 4 of the paper in section 2.1). Surprisingly,
tethering of CED or CED∆PAM2 also repressed expression of a poly(A) free re-
porter (RL-5BoxB-HSL+HhR) about five times (Figure 2.6, panel B). To estimate
the contribution of degradation to the repression, we monitored our reporters
by Northern blotting. Northern analysis revealed that whereas tethering of the
TNRC6C fragments CED or CED∆PAM2 induced marked degradation of the
poly(A)+ RNA, the level of RNA transcribed from RL-5BoxB-HSL+HhR plasmid
remained unaffected (Figure 2.6, panel C and D). These results suggest that the
CED represses function of both poly(A)+ and poly(A)– mRNAs.
In addition to the expected band at the size of RL-5BoxB-HSL+HhR RNA,
Northern analysis also revealed larger RNA fragments cross-reacting with the RL
probe. These bands were more prominent for samples isolated from cells transfected
with the RL-5BoxB-HSL+HhR plasmid, raising the possibility that RL activity
measured in cells expressing the RL-5BoxB-HSL+HhR reporter might originate, at
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least partially, from transcripts other than those processed at HSL and HhR sites.
To get additional evidence that the CED can repress translation independent of
poly(A) tail, Hansruedi Mathys transfected HEK293T cells with in vitro transcribed
poly(A) free RL-5BoxB RNA. Importantly, tethering of either CED or CED∆PAM2
repressed RL activity in cells transfected with non-polyadenylated RL-5BoxB RNA
(data not shown). This additional evidence clearly supports the conclusion that
the CED and CED∆PAM2 region of TNRC6C can repress RNA independently of
a poly(A) tail, hence very likely at the level of translation.
We previously showed that the CED recruits the CCR4–NOT complex to repress
protein synthesis. To address the question if the inhibitory effect on poly(A)–
mRNAs also depends on CCR4–NOT, Hansruedi Mathys in our laboratory tested
the D. melanogaster GW182 CED fragment in S2 cells depleted of NOT1. He
indeed could show that repression of poly(A)– mRNAs depends on the CCR4–NOT
complex (see Figure 6 of appendix B, [Chekulaeva et al., 2011])), consistent with
the demonstrated role of CAF1, a CCR4–NOT complex component, in inducing
inhibition of translation in microinjected Xenopus oocytes [Cooke et al., 2010].
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Figure 2.6: Tethering of the CED represses function of both
poly(A)+ and poly(A)– mRNAs. (A) Schematic representation of
the RL-5BoxB-HSL+HhR reporter construct used for the experiments.
(B) Effect of tethering the CED or CED∆PAM2 on activity of reporters
with and without poly(A) tail. HEK293T cells were cotransfected with
plasmids expressing NHA-CED or NHA-CED∆PAM2, and plasmids en-
coding either RL-5BoxB or RL-5BoxB-HSL+HhR, and also with FL-Con.
HA-CED served as a negative control. Normalized RL activity is indicated
as the percentage of activity in cells expressing HA-CED set as 100%. (C)
Analysis of RL-5BoxB and RL-5BoxB-HSL+HhR RNA levels by Northern
blotting in an experiment performed as described in panel (B). Total RNA
isolated from cells transfected with indicated plasmids was analyzed using
RL- or FL-specific probes. Cells transfected only with RL and FL reporters
served as control. Positions of RL and FL mRNAs are indicated. (D)
Quantification of Northern blots was performed using a PhosphorImager
and the Image-Quant software. Normalized values represent means ± SE
(n = 3).
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3Discussion
In the first part of this work (section 2.1), we characterized the human GW182
protein TNRC6C. In human, the C-terminal domain (CED) showed the most
prominent effect in repression (about ten times inhibition), while the N-terminal
GW-rich domain and the Q-rich domain only showed a repression of approximately
50%. This situation differs from D. melanogaster as shown in Chekulaeva et al.
[2009, in the same issue of RNA]. In this report, Chekulaeva et al. from our
laboratory concluded that in D. melanogaster, multiple independent domains (the
N-terminal effector domain (NED), the Q-rich region and the CED) function in
miRNA-mediated repression. We also performed site directed mutagenesis on the
RRM in the CED (Figure 5 of Zipprich et al. [2009], see section 2.1). Two single
point mutations showed a significant release of repression, H1537A and Y1556A
(see Figure 2.2). A later report from Izaurralde’s group presented a 3D structure of
the D. melanogaster GW182 RRM and revleaed that both amino acids reside in the
core of the RRM [Eulalio et al., 2009]. The implications of this finding are discussed
below. Furthermore, we could show that the repression mediated by the CED is
due to a combination of effects on the mRNA level and mRNA translation. While
Northern blots revealed only a ∼50% reduction of mRNA levels, repression of RL
activity was about 20 times. In cross-species experiments, we tested the potential
of the full-length Drosophila GW182 and its active subfragments to inhibit the
activity of the RL-5BoxB reporter in HEK293 cells. Interestingly, only the full-
length dGW182 and the N-terminal GW rich domain showed an effective repression
while the Q-rich domain and the C-terminal fragment repressed RL activity in
HEK293 cells only approximately two times (Figure 8 of Zipprich et al. [2009],
section 2.1). Activity of different domains of human TNRC6C was also tested in
Drosophila S2 cells [Chekulaeva et al., 2009]. Full-length TNRC6C inhibited activity
of the tethering reporter approximately six times. The most significant effect could
be observed for the C-terminal domain (CED), which showed a repression of 20
times. The N-terminal GW-rich region and the Q-rich region repressed protein
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synthesis ∼1.5 times and eight times, respectively. We concluded that although
the full-length GW182 proteins showed a strong repression in either organism, the
contribution of individual domains to this effect differed between human and D.
melanogaster proteins and cells. These results – the implication of the C-terminal
domain and the general role of TNRC6 proteins in miRNA-mediated repression –
have already been discussed in the discussion section of section 2.1.
In the second part of this study, we further characterized the C-terminal domain,
CED. The two regions flanking the RRM, M2 and Cterm, were found to mediate
the repressive effect. The PAM2 motif and the RRM did not contribute to the
repression. Both M2 and Cterm regions are predicted to be unstructured and
show significantly less conservation than the RRM or the PAM2 motif (see Figure
2.2 on page 47). We could further identify two direct interaction partners of the
CED, PABP and CNOT1. Both proteins interact with the CED, however with
its different sub-fragments. We also investigated the relevance of a poly(A)-tail of
the repressed reporter and therefore the importance of deadenylation in repression
mediated by miRNAs.
Below we first discuss the contribution of individual regions to the repression
and their role in interacting with other proteins, including the role of GW repeats.
This part is followed by a short discussion of the importance of deadenylation
for repression. Finally, we comment on the role of the CCR4–NOT complex in
miRNA-mediated gene silencing.
The PAM2 Motif Interacts with PABP
The relatively conserved PAM2 motif of TNRC6C has been shown to be important
for the interaction with PABP [Fabian et al., 2009; Jinek et al., 2010; Tritschler
et al., 2010]. It shares sequence similarity with the PAM2 motif of PAIP1 and
PAIP2, two proteins known for their interaction with PABP. The PAM2 motif
is recognized by the MLLE motif in the C-terminal domain of PABP (PABC).
Surprisingly, in D. melanogaster, the PAM2 motif seems to be dispensable for PABP
binding in cell lysates [Zekri et al., 2009]. This report instead identified the M2
and Cterm sequences as PABP interacting regions and showed that all four RRMs
from PABP are necessary for the interaction. Zekri et al. also argue that dGW182
competes with eIF4G for binding to PABP and interferes with the formation of an
mRNA closed loop, which leads to less efficient translation. A more recent study
from the same laboratory, however, identified two PABP-interacting regions, the
PAM2 motif and the M2 and Cterm regions in dGW182 [Huntzinger et al., 2010].
In contrast to human GW182 proteins, where PAM2 motif is essential for binding
to PABP, in dGW182, both regions seem to contribute to the PABP binding. This
leads to the conclusion that while both human and fly GW182 proteins bind to
PABP, the relative strength of the PABP-binding sites seem to be species-specific.
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The role of the GW182 binding to PABP is not yet entirely clear. Fukaya
and Tomari [2011] proposed that the GW182-PABP interaction is not essential for
miRNA-mediated repression in vitro. They added GST-PAIP2 to the lysates to
block PABP function and saw no effect on translational silencing or deadenylation.
This is consistent with our observations that CED∆PAM2 is still active in repression.
On the other hand, Fabian et al. [2011] reported that the PAN2/PAN3 deadenylase
associates with the human GW182 PAM2 motif, possibly through the interaction
with PABP. It is known that PABP interacts with the PAN2/PAN3 deadenylase
via the PAN3 subunit [Siddiqui et al., 2007]. Taken together, these results suggest
that the GW182 protein may interact with PABP to recruit the PAN2–PAN3
deadenylase complex. This however does not contradict the PABP-independent
repression we observed for the CED∆PAM2 fragment, since the PAN2–PAN3
complex has been shown not to be essential for miRNA-mediated deadenylation
[Behm-Ansmant et al., 2006].
These results are in agreement with reports from the Shyu laboratory, which
suggest a biphasic deadenylation. Yamashita et al. propose that the first deadeny-
lation step is mediated by the PAN2–PAN3 complex and shortens the poly(A) tail
to ∼110 nt. The second phase involves nearly complete deadenylation of mRNA
with the CCR4–NOT complex being the responsible catalytic enzyme. While this
puts the PAN2–PAN3 complex at the starting point of deadenylation, they also
suggest that „endogenous CCR4 may take over cytoplasmic deadenylation when
endogenous PAN2 activity is impeded“ [Yamashita et al., 2005]. In a more recent
report, Chen et al. show that repression by tethered human Ago proteins and
TNRC6C recapitulates the two deadenylation steps [Chen et al., 2009].
The RRM Does Not Directly Contribute to Repression
The function of the highly conserved and structured RRM present in GW182
proteins remains unclear. In tethering assays, deleting the RRM has no effect on
repression. All binding sites of proteins known to interact with TNRC6C have
been mapped to regions other than RRM, mainly the N-terminal GW-rich region
(AGO), the two RRM flanking regions (CNOT1) and the PAM2 motif (PABP).
Furthermore, the RRM does not bind RNA (Eulalio et al. [2009] and H. Mathys,
unpublished results). This could be explained by the presence of the additional
C-terminal α-helix, which folds on top of the β-sheet surface generally used by
RRMs to bind RNA [Eulalio et al., 2009]. The NMR structure was solved for the
dGW182 RRM, but due to the high degree of conservation, it can be assumed that
the RRM domain adopts a similar fold in vertebrates. While Eulalio et al. could
show that the RRM is dispensable for P-body localization, they also concluded
that the domain contributes to silencing since its deletion impairs the silencing
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activity of GW182 in a miRNA target-specific manner. We could not confirm this
result for experiments in which repression is mediated by tethering.
One has to keep in mind that RRM is flanked by unstructured regions, which
are responsible for mediating the downstream effect via GW repeats. It is possible
that the RRM serves as a scaffold to organize the tryptophans and so contributes
to the interaction. The hydrophobic cleft of the RRM [Eulalio et al., 2009] has been
suggested to interact with other proteins. Protein-protein interactions mediated by
RRMs are not uncommon [Clery et al., 2008]. Supporting evidence for a function of
the RRM in repression comes from the single point mutations described in Zipprich
et al. [2009] (see Figure 5 of section 2.1 and compare Figure 2.2 on page 47). Even
though the mutated amino acids are probably in the core of the RRM and are not
actively involved in any interaction, one can hypothesize that mutagenesis of these
residues might disturb the tertiary structure of the RRM which could in turn have
an effect on the organization of the two flanking regions. However, the observation
that full repression by tethering occurred even if the RRM was not present as
shown for the M2-RRM fusion construct speaks against this model. It is interesting
to note that the point mutations in the RRM only had an effect on translational
repression and not on deadenylation; interpretation of this observation is difficult
at present.
Importance of M2 and Cterm Regions
A. GW Repeats in M2 and Cterm Mediate Repression
In this study, we showed that the two unstructured and not particularly conserved
regions flanking the RRM, M2 and Cterm, are responsible for mediating the
repressive effect. The deletion of either one of the flanking regions (constructs
M2-RRM or RRM-Cterm) led to a significant reduction in repression. This result
was rather surprising since we expected the structured and far more conserved RRM
domain to mediate the effect. It was commonly believed that a functionality of a
given protein is determined by its specific three-dimensional structure. However,
the validity of this ‘lock and key’ model has been challenged by the discovery of
a significant number of unstructured proteins [see Uversky and Dunker, 2010, for
a comprehensive review]. A model which is now more fitting to our case is the
idea of the ‘induced fit’ mechanism. In such a scenario, an unstructured region
can either fold or fit into a given pocket, establishing an interaction between two
proteins. A prominent example is the C-terminal domain of the large subunit of
RNA polymerase II [Noble et al., 2005]. It consists of up to 52 repetitive sequences
and despite being disordered in solution, this region servers as a platform for many
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transcription and RNA processing factors. If we apply this idea to our case, the
two unstructured domains could indeed operate as a binding platform for their
protein partners.
We tried to examine how two unstructured and non-conserved protein regions
are able to mediate repression. Point mutations of partially conserved sequences
revealed the importance of tryptophans in the context of GW/WG repeats. In
human TNRC6C, M2 and Cterm contain five and four tryptophans, respectively.
Subsequent single point mutations of tryptophans present in the GW/WG context
in M2-RRM or RRM-Cterm had a significant effect on repression. Combinations
of single Trp→Ala mutations showed an additive effect even in the context of the
full CED [Chekulaeva et al., 2011], see Figure 2 of Appendix B. Since the regions
are predicted to be unstructures, the Trp→Ala substitutions most likely do not
affect the folding of the CED. The M2-M2 and the Cterm-Cterm fusion constructs
had similar repressive activity when compared to a M2-Cterm fusion. This as well
hints at an additive and redundant effect of GW repeats.
B. The CED Interacts with the CCR4–NOT Complex via GW repeats
The fact that the GW182 proteins mediate deadenylation via the CCR4–NOT
complex has been proposed earlier [Behm-Ansmant et al., 2006; Zekri et al., 2009;
Piao et al., 2010]. We could show in this work that TNRC6C interacts directly
with CNOT1 and thereby recruits the deadenylation machinery. In contrast to the
interaction with PABP, this binding to the CCR4–NOT complex is not mediated by
PAM2 but rather by the two regions flanking the RRM, M2 and Cterm. Deletion
of PAM2 or its mutation that disrupts the interaction between CED and PABP
did not affect the CED association with CCR4–NOT. This supports the idea that
the repression is mediated by the two regions flanking the RRM. Importantly, we
could show that single Trp→Ala mutations significantly decreased the interaction
of M2-RRM or RRM-Cterm with the CCR4–NOT complex (Hansruedi Mathys,
data shown in supplementary data of Chekulaeva et al. [2011], see appendix B).
Since it is unlikely that mutations have an effect on folding, the mutated amino
acids probably actively take part in the interaction.
The question remains if each GWmotif interacts with different CNOT1 molecules
or if several motifs bind to one CNOT1 protein? The spliceosome component
SF3b155 interacts with the U2 snRNP factor U2AF65. SF3b155 contains seven
RWD/E repeats with sequence similarity to the previously characterized U2AF65-
binding domain of SF1 [Thickman et al., 2006]. The repeats are located in a region
that lacks any detectable secondary structure and five of the seven tryptophan-
containing sites have the potential to bind to the U2AF65 homology motif. Thick-
man et al. proposed that the multiple U2AF65 binding sites of SF3b155 provide a
regulatory mechanism. It is tempting to speculate that such a scenario also applies
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to the GW repeats of GW182 proteins.
Poly(A)– RNA is Repressed by the CED
An important observation of this work is that the CED is able to repress reporters
without a poly(A) tail. The poly(A)– RNA is insusceptible to deadenylation.
We could show by Northern blotting that repressed poly(A)– reporters do not
undergo degradation. Although it is now widely accepted that mRNA decay
plays an important role in miRNA-mediated repression [Huntzinger and Izaurralde,
2010], our results clearly suggest that the CED also works via a mechanism which
represses RNA translation in a deadenylation independent manner. We identified
two downstream factors of the CED, PABP and CNOT1. This findings open
several possibilities for a translational repression. First, the interaction with PABP
could disturb the eIF4G-PABP interaction, loosening the closed loop of translated
RNAs. The model that miRNAs interfere with the closed loop of mRNAs has been
proposed previoulsy [Beilharz et al., 2010; Zekri et al., 2009]. The disturbance
of the closed loop would lead to a less efficient recycling of ribosome subunits
and to less efficient initiation, and consequently to a decrease in translation. The
second possibility is that the effect on translation is mediated by the interacting
protein complex, the CCR4–NOT complex. This implication is discussed in the
next paragraph.
Function of the CCR4–NOT Complex in Translational Repression
The recruitment of the CCR4–NOT deadenylation machinery by the RISC plausi-
bly explains the induced deadenylation but could it also explain the repression of
poly(A)– reporters? Cooke et al. showed that tethering of CAF1 to the microin-
jected reporter mRNA can repress translation at the initiation step in Xenopus
oocytes. Consistent with this finding, Hansruedi Mathys has found that tethering
of the components of the CCR4–NOT complex even in cells in which endogenous
GW182 has been knocked down repressed activity of poly(A)– reporters (data
shown in Figure 6 of appendix B, [Chekulaeva et al., 2011]). This indicated that
repression by tethering of CCR4–NOT proteins is dGW182-independent and that
CCR4–NOT proteins are involved directly in translational repression induced by
miRNAs. We can only speculate about which component of the CCR4–NOT com-
plex is responsible for the translational effect and what exactly is its mechanism.
TNRC6C interacts directly with CNOT1 but it is unlikely that CNOT1 mediates
the effect. A more likely candidate is CAF1, which represses mRNA function when
tethered to it in Drosophila S2 cells (Figure 6 of appendix B, [Chekulaeva et al.,
2011]) and in Xenopus oocytes [Cooke et al., 2010]. However, the exact molecular
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details of how CAF1 might interfere with translation, and which step is being
regulated, remains to be elucidated.
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Figure 3.1: Scheme of Possible GW182 Mediated Repression.
GW182 proteins are recruited to mRNA through direct interaction with
the miRNA-AGO complex. The PAM2 motif of GW182 interacts with
PABP. The GW182 protein also recruits, through the GW-motifs, the
CCR4–NOT complex that catalyzes mRNA deadenylation. The CCR4–
NOT complex most likely also represses translation, in all likelihood at the
level of initiation (dotted red line).
Concluding Remarks
In this work, we provide additional information about the role of GW182 proteins
in miRNA-mediated gene silencing. Five main conclusions can be drawn from this
study:
1. The C-terminal GW182 region, CED, is the main effector region mediating
the repression.
2. The two unstructured regions flanking the RRM mediate translational re-
pression. None of the known protein interactions maps to the RRM, but the
RRM might play a role in organizing its unstructured flanking regions.
3. The PAM2 motif of the TNRC6 CED interacts with PABP. This interaction
is not crucial for miRNA-mediated repression in the tethering assay. However,
it may help to stabilize the interaction with the CCR4–NOT complex and, in
addition, probably recruits the PAN2–PAN3 deadenylase complex. Further-
more, it may interfere with the PABP–eIF4G association, thus contributing
to both translational inhibition and mRNA deadenylation.
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4. The CCR4–NOT complex is recruited to the RISC via GW-motifs in the
GW182 CED that interacts directly with CNOT1. GW-repeats work in an
additive way and tryptophan residues are crucial for the interaction with the
CCR4–NOT complex and for mediating the repression.
5. Components of the CCR4–NOT complex can also repress activity of poly(A)–
RNA. The exact mode of their action is not yet known. However, it is likely
that the CCR4–NOT complex interferes with translation initiation.
Taken together, our data support and define the important role of GW182 proteins.
The current model (Figure 3.1) explains how RNA degradation is induced by miR-
NAs. The fact that the CCR4–NOT complex also induces translational repression
might help to understand at which step of translation mRNA expression is being
regulated. It is interesting to note that in S. cerevisiae and in D. melanogaster, the
CCR4–NOT complex is known to interact with the translational repressor Dhh1
[Coller et al., 2001]. Dhh1 has a clear role in decapping and in translation inhibi-
tion [Coller and Parker, 2005]. Moreover, evidence exists that its orthologues in
other organisms are required for miRNA-mediated repression [Chu and Rana, 2006;
Eulalio et al., 2007c], suggesting a possible mechanism by which the CCR4–NOT
complex could repress translation. More studies will be needed to clarify the role
of the CCR4–NOT complex in deadenylation-independent gene silencing.
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4.1 Cell Culture, Transfections and Luciferase
Assays
HEK293T cells were grown as described in the Methods section of Zipprich et al.
[2009], see 2.1 on page 31. Transfections were done in 6-well plates as described
and in 24-well plates using proportionally adjusted amounts of plasmid. Luciferase
activities were measured with the Dual-Luciferase Reporter Assay System (Promega)
as described. In all luciferase assays, values represent means ± S.E.M..
4.2 DNA constructs and protein mutants
Reporter plasmids RL-5BoxB and FL-Con [Pillai et al., 2004], plasmids encoding
TNRC6A, TNRC6C and its deletion fragments [Zipprich et al., 2009](see section 2.1)
as well as the the pEBG-∆1370 plasmid encoding TNRC6C GST-CED [Fabian et al.,
2009] have been described previously. To obtain the RL-5BoxB-HSL+HhR reporter,
the HhR motif was PCR amplified from the FL-5BoxB-HhR reporter described
in Eulalio et al. [2008b]. The HSL sequence was a kind gift from W.F. Marzluff.
Both fragments were cloned into the standard RL-5BoxB reporter [Zipprich et al.,
2009]. The TNRC6A clone lacks the first 312 amino acids [Eystathioy et al.,
2002]. Point mutations in TNRC6C and its fragments were introduced by site-
directed mutagenesis according to Zheng et al. [2004]. The 7W mutant of dGW182
used for the yeast two-hybrid system is described in Chekulaeva et al. [2011], see
appendix B. Sub-fragments of TNRC6C were generated by PCR-amplification of
the corresponding regions and cloning them into pCI-neo vector (Promega) bearing
an HA- or NHA-tag [Pillai et al., 2004]. To construct the plasmid expressing the
M2-Cterm fusion, the M2 and Cterm encoding regions were separately amplified
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by PCR and consecutively cloned into pCI-NHA vector. Two different variants of
the M2-Cterm fusion were cloned, with either AADGG or AAAGGGG as linker
between both regions.
4.3 Pull-down assays and Western Blotting
For GST pull-down assays, HEK293T cells grown in a 10 cm dish were transfected
with 5 µg plasmid expressing GST-TNRC6C CED. Cells were lysed 24 h after
transfection and GST-fusions were pulled down as described [Fabian et al., 2009].
Cells were lysed in buffer A (50mM Tris-HCl, pH 7.5, 150mM KCl, 0.5% (v/v)
Triton X-100, 1x complete EDTA-free protease inhibitor mix (Roche)), and cleared
lysates were treated with micrococcal nuclease (10 ng/µL) for 25min at 20 °C. The
lysates were incubated with glutathione (GSH)-Sepharose beads (GE Healthcare)
for 2 h at 4 °C; beads were washed 3x with buffer A containing 0.1% (v/v) Triton
X-100, and GST-fusions were eluted with 50mM GSH.
For western blotting analysis, input and pulled-down or immunoprecipitated
material were separated by SDS-PAGE using 10% linear polyacrylamid gels or
NuPAGE Novex 4-12% Bis-Tris Gels (Invitrogen). For estimating the expression
level of HA-fusion proteins in tethering assays, aliquots of cell lysates in Passive
Lysis Buffer (PLB, Promega) were analyzed by SDS-PAGE as described above.
Proteins were detected using ECL (GE Healthcare) or SuperSignal West Femto
Chemiluminescent Substrate (Thermo Scientific). The following primary antibodies
were used: anti-CNOT1, 1:250 dilution (provided by M. Collart); anti-CAF1
(Abnova), 1:1,000; anti-PABP (Cell Signaling Technology), 1:5,000; anti-GST (GE
Healthcare), 1:10,000; anti-α-tubulin (Sigma T5168), 1:10,000; anti-HA tag (Roche
3F10, 1:5,000 or Santa Cruz sc-7392, 1:2,000); and anti-LexA (Santa Cruz sc-7544),
1:2,000.
For MS analysis, cells in one 10 cm cell culture dish were transfected with 6 µg
plasmid expressing GST-TNRC6C CED. The lysate was cleared and incubated with
glutathione (GSH)-Sepharose beads as described above. After separating the bands
by SDS-PAGE, the Coomassie-stained bands were digested with trypsin. Tryptic
peptides were analyzed by nano-HPLC (Agilent 1100 nanoLC system, Agilent
Technologies, Santa Clara, CA) coupled to a 4000 Q TRAP mass spectrometer
(Applied Biosystems, Foster City, CA). Peptides were identified searching UniProt
database (version 13.8) restricted to H. sapiens using Mascot (version 2.1, Matrix
Science, London).
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4.4 Yeast two-hybrid assays
For all experiments, the strain W303-1B [MATα leu2-3,112 trp1-1 can1-100 ura3-1
ade2-1 his3-11,15 ] was used. LexA-CNOT1L (amino acids 648-2376), CNOT6
and CNOT7 constructs (in pEG202 backbone) were a kind gift from H.T.M.
Timmers (University of Utrecht) as was B42-CNOT2 (all described in Lau et al.
[2009]). B42-CED was cloned by amplifying the CED ORF by PCR with oligonu-
cleotides ATGATGCCCGGGCTCGTGCCAAATCTGACAGTGAT and GTCT-
GCTCGAAGCATTAACCC used as forward and reverse primers, respectively. The
PCR product was cloned into the pJG4-5 vector, also provided by H.T.M. Timmers.
Drosophila CED wild type and mutant were kindly provided by M. Chekulaeva
and are described in Chekulaeva et al. [2011], see appendix B. Both plasmids were
cloned as a B42-fusion into the pJG4-5 vector. The reporter plasmid pSH18-34 was
used to measure β-Gal activity [Sato et al., 1994]. Transformations with different
plasmids were carried out according to the protocol described in Amberg [2005].
For measurements of β-Gal activity, 100 µL synthetic complete (SC) medium [-Trp
-His -URA, containing 2% (w/v) lactate, 3% (v/v) glycerol and 2% (w/v) glucose]
was inoculated with a single colony and grown for 6-7 h. The preculture was diluted
1:100 in 5mL SC without glucose and grown overnight. Galactose was added to a
final concentration of 2% (w/v) and the culture was grown for 5 more hours. Cells
were pelleted and stored at -80 °C. The β-Gal-activity was analyzed according to
the protocol described in Amberg [2005].
4.5 Northern Blotting
10-20 µg of total RNA isolated from HEK293T cells using Trizol Reagent (Invitrogen)
was resolved in a denaturing 1% (w/v) agarose gel and transferred to Hybond-
N+ membrane (GE Healthcare Life Sciences) using 10x SSC. RL- or FL-specific
probes internally labelled with [α-32P]UTP using Random-primed DNA labeling Kit
(Roche) were hybridized to the RNA on the membrane in ULTRAhyb Ultrasensitive
Hybridization Buffer (Ambion) at 68 °C. After washing the membrane with 0.2x SSC
containing 0.1% (v/v) SDS at 68 °C, the signal was detected using a PhosphorImager
screen and a GE TyphoonTM 9400 scanner.
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SUMMARY
MicroRNAs (miRNAs) inhibit mRNA expression in
general by base pairing to the 30UTR of target mRNAs
and consequently inhibiting translation and/or initi-
ating poly(A) tail deadenylation and mRNA destabili-
zation. Here we examine the mechanism and kinetics
of miRNA-mediated deadenylation in mouse Krebs-2
ascites extract. We demonstrate that miRNA-medi-
ated mRNA deadenylation occurs subsequent to
initial translational inhibition, indicating a two-step
mechanism of miRNA action, which serves to consol-
idate repression. We show that a let-7 miRNA-loaded
RNA-induced silencing complex (miRISC) interacts
with the poly(A)-binding protein (PABP) and the CAF1
and CCR4 deadenylases. In addition, we demon-
strate that miRNA-mediated deadenylation is depen-
dent upon CAF1 activity and PABP, which serves
as a bona fide miRNA coactivator. Importantly, we
present evidence that GW182, a core component
of the miRISC, directly interacts with PABP via its
C-terminal region and that this interaction is required
for miRNA-mediated deadenylation.
INTRODUCTION
MicroRNAs (miRNAs) are short single-stranded RNAs (21 nt in
length) encoded within the genome of species ranging from
protozoans to plants to mammals (Bartel, 2004; Molnar et al.,
2007). miRNAs play key roles in a broad range of biological
processes including hematopoiesis, insulin secretion, apoptosis,
and organogenesis (Bartel, 2004). When assembled together
with Argonaute (Ago) proteins into the miRNA-induced silencing
complex (miRISC), miRNAs base pair with and repress mRNA
expression through mechanisms that are not fully understood
(Eulalio et al., 2008a; Filipowicz et al., 2008).
miRNAs were reported to employ different mechanisms to
inhibit expression of targeted mRNAs (Eulalio et al., 2008a; Fili-
powicz et al., 2008). Some data indicate that miRNAs interfere
with mRNA translation at the initiation step (Chendrimada
et al., 2007; Ding and Grosshans, 2009; Humphreys et al.,
2005; Mathonnet et al., 2007; Pillai et al., 2005; Thermann and
Hentze, 2007; Wang et al., 2008), whereas other studies
concluded that the miRNA machinery represses translation at
postinitiation steps (Gu et al., 2009; Lytle et al., 2007; Maroney
et al., 2006; Nottrott et al., 2006; Olsen and Ambros, 1999;
Petersen et al., 2006). miRNAs have been observed, although
not in every study, to mediate deadenylation and/or decay of tar-
geted mRNAs (Behm-Ansmant et al., 2006; Giraldez et al., 2006;
Wakiyama et al., 2007; Wu et al., 2006).
In addition to Ago proteins, GW182 proteins also play key roles
in miRNA-mediated repression. One GW182 protein (Gawky)
exists in Drosophila, and three GW182 paralogs (TNRC6A,
TNRC6B, and TNRC6C) are present in mammals. Direct interac-
tion of GW182 with Ago proteins is critical for miRNA-mediated
translation repression and mRNA decay (Eulalio et al., 2008b).
Studies conductedwith either TNRC6C or Gawky artificially teth-
ered to a reporter mRNA demonstrated that a region within their
C termini is required for repression of translation (Chekulaeva
et al., 2009; Eulalio et al., 2009b; Zipprich et al., 2009).
Cell culture-based assays invariably measure miRNA effects
hours or days after the initial mRNA target site recognition,
making it difficult to ascertain the temporal order and contribu-
tion of the different proposed mechanisms to mRNA repression.
Moreover, RNAi-based approaches for identifying miRNA-
associated factors may perturb cellular transcriptional programs
in such a way that it becomes difficult to determine direct
contributions. Thus, developing an in vitro system that faithfully
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recapitulates all aspects of miRNA-mediated repression is
necessary to elucidate the biochemistry of miRNA mechanisms
of action, especially at early time points. Such systems have
recently been reported (Mathonnet et al., 2007; Thermann and
Hentze, 2007; Wakiyama et al., 2007; Wang et al., 2006).
To explore the mechanisms that miRNAs utilize to repress
mRNA expression in mammals, we utilized an in vitro translation
extract frommouse Krebs-2 ascites cells (referred to throughout
as Krebs extract). We showed before that the earliest detectable
effect of miRNA action is the inhibition of cap-dependent
translation initiation (Mathonnet et al., 2007). We demonstrate
here that miRNA-mediated deadenylation follows the initial inhi-
bition of cap-dependent translation. We further show that
Ago2 interacts with the CNOT7/CAF1 (hereafter referred to as
CAF1) deadenylase and poly(A)-binding protein (PABP) in an
RNA-independent manner, and that both proteins are required
to facilitate miRNA-mediated deadenylation. Importantly, we
show that PABP physically interacts with the miRISC by
directly binding the C terminus of GW182 and is required for
deadenylation.
RESULTS
miRNA-Mediated Deadenylation Follows Initial
Translation Inhibition
We previously described an in vitro translation extract derived
from Krebs-2 ascites cells that contains high levels (150 pM)
of the let-7a (referred throughout as let-7) miRNA and displays
a faithful let-7 miRNA response (Mathonnet et al., 2007). The
Krebs extract manifests reduced translation initiation of
in vitro-transcribed let-7-targeted mRNAs starting within the first
15 min of incubation without detectable mRNA degradation
(Mathonnet et al., 2007). Since miRNAs were also reported to
induce mRNA deadenylation (Eulalio et al., 2009a; Giraldez
et al., 2006; Wakiyama et al., 2007; Wu et al., 2006), and since
deadenylation generally results in translational repression (Wor-
mington, 1993), we wished to determine whether miRNA-medi-
ated deadenylation can be recapitulated in a Krebs extract and
study the temporal relationship between translation inhibition
and deadenylation. A polyadenylated RL-6xBmRNA (Figure 1A),
labeled uniformly with 32P-UTP, was incubated in a Krebs
extract, and its integrity was analyzed by denaturing polyacryl-
amide-gel electrophoresis (PAGE) followed by autoradiography.
A new RNA band migrating faster than the full-length mRNA was
detected after1 hr of incubation (Figure 1B, lanes 3–7, and see
Figure S1 available online). Formation of the new RNA species
was dependent on let-7 miRNA as (1) inclusion of anti-let-7
20-O-methylated oligonucleotide (20-O-Me), but not anti-
miR122 20-O-Me, in the Krebs extract blocked the generation
of this product (lanes 8 and 9, respectively); and (2) a reporter
containing mutations in nucleotides complementary to the let-7
‘‘seed’’ sequence (RL-6xBMut-pA; see Figure 1A and Figure 1B,
lanes 1–7), and a reporter devoid of let-7 sites (RL-pA; Figure S1)
failed to give rise to this band. Cloning and sequencing of the
new RNA species using an oligonucleotide-ligation RT-PCR
strategy (FigureS2) demonstrated that it represents a deadenyla-
tion product of the RL-6xB-pA mRNA. Thus, let-7 miRNA medi-
ates deadenylation of the targeted mRNA in the Krebs extract,
but with the earliest detection only after 1.3 hr of incubation.
As translational inhibition (55%) occurs within the first hour of
incubation in the same Krebs extract in which deadenylation
has been monitored (Figure 1C; see also Mathonnet et al.
[2007]), it appears that miRNA-mediated inhibition of cap-
dependent translation precedes mRNA deadenylation. When
translation of RL-6xB-pA mRNA was allowed to proceed for
longer times, the degree of translation repression increased
from 55% at 1 hr to 77% at 2 hr (Figure 1C; three different
experiments). These data indicate that deadenylation may
consolidate the initial inhibition of cap-dependent translation.
Next, we asked whether deadenylation is dependent on trans-
lation. To this end, translation was inhibited in the Krebs extract
by the addition of either cycloheximide (Figure 1B, lanes
10–12), which blocks translation elongation, or hippuristanol
(lanes 13–15), which inhibits translation initiation (Bordeleau
et al., 2006). Inhibiting either step of translation failed to block
let-7-induced deadenylation of RL-6xB-pA mRNA. We then
examined whether the m7GpppG-cap structure is required for
miRNA-mediated deadenylation. Deadenylation assays were
conducted with RL-6xB-pA and RL-6xBMUT-pA mRNAs pos-
sessing an ApppG-cap, which cannot be bound by eIF4E but
protects the RNA against degradation by 50-30 exonucleases.
Neither the time course nor the extent of deadenylation of A-cap-
ped RL-6xB-pA significantly differed fromRL-6xB-pA bearing an
m7GpppG structure (Figure 1B). Since miRNA-mediated deade-
nylation is an m7GpppG-cap- and translation-independent
event, we examined whether any RNA element upstream of the
RL-6xB-pA 30UTR is required for miRNA-mediated deadenyla-
tion. ApppG-capped 30UTR transcripts were generated that
lack an open reading frame and contain six either functional
(6xB-30UTR) or mutated (6xBMUT-30UTR) let-7 sites and a 98 nt
poly(A) tail (Figure 1D). The 6xB-30UTR RNA recapitulated both
the time course and the deadenylation pattern observed for the
full-length RL-6xB-pA mRNA (Figure 1D). Deadenylation was
dependent on let-7 miRNA as (1) addition of anti-let-7a 20O-Me
oligonucleotide, but not a nonspecific anti-miR122 20-O-Me
oligonucleotide (Figure 1D, lanes 12 and 13, respectively), abro-
gated thedeadenylation of 6xB-30UTRRNA; and (2) the6xBMUT-
30UTRRNAwas not deadenylated (Figure 1D). A 6xB-30UTRRNA
with a longer poly(A) tail (150 nt, 6xB-30UTR*) behaved similarly to
the 6xB-30UTRRNA vis-a-vis the time course and the deadenyla-
tionpattern (Figure 1E). Taken together, our findingsdemonstrate
that no RNA determinant other than the let-7 target sites is
required for miRNA-mediated deadenylation.
Argonaute Proteins Interact with CAF1 and CCR4
Deadenylases
We used several approaches to identify the deadenylase(s)
involved in themiRNA-mediateddeadenylation. In oneapproach,
Myc-tagged Ago1 and Ago2 were stably transfected into
HEK293 cells. Tagged Ago proteins were immunopurified, and
theassociatedproteinswere identifiedbyusingmultidimensional
protein identification technology (MuDPIT) (Washburn et al.,
2001; Wolters et al., 2001). This method was validated by the
identification of known Ago2-interacting proteins such as
HSP90, DICER, TRBP, and GW182 (Figure 2A) (Chendrimada
et al., 2005; Landthaler et al., 2008; Liu et al., 2005; Meister
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et al., 2005). In addition, PABP was identified in both Ago1 and
Ago2 immunopurifications (Figure 2A) (Hock et al., 2007; Land-
thaler et al., 2008). One identified protein that was not reported
before to interact with Ago proteins was CAF1 deadenylase. To
validate this interaction, we performed coimmunoprecipitation
experiments using a micrococcal nuclease-treated Krebs
extract. When endogenous Ago2 was immunoprecipitated from
the Krebs extract, the precipitated fraction contained Ago2
and CAF1, but not eIF4E (Figure 2B). When endogenous CAF1
was immunoprecipitated from Krebs extracts, the precipitated
fraction contained CAF1, CCR4 (a CAF1-associated deadeny-
lase [Tucker et al., 2001]), and Ago2, but not eIF4E (Figure 2C).
Figure 1. Deadenylation Mediated by let-7 miRNA in a Krebs Extract
(A) Schematic representation of the Renilla luciferase (Rluc) reporter mRNAs. Sequences of the let-7-binding sites (RL-6xB) and mutated seed sites (RL-6xBMut)
are shown below the drawings.
(B) Time course of RL-6xB-pA and RL-6xBMUT-pAmRNA deadenylation as determined by autoradiography. Reporter mRNAswere incubated in the presence or
absence of 10 mM cycloheximide, 1 mM hippuristanol, or 10 nM 20-O-Me oligonucleotide (either anti-let-7a or anti-miR122).
(C) A time course of translation of RL-pA, RL-6xB-pA, and RL-6xB-pA in the presence of anti-let-7 20-O-Me. Average percentage repression is labeled below each
time point. Error bars represent the standard deviation of three independent experiments.
(D) Schematic representation of the 6xB-30UTR reporter RNA and time course of 6xB-30UTR and 6xBMUT-30UTR RNA deadenylation in a Krebs extract as deter-
mined by autoradiography. Reporters were incubated in the presence or absence of 10 nM 20-O-Me oligonucleotide (either anti-let-7a or anti-miR122), and their
stability was monitored by autoradiography.
(E) Schematic representation of the 6xB-30UTR reporter RNAs with either 98As or 150As (*). Time course of 6xB-30UTR and 6xB-30UTR* deadenylation in a Krebs
extract as determined by autoradiography. Polyadenylated and deadenylated mRNAs are marked on the right of the figure.
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To determine whether the CAF1 and CCR4 deadenylases can
be recruited by the let-7-loaded Ago2, we used a 20-O-Me RNA
target ‘‘bait’’ pulldown assay (Hutvagner et al., 2004). Biotinylated
20-O-Me oligonucleotides, which mimic partially complementary
mRNA target sites for let-7 or miR122 (a liver-specific miRNA
[Lagos-Quintana et al., 2002] that can pull down Ago2 from
lysates derived from Huh7 liver cells [Figure S3]), were incubated
in Krebs extract and pulled down using streptavidin beads. The
associated proteins were eluted and analyzed by western blot-
ting. Ago2 bound specifically to the anti-let-7 20-O-Me beads
and failed to bind to control beads or anti-miR122 20-O-Mebeads
(Figure2D, lanes2–4). Importantly, in thesepulldownexperiments
a similar patternof enrichmentwasobserved forCAF1andCCR4,
but not for eIF4Eor Tob (a protein that can associatewithCAF1 to
enhance deadenylation [Ezzeddine et al., 2007; Mauxion et al.,
2008]). These results demonstrate that CAF1 and CCR4 can be
specifically recruited to the target-bound let-7-loaded Ago2.
miRNAs Require CAF1 Activity to Promote
Deadenylation
To determine whether CAF1 is required for miRNA-mediated
deadenylation, it was immunodepleted (80%) from the Krebs
extract using an affinity-purified CAF1 antibody (Figure S4).
Analysis of the depleted extract (Figure 3) demonstrated that
miRNA-mediated translation inhibition is partially relieved in
both CAF1- and Ago2-depleted extracts (37.8% [Figure 3B]
and 14.9% repression [Figure 3D], respectively, after 3 hr incuba-
tion) when compared to the corresponding control-depleted
extracts (68.9% [Figure 3A] and 54.5% [Figure 3C] repression
after 3 hr incubation). The Ago2-depleted extract was dramati-
cally impaired in its ability to deadenylate the 6xB-30UTRRNA, in-
asmuchasdeadenylationwasbarely detectable even after 6 hr of
incubation (Figure 3E, lane5). A similar decrease in deadenylation
wasdetected in aKrebs extract depleted ofCAF1 (Figure 3F, lane
10). These deadenylation defects were specific, because in
a mock-depleted extract, 6xB-30UTR RNA was deadenylated
in a let-7-dependent manner (Figures 3E and 3F, lanes 1–3).
miRNA-mediated deadenylation was modestly restored (2.2-
fold increase; from5% to12%deadenylation) by the addition
of affinity-purified wild-type HA-CAF1 to the CAF1-depleted
extract (Figure 3F, lane 11), while wild-type HA-CAF1 had no
noticeable effect on mock-depleted extract (lane 4). Modest
restoration wasmost likely due to a small fraction of affinity-puri-
fied wild-type HA-CAF1 being bound to let-7-loaded miRISC. In
contrast, addition of affinity-purified catalytically inactive
HA-CAF1 mutant (D40A) (Zheng et al., 2008) decreased miRNA-
induced deadenylation in both mock- and CAF1-depleted
extracts (Figure 3F, lanes 5 and 12, respectively). This is likely
due to HA-CAF1(D40A) acting as a dominant-negative mutant
in both mock- and CAF1-depleted extracts. Taken together,
these results show that miRNA-induced deadenylation is
executed, at least in part, by the CAF1 deadenylase.
Ago2-GW182 Interaction Is Essential
for miRNA-Mediated Deadenylation
The Ago-binding protein GW182 is required for efficient miRNA-
mediated silencing in C. elegans and in Drosophila S2 cells
(Behm-Ansmant et al., 2006; Ding and Han, 2007; Eulalio et al.,
2008b). GW182 is required for the assembly of P bodies,
protein-RNA assemblies thought to contribute to translation
Figure 2. Ago Proteins Interact with PABP
and the CAF1/CCR4 Deadenylase Complex
(A) MuDPIT analysis of Ago1- and Ago2-interact-
ing proteins. Identified proteins are listed along
with corresponding peptide coverage for Ago1
and Ago2 coimmunoprecipitations.
(B) Immunoprecipitation of endogenous Ago2
protein from micrococcal nuclease-treated Krebs
extract using anti-Ago2 antibody. Immunoprecipi-
tated complexes were subjected to SDS-PAGE
and probed with anti-Ago2 antibody, anti-CAF1
antibody, anti-PABP antibody, or anti-eIF4E anti-
body.
(C) Immunoprecipitation of endogenous CAF1
protein from micrococcal nuclease-treated Krebs
extract using anti-CAF1 antibody. Immunoprecip-
itated complexes were subjected to SDS-PAGE
and probed with anti-Ago2 antibody, anti-CAF1
antibody, anti-CCR4 antibody, or anti-eIF4E
antibody.
(D) Pulldown of Ago2, CCR4, and CAF1 from
micrococcal nuclease-treated Krebs extracts
using biotin-conjugated anti-let-7 20-O-Me oligo-
nucleotide and streptavidin Dynabeads. Isolated
complexes were subjected to SDS-PAGE and
probed with anti-Ago2 antibody, anti-CAF1 anti-
body, anti-CCR4 antibody, anti-Tob antibody, or
anti-eIF4E antibody.
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inhibition andmRNA destabilization (Behm-Ansmant et al., 2006;
Ding and Han, 2007; Jakymiw et al., 2007; Liu et al., 2005; Pillai
et al., 2005; Rehwinkel et al., 2005). CAF1 also localizes to
P bodies in mammalian cells (Zheng et al., 2008). We therefore
investigated whether the GW182 interaction with Ago2 plays
a role in miRNA-mediated deadenylation in vitro. To this end, we
used a 22 amino acid fragment of GW182 (called ‘‘Ago hook’’)
(Figure 3G) that competes with GW182 for Ago binding and
inhibits miRNA-mediated repression in vivo (Till et al., 2007).
A Krebs extract was incubated with either GST alone, GST fused
toAgohook (GST-WThook), orGST fused toamutant hook (GST-
MUThook) containing two Trp to Leumutations that abrogate the
Figure 3. let-7-Mediated Deadenylation Requires CAF1, Ago2, and GW182
(A–D) Time course of RL-pA and RL-6xB-pA translation in rabbit anti-HA- (A), rabbit anti-CAF1- (B), mouse anti-HA- (C), and mouse anti-Ago2-depleted Krebs
extracts (D). Average percentage repression is labeled below each time point. Error bars represent the standard deviation of three independent experiments.
(E) 6xB-30UTR RNA deadenylation in the presence or absence of 10 nM anti-let-7a 20-O-Me in control (mouse anti-HA) or anti-Ago2-depleted Krebs extract. 6xB-
30UTR RNA deadenylation was followed by autoradiography. Polyadenylated and deadenylated mRNAs are marked on the right of the figure.
(F) 6xB-30UTR RNA deadenylation in control (rabbit anti-HA) or anti-CAF1-depleted extract in the presence or absence of either 10 nM anti-let-7a 20-O-Me oligo-
nucleotide, or WT or D40A HA-CAF1 protein.
(G) Wild-type and mutant hook peptides derived from GW182.
(H) 6xB-30UTR RNA deadenylation in Krebs extract in the presence or absence of either GST or GST hook peptides at concentrations ranging from 0.1 to 2.0 mg
per reaction, respectively.
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ability of the hook to bind toAgo (Till et al., 2007) (Figure S5). Addi-
tion of a recombinant GST-WT hook, but not GST alone or GST-
MUT hook to the Krebs extract, impaired the deadenylation of
6xB-30UTR RNA in a concentration-dependent manner (Fig-
ure 3H, lanes 7–9 compared to lanes 4–6 and 10–12, respec-
tively). These findings indicate that miRNA-mediated deadenyla-
tion in vitro requires GW182 contact with Ago2 at the hook site.
PABP Is Required for miRNA-Mediated Deadenylation
Since the MuDPIT analysis identified PABP as an Ago-interact-
ing protein, it was pertinent to determinewhether PABP is neces-
sary for miRNA-induced deadenylation. A Krebs extract was
depleted (>95%) of endogenous PABP using a GST-tagged
PABP-interacting protein 2 (Paip2) affinity matrix (Figure 4A).
Paip2 is a strong translational inhibitor and acts by sequestering
PABP and blocking PABP-poly(A) tail and PABP-eIF4G interac-
tions in vitro (Karim et al., 2006; Khaleghpour et al., 2001).
GST-Paip2 coupled to a resin was previously used to efficiently
deplete PABP from a Krebs extract, resulting in reduced transla-
tion (Kahvejian et al., 2005). Strikingly, the PABP-depleted
extract was severely impaired in its ability to deadenylate the
6xB-30UTR RNA (Figure 4B, compare lane 4 to lane 1). This
was a specific consequence of PABP depletion as a mock-
depleted extract still deadenylated the reporter RNA and was
responsive to the addition of anti-let-7 20-O-Me oligonucleotide
(Figure 4B, lanes 1 and 2, respectively). Moreover, addition of
recombinant GST-PABP (50% of endogenous PABP levels in
a Krebs extract [Figure S6]) to the PABP-depleted extract (lane
6), but not GST alone (lane 5), completely rescued miRNA-medi-
ated deadenylation of 6xB-30UTR RNA. The rescue was pre-
vented by the addition of anti-let-7 20-O-Me oligonucleotide
(Figure S7, lane 8). These findings clearly show that PABP is
essential for miRNA-mediated deadenylation in vitro.
PABP Function in miRNA-Mediated Deadenylation
Is Antagonized by eIF4G
How does PABP facilitate miRNA-mediated deadenylation?
PABP is probably not required for miRISC target site recognition,
as the let-7-loaded Ago2 can be pulled downwith anti-let-7 20-O-
Me oligonucleotide from a PABP-depleted Krebs extract almost
as well as from a nondepleted extract (Figure 2D, compare lanes
3 and 7). Moreover, PABP is required for recruiting neither CAF1
nor CCR4 as they are pulled down in similar amounts from
PABP-depleted extracts with anti-let-7 20-O-Me oligonucleotide
(Figure 2D, compare lanes 3 and 7). It is unlikely that PABP’s role
is to compete with other proteins for poly(A) tail binding, as add-
ing free poly(A) to PABP-depleted extracts (Figure S8) does not
rescue miRNA-mediated deadenylation.
The N-terminal region of PABP can interact with the translation
initiation factor eIF4G, and this interaction stimulates translation
(Imataka et al., 1998; Wakiyama et al., 2000). To determine
whether this interaction might antagonize deadenylation, Krebs
extract was incubated with increasing concentrations of either
an N-terminal eIF4G fragment (GST-eIF4G 41-244wt) that binds
the N terminus of PABP or a mutant eIF4G fragment (GST-eIF4G
41-244mut) that does not bind to PABP (Kahvejian et al., 2005)
(Figures 5A and S9). Addition of a wild-type (lanes 3–6), but not
the mutant eIF4G fragment (lanes 7–10), impaired the deadeny-
lation of 6xB-30UTR RNA in a concentration-dependent manner.
We next examined whether the effect of GST-eIF4G 41-244wt
on miRNA-mediated deadenylation was a result of its binding to
PABP. PABP-depleted extracts were supplemented with either
wild-type or PABP M161A that cannot bind eIF4G (Groft and
Burley, 2002) (Figures 5B, 5C, and S9). miRNA-mediated deade-
nylation in PABP-depleted extracts can be rescued equally well
with PABP M161A as compared to wild-type PABP (Figure 5B,
compare lanes 5–7 with lanes 10–12). Addition of GST-eIF4G
41-244wtblockeddeadenylation inaPABP-depletedextract sup-
plemented with wild-type PABP (lane 8) but decreased it only
minimally when supplementedwithPABPM161A (lane 13). These
findings suggest that the eIF4G-PABP interaction is not required
for, but rather interferes with, miRNA-mediated deadenylation.
PABP Interacts with the C-Terminal Region of GW182
GW182 is a core component of miRISC, and its contact with Ago
is required for miRNA-mediated repression (Eulalio et al., 2008b;
Till et al., 2007). Mammalian and C. elegans GW182 protein
orthologs were previously shown to coimmunoprecipitate with
PABP (Landthaler et al., 2008; Zhang et al., 2007), but whether
these associations were direct has not been determined. To
test for a direct interaction between GW182 and PABP, we
performed GST pulldown experiments using recombinant
His-taggedPABPand fourGST- andFLAG-taggedpartially over-
lapping fragments (covering amino acids 1–500, 400–900, 800–
1360, and 1260–1690) of the human GW182 protein TNRC6C
(Figure 6A). GST on its own and fusions with TNRC6C fragments
Figure 4. let-7-Dependent Deadenylation
Requires PABP
(A) Western blot analysis of Krebs-2 extracts
depleted with either GST (Control Extract) or
GST-Paip2 (PABP-depleted Extract) probed with
anti-PABP antibody and anti-b-actin antibody.
(B) A-capped 6xB-30UTR RNA incubated in either
mock-depleted (lanes 1–2) or PABP-depleted
extract (lanes 3–6). PABP-depleted extract was
supplemented with recombinant GST, GST-
PABP (100 ng, which is the equivalent of roughly
50% of endogenous PABP present in an in vitro
reaction), and RNA stability was monitored by
autoradiography. Polyadenylated and deadeny-
lated mRNAs are marked on the right of the panel.
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1–500, 400–900, and 800–1360 did not interact with PABP. In
contrast, the C-terminal 1260–1690 of TNRC6C, which harbors
both the domain of unknown function (DUF; Zipprich et al.,
2009) andRRMdomains of TNRC6Cpulled downPABPvery effi-
ciently (20% of input; Figure 6A). GST pulldown experiments
using overlapping fragments of another human GW182 paralog
(TNRC6A) and PABP yielded similar results (data not shown).
We next investigated whether the C-terminal region of
TNRC6C interacts with PABP in transfected HEK293 cells. Of
the HA-tagged fragments spanning different regions of TNRC6C
(Figure 6B), only the C-terminal fragment, DN1370, encompass-
ing residues 1370–1690, pulled down endogenous PABP
(Figure 6B, lane 8). In additional experiments, lysates from cells
expressing GST-DN1370 were used for GST pulldowns. In the
absence of micrococcal nuclease treatment, GST-DN1370
pulled down both PABP and eIF4G. However, in nuclease-
treated lysatesGST-DN1370 pulled down only PABP (Figure 6C),
demonstrating theRNA independence of the interaction between
TNRC6C and PABP. Taken together, these data indicate that the
C-terminal region of the GW182 protein TNRC6C interacts
directly with PABP in an RNA-independent manner.
GW182 Contact with the PABP C-Terminal Domain Is
Required for Maximal miRNA-Mediated Deadenylation
We next performed a sequence analysis of the C terminus of
GW182 proteins to identify any potential PABP-interacting
motifs. We observed a short sequence within the DUF that
shows similarity to the Paip2 PAM2 motif (Figure 7A) that
is required for Paip2 to bind the second half of the PABP
C terminus (C2) (Khaleghpour et al., 2001; Kozlov et al., 2004).
GST pulldown experiments were subsequently carried out using
recombinant GST-tagged C-terminal PABP fragments (GST-C1
and GST-C2) and the FLAG-tagged TNRC6C C terminus
(covering amino acids 1260–1690 [Figure 7B]). The PABP GST-
C1 fusion did not pull down the GW182 1260–1690 fusion. In
contrast, GST-C2 pulled down the TNRC6CC-terminal fragment
very efficiently (40% of input).
To determine whether miRNA-mediated deadenylation
requires GW182 contact with the PABP C2 domain, a Paip2-
derived PAM2 peptide that specifically binds the C2 domain
(Figure 7C) was used. Addition of increasing concentrations of
wild-type, but not mutant PAM2 peptide (F117A [Kozlov et al.,
2004]) to GST-PABP incubated with TNRC6C 1260–1690 frag-
ment, blocked, albeit not completely, the binding of the TNRC6C
C terminus to PABP (lanes 6–8 compared to lanes 9–11). Consis-
tently, addition of the wild-type, but not the mutant PAM2
peptide to a Krebs extract, interfered with miRNA-mediated
deadenylation in vitro in a dose-dependent manner (Figure 7D,
lanes 3–6 compared to lanes 7–10). Taken together, these find-
ings demonstrate that maximal miRNA-mediated deadenylation
in vitro requires GW182 contact with the PABP C2 domain.
To further assess the function of the GW182 C terminus in
miRNA-mediated deadenylation, we added the C-terminal
recombinant 1260–1690 fragment to in vitro deadenylation reac-
tions. The fragment dramatically enhanced miRNA-mediated
deadenylation in vitro (Figure 7E, lanes 7–10 as compared to
lane 2). The enhancement is specific, since adding a TNRC6C
fragment 800–1360 that overlaps the 1260–1690 fragment but
cannot bind PABP inhibited rather than enhanced the deadeny-
lation in the same assays (lanes 11–14 as compared to lane 2).
These data demonstrate the key role that the PABP-GW182
interaction plays in miRNA-mediated deadenylation.
DISCUSSION
In this report we used a mammalian cell-free extract to demon-
strate that miRNAs mediate deadenylation of a target mRNA
subsequent to initial inhibition of cap-dependent translation.
Figure 5. eIF4G Contact with PABP Antagonizes miRNA-Mediated
Deadenylation
(A) 6xB-30UTR RNA deadenylation in Krebs extract in the presence or absence
of increasing concentrations (0.15, 0.5, 1.0, and 3.0 mg per reaction) of wild-
type or mutant GST-eIF4G 41-244.
(B) 6xB-30UTR RNA deadenylation in mock- or PABP-depleted Krebs extract
in the presence or absence of increasing concentrations (25, 50, or 100 ng per
reaction, respectively) of either wild-type (lanes 5–7) or M161A PABP (lanes
10–12) and/or wild-type (lanes 8 and 13) or mutant (lanes 9 and 14) GST-
eIF4G (41-244).
(C) Quantification of deadenylated bands as a percentage of total RNA in (B) is
shown in bar graphs (with standard deviations).
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Biochemical methods and functional assays in this in vitro
system elucidated some of the protein and RNA requirements
for miRNA-mediated mRNA deadenylation.
CAF1 and CCR4 Are Mammalian miRISC-Associated
Deadenylases
miRNAs have previously been implicated in the deadenylation of
targeted mRNAs in mammalian cells (Wu et al., 2006). Onemajor
deadenylase complex in mammals is the multisubunit CCR4-
NOT complex, which contains two proteins having deadenylase
activity, CCR4 and CAF1 (Yamashita et al., 2005; Zheng et al.,
2008). Although CCR4 is the active deadenylase in the yeast
CCR4-NOT complex (Tucker et al., 2001, 2002), mammalian
CAF1 is also a processive deadenylase that regulates mRNA
decay (Bianchin et al., 2005; Funakoshi et al., 2007; Schwede
et al., 2008; Viswanathan et al., 2004; Zheng et al., 2008).
Previous work carried out in Drosophila S2 cells demonstrated
that the CCR4-NOT complex (which contains CAF1) facilitates
miRNA-mediated deadenylation (Behm-Ansmant et al., 2006).
Our results bolster these findings and show that the association
of the miRISC with the deadenylase complex is conserved
between Drosophila and mammals. Moreover, we provide
biochemical evidence that both deadenylases physically interact
with the mammalian miRISC, and that CAF1 activity is respon-
sible, at least in part, for miRNA-mediated deadenylation. As
CAF1 interacts with both Ago1 and Ago2 in HEK293 cells, this
suggests that both Ago proteins are involved in facilitating
miRNA-mediated deadenylation in mammals.
Figure 6. The C Terminus of TNRC6C
Directly Binds PABP
(A) Schematic representation of human TNRC6C
and GST- and FLAG-tagged recombinant protein
fragments. Western blot analysis of GST pull-
downs of PABP incubated with GST or various
fragments of GST-TNRC6C-FLAG and probed
with anti-PABP and anti-GST antibodies.
(B) Schematic representation of human TNRC6C
HA-tagged fragments transfected into HEK293
cells. Cell extracts of HEK293 cells, transiently
expressing the indicated fusion proteins, were
incubated with Anti-HA Affinity Matrix (Roche),
and immunoprecipitated proteins were analyzed
by western blotting using the indicated antibodies.
Inputs represent 1% of the cell extract used for IP.
Nontransfected cells served as a control.
(C) Cell extracts of HEK293 cells transiently
expressing GST-DN1370 were pulled down using
glutathione Sepharose resin in the presence or
absence of micrococcal nuclease. GST pulldowns
were analyzed by western blotting using anti-
PABP, anti-eIF4G, and anti-GST antibodies. Non-
transfected cells served as a control.
PABP as a Coactivator of
miRNA-Mediated Deadenylation
Studies aimed at characterizing miRISC-
associated proteins have previously iden-
tified PABP by mass spectrometry of
immunoprecipitates not subjected to
ribonuclease treatment (Hock et al., 2007; Landthaler et al.,
2008; Zhang et al., 2007). We show that PABP is required for
miRNA-mediated deadenylation and physically interacts with
themiRISC via direct contact with GW182. Moreover, our results
suggest that PABP-GW182 interaction is required to facilitate
miRNA-mediated deadenylation. Previous studies have shown
that PABP augments the activity of different deadenylases.
PABP helps to recruit the PAN2/3 deadenylase complex to
poly(A) tails in both yeast and mammalian systems via a direct
interaction between the PAN3 subunit and the PABP C-terminal
domain (Lowell et al., 1992; Uchida et al., 2004). The PABP C-
terminal domain directly binds to the CAF1-interacting protein
Tob, which may contribute to the CCR4-CAF1-mediated deade-
nylation of somemRNAs (Ezzeddine et al., 2007; Simon and Ser-
aphin, 2007). In contrast to these modes of PABP-dependent
deadenylation, our data show that PABP is not required for
recruitment of either themiRISCor themiRISC-associated dead-
enylase complex to miRNA-targeted mRNAs (Figure 2D).
Furthermore, while CAF1 is recruited to the miRISC, Tob is not
(Figure 2D).
PABP-GW182 Interaction and miRNA-Mediated
Repression
GW182 is a core component of the miRISC and is critical for
miRNA-mediated repression. All three mammalian paralogs of
GW182 (TNRC6A, TNRC6B, and TNRC6C) are involved in
miRNA-mediated repression (Jakymiw et al., 2007; Lazzaretti
et al., 2009; Liu et al., 2005; Till et al., 2007; Zipprich et al.,
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2009). Tethering experiments of different TNRC6C fragments to
a reporter mRNA demonstrated that a C-terminal fragment of
TNRC6C, harboring both the DUF and RRM domains, represses
protein synthesis as effectively (>10-fold) as a full-length
TNRC6C protein (Zipprich et al., 2009). Experiments performed
with Drosophila GW182 protein in S2 cells also pointed to the
importance of the protein C terminus for repression of protein
synthesis (Chekulaeva et al., 2009; Eulalio et al., 2009b), implying
functional conservation. We demonstrate that the mammalian
GW182 C terminus directly binds PABP in an RNA-independent
manner. Importantly, we show that GW182-PABP contact
through the PABP C2 domain is required for efficient miRNA-
mediated deadenylation. Because PABP functions as a bona
fide translation initiation factor (Kahvejian et al., 2005), these
data provide evidence that themammalian miRISC directly inter-
acts with a component of the translation initiation machinery. It is
possible that PABP binding to GW182 may compete with eIF4G
binding, as adding an eIF4G fragment that binds to the N
terminus of PABP blocks miRNA-mediated deadenylation
in vitro (Figure 5). In addition, it is conceivable that PABP binding
to GW182 may function to juxtapose the poly(A) tail against the
miRISC-associated deadenylase complex (see model, Figure 8).
Although intriguing, these possibilities are still speculative at this
point and await future experimental validation.
Temporal Mode of miRNA Action
miRNAs inhibit translation and/or mediate deadenylation and
decay of target mRNAs (Filipowicz et al., 2008). In previous
studies, mostly carried out in cultured cells, it was impossible
Figure 7. GW182 Binding to PABP Is
Required for miRNA-Mediated Deadenyla-
tion
(A) Alignment of GW182 DUF sequences with
Paip2 PAM2 motif.
(B) Western blot analysis of GST pulldowns of
TNRC6C (1260-1690)-FLAG incubated with
various C-terminal (C1 and C2) fragments of
GST-PABP and probed with anti-FLAG and anti-
GST antibodies.
(C) Western blot analysis of GST pulldowns of
GST-PABP incubated with TNRC6C (1260-
1690)-FLAG and/or wild-type or mutant PAM2
peptide and probed with anti-FLAG and anti-
GST antibodies.
(D) 6xB-30UTR RNA deadenylation in Krebs
extract in the presence of increasing concentra-
tions (1, 10, 50, and 100 mM) of wild-type or mutant
(F > A) Paip2 PAM2 peptides.
(E) 6xB-30UTR RNA deadenylation in Krebs
extract, as determined by autoradiography, in
the presence of increasing concentrations (0.5,
1.0, and 2.0 mg per reaction) of GST, TNRC6C
(1260-1690), or TNRC6C (800-1360).
to determine the earliest events leading
to the miRNA-mediated repression
(Behm-Ansmant et al., 2006; Giraldez
et al., 2006; Humphreys et al., 2005; Pe-
tersen et al., 2006; Pillai et al., 2005). We
have demonstrated that miRNAs inhibit translation initiation as
early as 15–40 min after addition of mRNA to the Krebs extract
(Mathonnet et al., 2007, and this study). As shown in this work,
the miRNA-induced deadenylation of targeted mRNAs in vitro
is a slower event, which follows themiRISC-mediated repression
of translation initiation. These results indicate that miRNAs can
function by two complementary and likely sequential mecha-
nisms, first by inhibiting initiation of cap-dependent translation,
which is then followed by the deadenylation of the target
mRNA. As miRNA-mediated repression in Krebs extract further
increases between 1 and 2 hr of incubation and miRNA-medi-
ated translation repression is partially inhibited in CAF1-depleted
extract, it is possible that deadenylation has an additional
repressive effect supplementary to the initial inhibition of cap-
dependent translation.
EXPERIMENTAL PROCEDURES
DNA Constructs and Protein Purification
Myc-Ago1 and Ago2 DNA constructs have been described (Liu et al., 2005).
HA-CAF1 wild-type and HA-CAF1 D40A constructs have been described
(Zheng et al., 2008). pGST-Paip2 and pGST-PABP full-length and fragments
C1 andC2 have been described (Khaleghpour et al., 2001). Plasmids encoding
wild-type and mutant HA-fused CAF1 proteins were transfected into HeLa
cells and proteins were eluted with HA peptide (Anaspec). Eluted proteins
were analyzed by western blot analysis using CAF1 and Ago2 antibodies.
The plasmids pCI-NHA-1-405, pCI-NHA-1-1034, pCI-NHA-1-1368, pCI-
NHA-DN1370, and pCI-NHA-1505-1610 were previously described (Zipprich
et al., 2009). To generate the plasmid pEBG-DN1370, the sequence
encoding a C-terminal part of TNRC6C was PCR amplified using CCCGTCG
GATCCCGTGCCAAATCTGACAG TGA and AACCCTCACTAAAGGGAAGC
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oligonucleotides as primers and pCI-NHA-DN1370 as template. The fragment
was digested with BamHI and NotI and inserted into pEBG-Piwi (Tahbaz et al.,
2004; Zipprich et al., 2009) precut with BamHI and NotI.
To generate the plasmids used for bacterial expression of GST-FLAG-
TNRC6C fragments (pGST-TNRC6C1-500, pGST-TNRC6C400-900, pGST-
TNRC6C800-1360, and pGST-TNRC6C1260-1690), the appropriate DNA
was amplified by PCR using pCI-NHA-TNRC6C as template and the following
primer pairs: GGCCGGCCGTCGACTCATGGC TACAGGGAGTGCCCAGGG
CAAC and CTTGTCATCGTCGTCCTTGTAGTCAGCA CTGTTCATGATGGAC
CCATCGTTCTTC (1–500), GGCCGGCCGTCGACTCAGTG ATGGTTCTGGC
AACCACAATGAAG and CTTGTCATCGTCGTCCTTGTAGTCAG CCACGTC
CCCTTCTTCATCCTCCCACTG (400–900), GGCCGGCCGTCGACTCTC ATC
AGGCTGGGGAGAAATGCCTAATG and CTTGTCATCGTCGTCCTTGTAGTC
AGCGGGAGGACTGGCTGGTGACTCACTGTTC (800–1360), and GGCCGGC
CGTC GACTCAACACCTTTGCTCCTTACCCTCTCGCTG and CTTGTCATCG
TCGTCCTT GTAGTCAGCCAGGGACTCCCCGCTGAGCAGGTCCCC (1260–
1690). These PCR products were subjected to a second round of PCR ampli-
fication using the original forward primer and a new reverse primer (CCGGC
CGCGGCCGCTCACTTGTCATCGT CGTCCTTGTAGTCAGC). The product
of these PCR reactions was then gel purified, digested with SalI and NotI
restriction enzymes, and ligated into similarly digested pGEX-6P-1 expression
vector (GE Healthcare). This strategy resulted in constructs that express the
appropriate fragment of TNRC6C carrying N-terminal GST and C-terminal
FLAG epitopes. TNRC6C fragments were expressed in Rosetta-2(DE3)
E. coli cells (EMD Biosciences) and purified by two sequential affinity chroma-
tography steps, first over glutathione Sepharose 4B resin (GE), followed by
M2-FLAG affinity resin (Sigma).
In Vitro Transcription
Plasmids that lack or contain six let-7 target sites (RL and RL-6xB, respec-
tively) were described (Pillai et al., 2005). A 98 base pair poly(A) sequence
was added to the 30UTR of both constructs. RL-6xBMut was constructed as
previously published (Mathonnet et al., 2007; Pillai et al., 2005). A 150 base
pair poly(A) sequence was synthesized (IDT) and added to the 30UTR of
RL-6xB (RL-6xB-pA*). For in vitro transcription, plasmids were linearized
with ApaI and filled in using the Klenow fragment. Transcription reactions
were performed using MAXIscript In Vitro Transcription Kit (Ambion) in 20 ml
at 37C according to the manufacturer’s protocol in the presence of the cap
analog m7(30-O-methyl)(50)Gppp(50)G (anti-reverse cap analog, ARCA; New
England Biolabs). ApppG-capped mRNAs were synthesized using ApppG
(New England Biolabs) instead of ARCA. 6xB-30UTR and 6xBMUT-30UTR tran-
scripts were generated from PCR products derived from RL-6xB-pA and
RL-6xBMUT-pA templates and T7-30UTR (GGCGCCTAATACGACTCACTAT
AGGGGTAAGTACATCAAGAGCTTCG) andOligo 3R() (GGTGACACTATAGA
ATAGGGCCC) primers. PCR products were digested with ApaI and filled
in using the Klenow fragment. To synthesize radiolabeled mRNAs, UTP was
substituted with [a-32P]UTP (800 Ci/mmol, 10 mCi/ml; PerkinElmer) according
to the manufacturer’s protocol. The mRNA was loaded on a mini Quick Spin
RNA Column (Roche) to remove unincorporated nucleotides.
In Vitro Translation Assays
Krebs-2 ascites cell extract was prepared as previously described (Svitkin and
Sonenberg, 2004). Translation reactions were performed in a total volume of
10 ml at 30C. A typical reaction mixture contained 7 ml extract, 1 ml mRNA,
and, where indicated, 20-O-Me oligonucleotide complementary to let-7a or
miR-122a or poly(A)30 oligonucleotide (Dharmacon) in water. The mixture
was preincubated for 20 min at 16C and then at 30C for 120 min. When
the 20-O-Me oligonucleotide was added, the extract was first incubated at
30C for 20 min in the absence of mRNA to allow for the annealing of the oligo-
nucleotide with its target miRNA. The reaction was stopped by addition of 20 ml
cold 1 3 PBS. For time course experiments, the reaction was scaled up to
80 ml, and 10 ml was withdrawn at each time point. Luciferase activity was
measured by using the Dual-Luciferase Reporter Assay System (Promega)
according to the manufacturer’s protocol.
mRNA Stability Assay
Radiolabeled RNA (0.1 ng) was incubated in Krebs-2 ascites in a total volume
of 10 ml in the absence or presence of 10 nM let-7 20-O-Me oligonucleotide.
Aliquots of the reaction mixture were withdrawn at specific intervals, and the
RNA was extracted using TRIzol reagent (Invitrogen) and loaded on a 4% or
4.5% polyacrylamide/urea gel. The gel was dried and analyzed using
a Typhoon PhosphorImager (GE Healthcare).
Oligonucleotide Ligation-Mediated Cloning of RNA
Radiolabeled RNA from Krebs extract was extracted with TRIzol and loaded
on a 4% polyacrylamide/urea gel. Specific RNA bands were cut from the gel
and eluted in 2x proteinase K buffer (100 mM Tris-HCl, pH 8.3; 25 mM
EDTA, pH 8.0; 300 mM NaCl; 2% (w/v) SDS), purified and ligated to a miRNA
universal linker (NEB) using T4 RNA ligase 1 in the absence of ATP. Ligation
products were purified and reverse transcribed with Superscipt III (Invitrogen),
and amplified using Titanium DNA polymerase (Clontech). PCR products were
cloned and sequenced.
Immunodepletion Assay, GST Pulldown Assay, Western Blotting,
and Antibodies
protein G-Sepharose (GE Healthcare) (20 ml) was washed and incubated in
100 ml of Krebs extract with 6 mg of either mouse monoclonal anti-HA
Figure 8. Model for Temporal Stepwise miRNA-Mediated Gene
Silencing
(i) mRNA circularization via eIF4G-PABP interaction stimulates cap-dependent
translation by enhancing eIF4E’s binding to the mRNA 50 cap structure (strong
binding [Kahvejian et al., 2005]).
(ii) miRISC binds to its target site in the 30UTR. GW182 binds to PABP, hypo-
thetically inhibiting its interaction with eIF4G, thereby repressing cap-depen-
dent translation by decreasing eIF4E’s binding to the 50 cap structure (weaker
binding), and sequestering the poly(A) tail into the vicinity of CAF1 and CCR4
deadenylases (illustrated by an arrow) to facilitate deadenylation of the mRNA.
The interaction between CAF1/CCR4 and Ago2 is probably indirect through
other proteins (depicted as question marks).
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(Covance), rabbit anti-HA (Sigma), mouse monoclonal anti-Ago2 (Wako
Chemicals), or affinity-purified rabbit polyclonal anti-CAF1 with gentle agita-
tion for 2 hr at 4C. The resin was then centrifuged at 500 3 g, and the super-
natant was collected. GST pulldown assays of Krebs extract have been
described (Kahvejian et al., 2005). Antibodies and their working dilutions for
western blotting were as follows: rabbit polyclonal anti-Ago2, 1:1000; rabbit
polyclonal anti-PABP, 1:1000 (Cell Signaling Technologies); mouse mono-
clonal anti-Actin, 1:5000 (Sigma); mouse monoclonal anti-FLAG, 1:5000
(Sigma); mouse monoclonal anti-CAF1, 1:1000; mouse monoclonal anti-Tob
4B1, 1:1000 (Sigma); and mouse monoclonal anti-CCR4, 1:1000. For the
GST pulldown assay with HEK293 cell extracts, cells were lysed with 50 mM
Tris-HCl (pH 7.5) containing 150 mM KCl, 0.5% Triton X-100, 2 mM DTT,
and complete EDTA-free protease inhibitor cocktail (Roche). The cleared
lysate was incubated with glutathione Sepharose 4B (GE Healthcare) followed
by washing with 50 mM Tris-HCl (pH 7.5), containing 150 mMKCl, 0.1% Triton
X-100, 2 mM DTT, and complete protease inhibitor cocktail (Roche). Proteins
associated with glutathione Sepharose beads were eluted with 50 mM gluta-
thione in the same buffer as used for washing the beads and analyzed by
western blotting using anti-PABP1 antibody (Cell Signaling Technology),
anti-eIF4GI antibody (Gradi et al., 1998), and anti-GST antibody (GE Health-
care). To examine RNA dependence of protein-protein interactions, cleared
lysates were treated with micrococcal nuclease (Roche) (10 mg/ml) for 25 min
at room temperature in the presence of 1 mM CaCl2 before incubation with
glutathione Sepharose 4B beads.
Anti-let-7 20-O-Me Oligonucleotide Biotin Pulldown Assay
M-280 streptavidinmagnetic Dynabeads (Invitrogen) were washed three times
in buffer D (25 mM HEPES-KOH [pH 7.3], 2 mM MgCl2, 50 mM KCl, 75 mM
KOAc) and resuspended in buffer D with 2 mM DTT and 1 M NaCl and incu-
bated with biotin-labeled anti-let-7 20-O-Me, anti-miR122 20-O-Me, or anti-
miR35 20-O-Me oligonucleotide (Integrated DNA Technologies) for 60 min at
4C. 20-O-Me-bound beads were washed three times in buffer D and then
incubated in aliquots of Krebs extract containing protease inhibitors at 30C
for 60 min. Beads were washed three times in buffer D with 0.5% NP-40 and
boiled in SDS sample buffer and analyzed by SDS-PAGE andwestern blotting.
Cell Lines
HEK293 cells were transfectedwithMyc-Ago1 andMyc-Ago2 DNA constructs
using LT-1 transfection reagent according to the manufacturer’s instructions
(Mirus). All constructs contain a G418 resistance cassette. Stable transfec-
tants were selected with 500 mg/ml G418 (Roche) for at least 2 weeks prior
to being used in experiments.
Other HEK293T cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM; GIBCO-BRL) supplemented with 2 mM L-glutamine and 10% heat-
inactivated fetal calf serum (FCS). Transfections were performed in 10 cm
cell culture dishes with60% confluent cells using Nanofectin (PAA Laborato-
ries), following the manufacturer’s instructions. For mass spectrometry anal-
ysis, cells in one 10 cm cell culture dish were transfected with 6 mg of the
plasmid pEBG-DN1370. For IP experiments, cells in 10 cm cell culture dishes
were transfectedwith 6 mg of the plasmids pCI-NHA-1505-1610 and pCI-NHA-
DN1370 and 20 mg of the plasmids pCI-NHA-1-405, pCI-NHA-1-1034, and
pCI-NHA-1-1368. For the GST pulldown experiment cells, 10 cm cell culture
dishes were transfected with 4 mg of the plasmid pEBG-DN1370.
Mass Spectrometry Analysis
Cells were lysed with 50 mM Tris-HCl (pH 7.5) containing 150 mM KCl, 5 mM
MgCl2, 1 mM CaCl2, 0.5% Triton X-100, 2 mM DTT, and EDTA-free protease
inhibitor cocktail (Roche). The cleared lysate was incubated with glutathione
Sepharose 4B (GE Healthcare) followed by washing with 50 mM Tris-HCl
(pH 7.5) containing 150 mM KCl, 5 mM MgCl2, 1 mM CaCl2, 0.5% Triton
X-100, 2 mMDTT, and EDTA-free protease inhibitor cocktail (Roche). Cysteine
residues of proteins associated with the beads were reduced and alkylated
prior to gel separation. The Coomassie-stained bands were digested with
trypsin, and tryptic peptides were analyzed by nano-HPLC (Agilent 1100
nanoLC system, Agilent Technologies, Santa Clara, CA) coupled to a 4000 Q
TRAP mass spectrometer (Applied Biosystems, Foster City, CA). Peptides
were identified searching UniProt database (version 13.8) restricted to human
using Mascot (version 2.1, Matrix Science, London).
MuDPIT and Coimmunoprecipitation Analysis
Samples were prepared as follows: HEK293 cells were harvested and washed
with phosphate-buffered saline (PBS). Cells were washed once in hypotonic
lysis buffer (10 mM Tris-HCl [pH 7.5], 10 mM KCl, 1.5 mM MgCl2, 5 mM
DTT, and EDTA-free protease inhibitor cocktail [Roche]) and allowed to swell
for 20 min on ice prior to homogenization. Cell extracts were centrifuged in
a tabletop centrifuge at 10,000 rpm for 30 min at 4C to clarify the lysate.
The salt concentration in the extract was raised to 100 mM KCl. To immuno-
precipitate Ago and Ago-interacting proteins, Myc-agarose beads (Sigma)
were added to the extract and allowed to incubate for 6 hr with gentle rotation.
Immunoprecipitates were washed (wash buffer, 10 mM Tris-HCl [pH 7.5],
100 mM KCl, 1.5 mM MgCl2, 5 mM DTT, and EDTA-free protease inhibitor
cocktail [Roche]) four times for 30 min each. Immunocomplexes were eluted
from Myc-agarose beads by two serial washes in elution buffer (100 mM
Tris-HCl [pH 8.0], 8M urea). Proteins in eluates were precipitated with trichloro-
acetic acid and submitted for MuDPIT analysis (Washburn et al., 2001).
Samples analyzed for coimmunoprecipitation of Ago and Ago-interacting
proteins from HEK293 cells were prepared as above. In cases in which immu-
noprecipitates were subjected to RNase A treatment, immunoprecipitation
was performed as described, but the next to last washing step was done in
the presence of RNase A (10 units/ml in wash buffer). Samples were washed
an additional two times prior to SDS-PAGE andwestern blot analysis. Samples
analyzed for coimmunoprecipitation of Ago2- and CAF1-interacting proteins
from Krebs extracts were prepared as follows: Krebs extracts were treated
with micrococcal nuclease (Roche) in the presence of CaCl2 for 30 min at
20C and subsequently with EGTA as previously described (Svitkin and
Sonenberg, 2004). Krebs extracts were then mixed with protein G Dynabeads
(Invitrogen) already bound to either mouse monoclonal anti-HA (Covance),
rabbit anti-HA (Sigma), mouse monoclonal anti-Ago2 (Wako Chemicals), or
affinity-purified rabbit anti-CAF1 and gently mixed at 30C for 60 min. Immu-
noprecipitates were washed five times with buffer D containing 0.5% NP-40
prior to SDS-PAGE and western blot analysis. For HA epitope IP reactions,
cells were lysed with 50 mM Tris-HCl (pH 7.5) containing 150 mM KCl, 0.5%
Triton X-100, 2 mM DTT, and protease inhibitor cocktail (Roche). The cleared
lysate was incubated with Anti-HA Affinity Matrix (Roche). After washing
with 10 mM Tris-HCl (pH 7.5) containing 200 mM KCl, proteins associated
with the beads were analyzed by western blotting using anti-HA 3F10
antibody (Roche) and PABP1 antibody (Cell Signaling Technology) (Polacek
et al., 2009).
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The CED of both human and fly GW182s interacts with PABP, and 
this interaction, possibly by interfering with the PABP-eIF4G associa-
tion, promotes target mRNA deadenylation by recruiting, through PABP, 
the components of the CCR4–NOT deadenylation complex7,8,12,13. In 
addition, others14–16 have demonstrated the role of CCR4–NOT and 
PAN2–PAN3 deadenylation complexes in the deadenylation of miRNA 
targets. It is unclear how GW182 proteins recruit these deadenylase com-
plexes and how translation repression is modulated. One possible model 
is that the interaction of CED with PABP interferes with the PABP-
eIF4G association and reduces translation7,12,13. However, interfering 
with eIF4G-PABP interaction and binding of the CCR4–NOT complex 
through PABP cannot explain the repression of mRNAs bearing no 
poly(A) tails (reviewed in refs. 2,3), nor can it explain the repression by 
GW182 domains other than CED.
Previous work on the fly GW182 and human NED indicated a role 
for glycine-tryptophan (GW) repeats as effector motifs contributing 
to miRNA-mediated silencing17,18. Here we set out to investigate how 
the GW182 CED and NED regions bring about mRNA repression. We 
found that motifs bearing tryptophan residues also in contexts other 
than GW or WG function as important repressive sequences in the 
CED, both in human and D. melanogaster cells. The effector G/S/TW 
and WG/S/T motifs in the NED and CED recruit the components of 
CCR4–NOT and PAN2–PAN3 complexes in a PABP-independent 
manner to repress function of both poly(A)+ and poly(A)– mRNAs. 
These results identify the recruitment of the CCR4–NOT complex 
MicroRNAs (miRNAs) are small, ~21-nt–long RNAs that post-
transcriptionally regulate gene expression in eukaryotes. In animals, 
miRNAs bind to partially complementary sites in mRNAs, leading to 
translational repression and mRNA deadenylation and degradation1–4. 
miRNAs function as part of ribonucleoprotein complexes, miRNPs, 
with Argonaute (AGO) and GW182 family proteins being the crucial 
components. GW182s interact directly with AGO proteins and function 
downstream as effectors mediating mRNA repression. Hence, under-
standing the function of GW182 proteins is critical for understanding 
miRNA-mediated repression.
GW182 functional regions have been mapped in D. melanogaster 
and mammalian proteins. In D. melanogaster, three regions were found 
to repress tethered mRNA to a similar extent5: the N-terminal effec-
tor domain (NED) having multiple GW-repeats, the middle Q-rich 
region, and the C-terminal effector domain (CED) containing the 
poly(A) binding protein (PABP)-interacting motif 2 (PAM2) and the 
RNA-recognition motif (RRM). The role of the CED in repression was 
also previously established by others6–8. In mammals, tethering of the 
three regions mentioned above also represses reporter mRNA, with 
the major contribution being provided by the CED9–11. The mecha-
nism by which GW182 domains repress mRNA function appears to 
be evolutionarily conserved, as dGW182 can repress mRNA function 
in mammalian cells, and human TNRC6 proteins (mammals express 
three counterparts of dGW182: TNRC6A, B and C) act as repressors in 
D. melanogaster cells5,8,9.
miRNA repression involves GW182-mediated recruitment 
of CCR4–NOT through conserved W-containing motifs
Marina Chekulaeva1,4, Hansruedi Mathys1,2,4, Jakob T Zipprich1,2, Jan Attig1, Marija Colic1, Roy Parker3  
& Witold Filipowicz1,2
mirna-mediated repression in animals is dependent on the gW182 protein family. gW182 proteins are recruited to 
the mirna repression complex through direct interaction with argonaute proteins, and they function downstream to 
repress target mrna. Here we demonstrate that in human and Drosophila melanogaster cells, the critical repressive 
features of both the n-terminal and c-terminal effector domains of gW182 proteins are gly/ser/thr-trp (g/s/tW) or 
trp-gly/ser/thr (Wg/s/t) motifs. these motifs, which are dispersed across both domains and act in an additive manner, 
function by recruiting components of the ccr4–not deadenylation complex. a heterologous yeast polypeptide with 
engineered Wg/s/t motifs acquired the ability to repress tethered mrna and to interact with the ccr4–not complex. 
these results identify previously unknown effector motifs functioning as important mediators of mirna-induced 
silencing in both species, and they reveal that recruitment of the ccr4–not complex by tryptophan-containing motifs 
acts downstream of gW182 to repress mrnas, including inhibiting translation independently of deadenylation.
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in human cells8,13. Deletion of PAM2 (CEDDPAM2) abrogated the 
 association with PABP without affecting the interaction with CNOT1 
and CAF1, suggesting that the CED interaction with CCR4–NOT is 
PABP-independent (Fig. 1d). Moreover, the observed interactions were 
not mediated by RNA, as they were resistant to micrococcal nuclease 
treatment (Fig. 1d and Online Methods).
To identify sequences in CED∆PAM2 responsible for the CCR4–NOT 
interaction, we did pull-down assays with CED∆PAM2 subfragments (see 
Fig. 1a). Deleting either M2 or C-terminal (Cterm) regions reduced the 
interaction with CNOT1 and CAF1. The RRM alone did not pull down 
CNOT1 or CAF1, whereas a fusion of M2 and Cterm regions pulled 
them down with an efficiency similar to that of CEDDPAM2 (Fig. 1d).
repression by the ceD correlates with ccr4–not interaction
The CED domain and its subfragments were tested for activity in repress-
ing protein synthesis in an mRNA-tethering assay (Supplementary 
Fig. 2a). Tethering of the CED or CED∆PAM2 repressed Renilla luciferase 
expression by approximately ten times, when compared to proteins lacking 
the N-peptide (Fig. 1f). Constructs lacking either M2 or Cterm regions 
showed reduced repression, whereas the M2-Cterm fusion repressed 
almost as well as CED∆PAM2 (Fig. 1f). Hence, similarly to their require-
ment for the interaction with the CCR4–NOT complex, the combined M2 
and Cterm regions are sufficient for effective mRNA repression8.
as a critical event for miRNA-mediated mRNA degradation and 
 translation repression.
results
the ceD of tnrc6c interacts with the ccr4–not complex
The CED of human TNRC6C (DN1370 fragment; Fig. 1a) functions 
as an autonomous repressive domain, inducing both translational 
inhibition and mRNA degradation9. To elucidate how the CED 
induces the repression of target mRNAs, it was expressed as a gluta-
thione S-transferase (GST) fusion in HEK293T cells and used for pull-
down experiments. Among the pulled-down proteins, MS identified 
several components of the CCR4–NOT complex, including CNOT1, 
its scaffolding component and CNOT8, a paralog of the deadenylase 
CNOT7/CAF1 (Fig. 1b). PABP was also among the interacting pro-
teins, consistent with previous findings8,12,13. The interaction of the 
CED with different components of CCR4–NOT, either endogenous or 
ectopically expressed, was confirmed by western blotting (Fig. 1c,d). 
Notably, endogenous TNRC6A could also co-immunoprecipitate 
CNOT1 (Fig. 1e).
CAF1 was reported to interact with PABP through the TOB1 pro-
tein19, raising the possibility that the CED recruits CCR4–NOT through 
PABP. The PAM2 motif (Fig. 1a and Supplementary Fig. 1) represents 
the main region in the CED responsible for its interaction with PABP 
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to as W-motifs), rather than only GW or WG repeats, must have a role 
in repression. The TNRC6C CED contains eight W-motifs (Fig. 2a and 
Supplementary Fig. 1). We analyzed the effect of Trp→Ala mutations 
in W-motifs on expression of the tethered mRNA (Fig. 2a). Notably, 
although single Trp→Ala mutations had no marked effect on repres-
sion by the CED, their combinations had a progressive additive effect. 
Notably, when all eight tryptophans were mutated (W8), repression by 
the CED was fully alleviated. We observed no alleviation when other con-
served amino acid stretches were mutated in either PAM2 or M2 regions. 
Western blot analysis showed that the differences in repressive poten-
tial could not be explained by differences in expression levels (Fig. 2a). 
The most conserved tryptophan residue, Trp1515, did not contribute to 
repression (8W and 7W mutants differ only in the Trp1515 mutation). 
Trp1515 participates in the RRM structure6, whereas other W-motifs 
reside in regions predicted as disordered (http://dis.embl.de). Otherwise, 
W-motifs seem to contribute to repression independently of the degree 
of conservation and the context; that is, whether they are located next to 
glycine, serine or threonine residues (Fig. 2a).
Because the CED Trp→Ala mutants relieve repression activity, we 
determined, by MS, how these mutations affect the interaction of pro-
teins with the CED (Supplementary Fig. 4a). As expected, the wild-type 
CED associated with different components of the CCR4–NOT complex. 
However, none of them associated with the 7W mutant, indicating that 
the CED interacts with CCR4–NOT in a W-dependent manner. As both 
wild-type and 7W mutant CEDs contain the PAM2 region, each associ-
ated with PABP. We also observed that the PAN2–PAN3 deadenylase 
complex components were present among proteins bound by wild-type 
but not 7W mutant fusions, though PAN2 and PAN3 were found in 
smaller amounts than CCR4–NOT proteins.
When analyzed in the context of full-length TNRC6C, deletion of 
M2 and Cterm regions alleviated mRNA repression to a level com-
parable to that seen when the entire CED is deleted (Supplementary 
Fig. 2b). Similarly, both TNRC6C deletion mutants interacted less 
strongly with CAF1 and CNOT1 (Supplementary Fig. 2c). The ability 
of both mutants to still partially repress mRNA function and associate 
with CCR4–NOT is readily explained by observations that, in addition 
to the CED, N-proximal regions of GW182s have the potential to repress 
mRNAs5,9,17,18 and associate with CCR4–NOT components (see below).
To determine the features of M2 and Cterm regions that repress 
mRNA function, we identified conserved regions of two to six amino 
acids by alignment of different GW182 proteins (Supplementary 
Fig. 1). Because their mutagenesis in the context of CEDDPAM2 had 
a very limited effect (data not shown), we tested the mutations in the 
context of CEDDPAM2 subfragments, M2-RRM or RRM-Cterm (Fig. 1a 
and Supplementary Fig. 2d–h). This analysis revealed considerable 
redundancy of the CED sequences responsible for mediating both 
the interaction with CCR4–NOT and repression of mRNA function. 
Unexpectedly, our results also showed that all mutations appreciably 
affecting both activities were in elements containing tryptophan resi-
dues, and those tryptophan residues were important for the repres-
sive activity, in a manner that involved recruitment of CCR4–NOT 
(Supplementary Figs. 2d–h and 3a,b and Supplementary Results).
W-motifs represent signals recruiting deadenylase complexes
When inspecting the alignment of the CED across different species, we 
noted that GW or WG repeats in one GW182 homolog often align with 
the S/TW or WS/T repeats in other homologs (Supplementary Fig. 1). 
We hypothesized that reiterated G/S/TW or WG/S/T repeats (referred 
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Figure 2  W-motifs in GW182 proteins mediate mRNA repression by recruiting CCR4–NOT and PAN2–PAN3 deadenylation complexes. (a) Mutations of 
tryptophan residues in W-motifs alleviate repression by the TNRC6C CED. Schematic representation of the TNRC6C CED with positions of W-motifs marked 
with asterisks is shown above the graph. Plasmids encoding either wild-type NHA-CED or its mutants (mutations always to alanine; when several consecutive 
amino acids are mutated, the number corresponds to the first residue in the mutated stretch) were co-transfected to HEK293T cells, together with RL-5BoxB 
and FL-Con. As negative controls, plasmids encoding untethered HA-TNRC6C or HA-CED were used. Mutants 2W through 8W contain Trp→Ala mutations in 
W-motifs (for details, see Online Methods). All GW, W1487 W1494 W1648 W1659; most conserved tryptophan, W1504 W1515; less conserved tryptophan, 
W1487 W1605 W1648 W1659. Values represent percentages of Renilla luciferase produced in the presence of untethered HA-CED control. Expression  
of HA- or NHA- fusion proteins was estimated by western blotting (lower panel). (b) Proteins identified as interacting with the CED in a tryptophan-dependent 
manner by MS (Supplementary Fig. 4a) were validated by GST pull-down assays and western blotting. Positions of protein size markers are indicated.  
(c) W-motifs are required for repression by the D. melanogaster GW182 CED. NHA-dGW182 CED, either wild-type or with mutations, were co-transfected 
with FL-5BoxB and RL-Con in S2 cells. As negative controls, plasmids encoding HA-dGW182 and HA-dGW182 CED were used. Mutants 2W through 8W 
contain mutations in W-motifs, with some (5Wa and 7Wa) having different combinations of mutated tryptophans (positions of W-motifs are marked with 
asterisks in the scheme above; for details, see Online Methods). Expression of firefly luciferase was normalized to Renilla luciferase. Values represent 
percentages of firefly luciferase produced in the presence of HA-CED. Expression of HA-fusions was estimated by western blotting.
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also weakly interact with the CED through PABP, which is consistent 
with the direct PAN3-PABP interaction previously described20.
To investigate whether the role of W-motifs in repression is conserved 
across the species, we also introduced Trp→Ala mutations into the eight 
W-motifs in the dGW182 CED (Fig. 2c and Supplementary Fig. 1). 
The mutant proteins were tethered to the firefly luciferase reporter 
FL-5BoxB, expressed in fly S2 cells. As in the case of the TNRC6C CED, 
mutations alleviated repression in an additive manner, leading to almost 
no repression when all tryptophans were mutated. In contrast, mutation 
of other conserved sequences had no appreciable effect (Fig. 2c).
Taken together, our data indicate that the role of W-motifs in mRNA 
repression is evolutionarily conserved and that W-motifs function by 
recruiting CCR4–NOT and PAN2–PAN3 complexes independently 
of PABP.
repression by neD and ceD follows a similar mechanism
To test if the recruitment of the CCR4–NOT complex represents a 
mechanism conserved across different effector domains and across spe-
cies, we analyzed the function of the dGW182 NED in human HEK293T 
cells. Our previous work demonstrated that the dGW182 NED is able 
to repress the tethered mRNA in human cells9, and we investigated 
whether mutations in W-motifs in that region would affect its repres-
sive potential. Because the 205–490 dGW182 fragment, studied previ-
ously in S2 cells, was less effective in human cells (data not shown), 
We also analyzed the pull-down assays by western blotting (Fig. 2b). 
Both CNOT1 and CAF1 interacted with wild-type CED but not with its 
7W mutant. Mutations of W-motifs also strongly affected association 
with PAN2 and PAN3 but had no major effect on interaction with PABP. 
In two out of four experiments, however, PABP binding was slightly 
affected in the 7W mutant (1.5-fold to two-fold; not shown). This could 
be explained by the secondary weak PABP binding site located in the M2 
or Cterm regions7,13. Interactions with PABP through this site seemed 
to be indirect8, suggesting that they occur through components of the 
CCR4–NOT or PAN2–PAN3 complexes.
We have mapped regions in the CED required for PABP and CCR4–
NOT interactions, so we were able to determine the interdependence of 
these interactions. Mutations in PAM2 that disrupted the CED-PABP 
interaction (mutant EF1388; mutations are always to alanine; when 
several consecutive amino acids are mutated, the number corresponds 
to the first residue in the mutated stretch) did not affect the associa-
tion of CED with CCR4–NOT, whereas the 7W mutant that did not 
interact with CCR4–NOT still interacted with PABP (Fig. 2b). Hence, 
the CED interactions with CCR4–NOT and PABP are independent. 
The PAN2–PAN3 interactions were more complex: mutation of PAM2 
somewhat reduced binding of PAN2 and PAN3, though not as strongly 
as mutations of W-motifs, and the double EF1388 7W mutant showed no 
PAN2–PAN3 binding (Fig. 2b). These results suggest that PAN2–PAN3 
is primarily recruited through the function of W-motifs but that it can 
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Figure 3  W-motifs present in the dGW182 NED and the engineered yeast protein fragment repress 
tethered mRNA and recruit components of CCR4–NOT. (a) The dGW182 NED W-motifs function in 
mRNA repression. HEK293T cells were transfected with RL-5BoxB, FL-Con and plasmids expressing 
either full-length NHA-dGW182 or its NED (1–490) (WT or 6W mutant; for description of the  
mutant, see ref. 17). As negative controls, HA-dGW182 and HA-dGW182(1–490) were used. As 
positive controls, TNRC6C NHA-CED and full-length NHA-dGW182 were tethered. Values represent 
percentages of Renilla luciferase produced in the presence of HA-dGW182(1–490). Western blot 
analysis of HA- or NHA-fusion proteins is presented below. (b) GST fusions of the dGW182(1–490), 
WT and 6W mutant, expressed in HEK293T cells, were used for GST pull-down assays. Inputs (7% for 
anti-CNOT1, anti-CAF1, anti-tubulin and anti-GST; 15% for anti-PABP, anti-PAN2 and anti-PAN3) and 
the pulled-down material were analyzed by western blotting, using indicated antibodies. Additional western blots (on the right) for PABP, PAN2 and PAN3 
represent pull-down assays done with the TNRC6C GST-CED analyzed in parallel on the same gel. Anti-PAN3 antibody cross-reacts with GST (asterisk).  
(c) W-motifs are sufficient to induce repression of tethered mRNA. HEK293T cells were transfected with RL-5BoxB, FL-Con and plasmids encoding 
engineered N-Sic-GST protein fusions having either four (N-Sic4xW-GST) or seven (N-Sic7xW-GST) W-motifs. N-Sic-GST containing no tryptophan residues, 
and NHA-GST, served as controls; plasmids encoding TNRC6C N-CED-GST, WT and 7W mutant were transfected for comparison. (d) GST pull-down assays 
with GST-Sic7xW, GST-CED (positive control), and GST-CED 7W and GST-Sic (negative controls), were done as in Figure 1d. The pulled-down material was 
analyzed by western blotting, using indicated antibodies.
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GST polypeptides and their activity tested in the tethering assay. 
Notably, the proteins containing W-motifs were able to repress Renilla 
 luciferase-5BoxB (RL-5BoxB) mRNA, with the degree of repression 
being dependent on the number of motifs (Fig. 3c). Moreover, GST pull-
down experiments revealed that both CAF1 and CNOT1, but not PABP, 
were bound by Sic7xW but not the control tryptophan-free fragment 
(Fig. 3d). Hence, W-motifs are not only necessary but also sufficient to 
induce mRNA repression by recruiting CCR4–NOT.
W-motifs function in a genuine mirna-mediated repression
We next investigated whether W-motifs also function in the context 
of full-length GW182 proteins. Mutation of tryptophan residues in 
W-motifs of the CED strongly compromised the repressive potential of 
TNRC6C in HEK293T cells (Fig. 4a, mutants 7W and 8W, ~four-fold 
effect; for clarity, the data are also shown as fold derepression in the right 
panels of Fig. 4a,b). A more marked effect (~ten-fold) of tryptophan 
mutations on activity of the CED alone (Fig. 4a; see also Fig. 2a) is read-
ily explained by the potential of the TNRC6 N-proximal sequences to 
partially repress the tethered mRNA9,18. In the context of the full-length 
TNRC6C, the PAM2 mutation EF1388 led to moderate alleviation of 
repression, consistent with previous data8.
a longer 1–490 fragment was used instead. We observed that six 
Trp→Ala mutations in GW repeats in the 205–490 region (mutant 
NHA-dGW182(1–490)6W) led to a marked alleviation of repression 
(Fig. 3a), similar to that observed in D. melanogaster S2 cells17.
Analysis of interaction partners of the dGW182 NED(1–490) in 
HEK293T cells revealed that it interacts with CNOT1 and CAF1 in 
a W-dependent manner (Fig. 3b), suggesting that the mechanism of 
mRNA repression by different GW182 domains is similar and involves 
the recruitment of CCR4–NOT through W-motifs. Neither PABP nor 
PAN2–PAN3 was detected in the NED GST pull-down assays, whereas 
they were pulled down with the TNRC6C CED (Fig. 3b, lower panels). 
Thus, interaction with PABP and PAN2–PAN3 may not be required 
for repression by the NED.
engineered W-motifs are sufficient to induce repression
We investigated whether W-motifs are not only required but also  sufficient 
to induce mRNA repression. We introduced X→Trp mutations (with X 
corresponding to any amino acid) to the unstructured fragment of the 
yeast protein Sic1p21. The resulting engineered proteins, having either four 
(Sic4xW) or seven (Sic7xW, Supplementary Fig. 4b and Supplementary 
Methods) sequences resembling the W-motifs, were fused to N- and 
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Figure 4  W-motifs are necessary for 
repression by full-length GW182 and 
function in bona fide miRNA repression. 
(a) W-motifs are required for repression 
by tethered full-length TNRC6C. The 
experiment was done as in Figure 2a 
but included the full-length TNRC6C. 
The right panel shows fold derepression 
relative to repression induced by WT 
NHA-TNRC6C or NHA-CED taken to 
be a value of 1 (broken line). Western 
analysis of expression levels of relevant 
mutants in a and other panels, with 
anti-HA antibody, is shown below the 
graphs. (b) Mutations in W-motifs lead to partial derepression of tethered mRNAs in D. melanogaster S2 cells. The assay was done as in Figure 2c but with 
the full-length dGW182 and TNRC6C. 6W, 7W and EF1388 mutations were described in Figures 2 and 3a but are here introduced into the full-length 
proteins. 13W mutant combines 6W and 7W; PAM2mut has EF960 WK967 Thr982 mutated. NHA-Q–rich (1080–1245) and NHA-CED represent TNRC6C 
fragments. In the right panel, data are presented as in a. (c) W-motifs are required to rescue depletion of endogenous dGW182. Endogenous dGW182 was 
depleted in D. melanogaster S2 cells with dsRNA (open bars); a batch of cells was treated with GFP-specific dsRNA as a control (black bars). Cells were 
transfected with RL-Con, FL-nerfin, and plasmids encoding miR-9b or miR-12, or the empty vector. To rescue depletion of dGW182, increasing amounts 
of plasmids encoding NHA-dGW182, NHA-TNRC6C or their mutants were co-transfected. In panels c and d, extracts from cells transfected with highest 
plasmid concentrations were used for western blotting. (d) W-motifs are necessary to complement the knockdown of endogenous TNRC6 proteins. HeLa cells 
were transfected with siRNAs targeting three endogenous TNRC6 proteins (open bars) or AllStars siRNA (negative control, black bars), RL-hmga2 reporter 
containing let-7 sites or its mutant version (RL-hmga2 mut), and increasing amounts of plasmids expressing NHA-TNRC6A or its mutants: 8W has Trp→Ala 
mutations in W-motifs within the CED region (Supplementary Fig. 1 and Online Methods); EF1358 has PAM2 mutated.
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role of W-motifs and ccr4–not in poly(a)– mrna repression
Recruitment of the CCR4–NOT deadenylase explains how miRNAs 
and tethered GW182 silencing domains induce deadenylation and 
mRNA decay2,3. Indeed, we observed that tethering of the dGW182 
CED induces deadenylation of the FL-5BoxB reporter and that this 
effect is dependent on W-motifs (Supplementary Fig. 5). Do the CED 
and CCR4–NOT also mediate the translational repression known to 
be induced by miRNA machinery2–4? To address this question we first 
tested whether the dGW182 CED can repress, in a W-motif– dependent 
manner, tethered mRNAs in which the polyadenylation signal is sub-
stituted by either a histone stem loop (HSL) or a hammerhead ribo-
zyme (HhR). These mRNAs, FL-5BoxB-HSL and FL-5BoxB-HhR, 
were previously shown to have no poly(A) and to undergo transla-
tional repression in S2 cells in response to tethered dGW182, without 
changes in mRNA levels25. Tethering of dGW182 to FL-5BoxB-HSL 
and FL-5BoxB-HhR repressed their activity by four and two times, 
respectively (Fig. 5a), as reported25. Tethering of the dGW182 CED 
or its longer version extending to the dGW182 C terminus (CED*) 
was slightly less inhibitory, but, notably, the inhibition was nearly fully 
relieved by mutating W-motifs. Similarly to the effect of CED domains, 
direct tethering of the fly Caf1 (dCAF1) and human CNOT1 (the 
D. melanogaster clone is not available) reduced, by 55% to 75%, activity 
of both poly(A)+ and poly(A)– reporters in S2 cells (Fig. 5b). Although 
the inhibition of poly(A)+ RNA by either the dGW182 CED domain or 
CCR4–NOT components was associated with a decrease of approxi-
mately two times in mRNA levels, repression of poly(A)– mRNAs was 
not accompanied by pronounced mRNA degradation (Fig. 5b).
We also investigated whether human TNRC6C CED and human 
CCR4–NOT proteins can repress tethered mRNA independently of 
poly(A) in HEK293T cells. We found that both classes of proteins repress 
activity of the poly(A)– reporter that was either expressed from plasmids 
or transfected as in vitro transcribed mRNA, the latter bearing the cordy-
cepin residue at the 3ʹ end to prevent its potential adenylation in the cell. 
Inhibition of the poly(A)– mRNAs was not accompanied by their degrada-
tion (Supplementary Figs. 6a–e and 7a–d and Supplementary Results).
Collectively, these results show that recruitment of the GW182 CED 
or components of CCR4–NOT also induces silencing of poly(A)– 
mRNAs, without any accompanying RNA degradation, suggesting that 
the CCR4–NOT complex mediates not only mRNA deadenylation but 
also translational repression.
repression of poly(a)– rna by gW182 depends on ccr4–not
If the CCR4–NOT complex functions downstream of GW182 during 
repression of poly(A)– mRNAs, the inhibitory effect of GW182 should 
be dependent on CCR4–NOT. To address this assumption, dGW182 and 
its fragments were tested for their ability to repress the poly(A)– mRNA 
in S2 cells depleted of NOT1, a large CCR4–NOT complex scaffolding 
protein26. Depletion of NOT1 resulted in a marked alleviation of repres-
sion, more pronounced for the fragments of dGW182 (2.5-fold to three-
fold) than the full-length dGW182 (two-fold) (Fig. 6a). This is probably 
due to dGW182 also containing domains (for example, Q-rich5) that 
may repress mRNA by a CCR4–NOT–independent mechanism.
The observation that repression of poly(A)– RNA by tethering 
dGW182 and its fragments depends on NOT1 suggested that the CCR4–
NOT complex also acts downstream of GW182 in translational repres-
sion. Consistently, repression caused by tethering of the CCR4–NOT 
proteins dCAF1 and CNOT1 to FL-5BoxB-HSL RNA was not affected 
by depletion of endogenous dGW182 (Fig. 6b). Of note, the dGW182 
depletion resulted in partial (30–40%) alleviation of the repression of the 
poly(A)+ FL-5BoxB reporter (Fig. 6b). This is consistent with results indi-
cating that GW182 affects repression not only through the  recruitment 
In D. melanogaster S2 cells, mutating W-motifs also led to allevia-
tion of repression induced by either dGW182 or TNRC6C, though the 
effects were less pronounced than in human cells (Fig. 4b). This can be 
explained by a marked contribution of the Q-rich domains of these pro-
teins to the repression in S2 cells (Fig. 4b, NHA-Q-rich and ref. 5). For 
dGW182, mutating W-motifs in either NED (mutant 6W) or CED (7W) 
alone had only a mild effect (~two-fold), but combining these mutations 
(13W) led to more than four-fold alleviation of repression. Mutating 
seven tryptophans within the CED of TNRC6C alleviated repression 
~three-fold, with mutations in PAM2 having no effect (Fig. 4b).
Having demonstrated that W-motifs function in the context of 
full-length GW182 proteins, we analyzed their importance in a bona 
fide miRNA repression assay. We depleted S2 cells of the endogenous 
dGW182 and tested tryptophan mutants of dGW182 for activity to 
rescue miRNA repression. To assess miRNA-mediated silencing, cells 
were co-transfected with the firefly luciferase–nerfin (FL-nerfin) 
reporter and the plasmid expressing miR-9b, which targets the 
FL-nerfin 3ʹ UTR. miR-9b efficiently repressed FL-nerfin mRNA in 
control cells (Fig. 4c, black bars), and depletion of dGW182 (open 
bars) partially alleviated miR-9b–induced repression; as expected, 
transfection of a plasmid encoding wild-type dGW182 resistant to 
RNAi rescued the repression. Mutations of tryptophans in either NED 
(6W) or CED (7W) had only a minor effect on the functionality of 
dGW182 in the rescue, consistent with independent repression by 
NED and CED domains5. However, combining the tryptophan muta-
tions in both regions led to a strong alleviation of repression, demon-
strating the role of W-motifs in miRNA-mediated silencing. Mutation 
of the PAM2 motif had no appreciable effect.
Because GW repeats present in the N-terminal part of dGW182 
contribute to dAGO1 binding22, we tested if mutations of tryptophans 
introduced into dGW182 affect its interaction with dAGO1. We found 
that whereas the 7W mutant interacted with dAGO1 as efficiently as 
wild-type dGW182, the 6W and 13W mutants showed lower levels 
of binding (Supplementary Fig. 4c). Consequently, it is possible that 
tryptophan residues in the NED contribute to the rescue not only by 
enhancing the CCR4–NOT interaction (Fig. 3b) but also by increasing 
the affinity of dGW182 for dAGO1. However, as 6W and 13W mutants 
have similar dAGO1-binding properties (Supplementary Fig. 4c), we 
can conclude that W-motifs in the CED are required for the dGW182 
function in miRNA repression (Fig. 4c).
Because human TNRC6C is able to complement the knockdown of 
dGW182 in S2 cells8 (Fig. 4c), we tested the effect of tryptophan muta-
tions on its function in rescue experiments. Notably, mutations of the 
W-motifs within the CED region (7W) strongly alleviated repression 
by TNRC6C. This is consistent with findings that the CED represents 
the major repressive region of human GW182 proteins6,9,11. To test the 
requirement of W-motifs for miRNA repression in human cells, we used 
a reporter having the 3ʹ UTR of the HMGA2 gene (RL-hmga2), which is 
targeted by let-7 miRNA23,24. This miRNA is expressed endogenously 
in HeLa cells, and it represses RL-hmga2 by about three times when 
compared with its mutant version that has disabled let-7 sites (Fig. 4d, 
black bars). Depletion of all three TNRC6 proteins by RNAi led to almost 
full alleviation of the repression (Fig. 4d, open bars), which could be 
rescued with the wild-type TNRC6A (we used a TNRC6A paralog, as it 
functions most efficiently in the complementation assay8). Mutation of 
PAM2 (EF1358) partially interfered with the rescue, consistent with the 
previous report8. Notably, mutations of W-motifs either alone (8W) or 
in combination with PAM2 mutation (EF1358 8W) led to a nearly com-
plete loss of TNRC6A function in miRNA repression. We conclude that 
W-motifs of both D. melanogaster and human GW182s are important 
for bona fide miRNA-mediated silencing.
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dGW182, TNRC6C and TNRC6A to rescue miRNA-mediated silenc-
ing in GW182-depleted cells was strongly compromised upon mutation 
of W-motifs. (v) Finally, fragments of the yeast protein Sic1p having 
engineered W-motifs acquired the ability to repress mRNA and to inter-
act with the CCR4–NOT components. Hence, W-motifs are not only 
required but also sufficient to induce repression by recruitment of the 
CCR4–NOT complex. Notably, two motifs in TNRC6C, identified in 
an accompanying paper27 as important for mediating deadenylation 
and CCR4–NOT interaction in vitro, also contain tryptophan residues.
It is unlikely that alleviation of mRNA repression by Trp→Ala 
substitutions is due to perturbation by the higher-order structure of 
the polypeptides or by their folding upon binding to target proteins. 
First, the mutated W-motifs are located in the NED and CED regions 
that are predicted to be disordered (http://dis.embl.de). Indeed, NMR 
analysis of the TNRC6C NED confirmed its disordered character 
(F. Laughlin, M. Chekulaeva, W.F. and F. Allain, unpublished data). 
Second, in the case of the CED ‘half ’ regions—that is, the M2-RRM 
and RRM-Cterm regions—mutating even one or two tryptophan 
residues had an  appreciable effect on repression. Third, the Sic1p pro-
tein fragment used for the gain-of-repression experiments is known 
to be unstructured21 and, apart from engineered W-motifs, shows no 
sequence similarity to repressive GW182 fragments.
We also observed that the CED domain interacts with the PAN2–PAN3 
complex in a manner dependent on W-motifs. Others15 have previously 
shown that PAN2 contributes to miRNA-mediated deadenylation, most 
probably at its initial stage. Our data indicate that PAN2–PAN3 is primar-
ily recruited through the function of the W-motifs in the CED, but it can 
also weakly interact with the CED through PABP (Fig. 2c), consistent with 
the previously described direct PAN3-PABP interaction20.
of CCR4–NOT but also through the association with PABP, and the 
latter interaction has been shown to be important for miRNA-induced 
de adenylation7,12,13. We conclude that the CCR4–NOT complex also 
functions downstream of GW182 during repression of poly(A)– mRNAs, 
consistent with its role in mediating inhibition of translation.
Discussion
We here provide evidence that human and D. melanogaster GW182 
proteins repress mRNAs by recruiting the CCR4–NOT complex to 
the mRNA, in a PABP-independent manner. This recruitment speci-
ficity comes from W-motifs that are dispersed throughout the N- and 
C-terminal regions of the proteins and that act in an additive manner. 
Moreover, we found that recruitment of CCR4–NOT represses both 
poly(A)+ and poly(A)– mRNAs, arguing that this complex, in addition 
to catalyzing mRNA deadenylation, also mediates miRNA-induced 
translational repression.
The following evidence supports the conclusion that W-motifs rep-
resent critical signals for recruiting CCR4–NOT and inducing mRNA 
repression. (i) Exhaustive mutagenesis of the CED identified redundant 
W-containing elements in the CED M2 and Cterm regions and dem-
onstrated a strong correlation between repression and interaction with 
CCR4–NOT. (ii) Introduction of an increasing number of Trp→Ala 
mutations, in both GW (or WG) and S/TW (or WS/T) contexts, across 
the CED regions of either TNRC6C or dGW182, had an additive effect 
on alleviating repression, regardless of whether these substitutions were 
tested in the CED or full-length proteins. (iii) W-motifs present in the 
NED and CED regions functioned in an additive manner and by similar 
mechanisms that involved the recruitment of the CCR4–NOT complex. 
(iv) In the assay measuring bona fide miRNA repression, the activity of 
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Figure 5  The CED W-motifs and CCR4–NOT complex contribute to repression of poly(A)– mRNAs 
in fly cells. (a) The CED W-motifs contribute to repression of poly(A)– mRNA in fly cells. S2 cells 
were co-transfected with plasmids encoding NHA fusions of the WT dGW182 CEDs (NHA-CED 
or NHA-CED*) or its indicated mutants, together with plasmids encoding the indicated reporters 
(FL-5BoxB, FL-5BoxB-HSL or FL-5BoxB-HhR) and RL-Con. Normalized firefly luciferase activity 
is indicated as the percentage of activity in cells expressing NHA-lacZ set as 100%. Expression 
of relevant HA- and NHA-fusion proteins was estimated by western blotting and is shown in the 
panel on the right. (b) Tethering dCAF1 or human CNOT1 represses poly(A)+ and poly(A)– mRNAs 
in fly cells. Cells were co-transfected with plasmids expressing HA or NHA fusions of dCAF1 or 
human CNOT1 and plasmids encoding indicated reporters. Normalized firefly luciferase activity is indicated as the percentage of activity in cells expressing 
HA fusions of dCAF1 or human CNOT1 set as 100%. Expression levels of HA- and NHA-fusion proteins were estimated by western blotting (shown above the 
graph). HA- and NHA-CNOT1 were only detectable after enrichment by anti-HA antibody immunoprecipitation. Lower signal of the NHA-tagged, compared to 
HA-tagged protein, may be partially due to the lower reactivity of anti-HA antibody with the internally located epitope. Analysis of mRNA levels by northern 
blotting is shown below the graph. Identity of analyzed reporters (including Renilla luciferase mRNA as a reference) is shown on the left, and the co-
transfected CCR4–NOT complex components are indicated at the bottom.
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the TNRC6C CED and CCR4–NOT most probably occurs through 
the CNOT1 subunit of the complex, because human CNOT1, but not 
CNOT6 or CNOT7/CAF1, interacted with the CED in the yeast two-
hybrid system (Supplementary Fig. 8). CNOT1 was also by far the most 
effectively pulled down CCR4–NOT complex component identified by 
MS (Fig. 1b and Supplementary Fig. 4a).
One of the most important findings of our work is that components 
of the CCR4–NOT complex are able to repress not only polyadenyl-
ated but also poly(A)-free mRNAs. The observation that repression of 
poly(A)– RNA by dGW182 and its fragments depends on CCR4–NOT, 
whereas repression by tethering of CCR4–NOT proteins is dGW182-
independent, indicates that the CCR4–NOT complex acts downstream 
of GW182 proteins also during repression of poly(A)– mRNAs. Together 
with the finding that the CCR4–NOT repression of poly(A)– RNAs is not 
associated with a decrease in mRNA levels, these data strongly implicate 
the CCR4–NOT proteins in mediating translational repression induced 
by miRNAs. These results are consistent with recent work29 showing that 
tethering of CAF1 to the microinjected reporter mRNA can repress trans-
lation at the initiation step in Xenopus laevis oocytes. Our experiments 
extend these results by demonstrating that the CCR4–NOT complex may 
be responsible for translational repression induced by miRNAs. We also 
found that in HEK293T and S2 cells, the tethering of CAF1 and, notably, 
other subunits of the CCR4–NOT complex, repressed mRNA activity 
(Supplementary Fig. 7c), without affecting the levels of poly(A)– mRNA 
(Fig. 5b and Supplementary Fig. 7b). Jointly, these observations indi-
cate that W-motif–mediated recruitment of the CCR4–NOT complex 
causes both translational repression and  deadenylation of target mRNAs 
The additive contribution of W-motifs, distributed in disordered pro-
tein regions, raises the question of how these motifs promote the interac-
tion of GW182 and CCR4–NOT. Does the sheer quantity of the motifs 
just increase the probability of initial productive interactions? Do the 
 tryptophan-containing regions recruit more than one CCR4–NOT com-
plex at a time? One model of GW182 function is reminiscent of protein-
protein interactions reported for the U2AF homology motif (UHM) of 
the U2 snRNP factor U2AF65 (ref. 28). In that case, the spliceosome com-
ponent SF3b155 binds to the U2AF65 UHM through motifs having an 
essential tryptophan and consensus RWD/E. Similarly to GW182 proteins, 
SF3b155 contains an unstructured region with seven RWD/E repeats28.
The CCR4–NOT components CAF1 and CNOT1 were previously 
identified as important for miRNA-mediated deadenylation in both 
flies and mammals, and it has been suggested that the interaction of 
GW182 with PABP might lead to the recruitment of CCR4–NOT to 
mRNA7,12,14–16. Our data indicate that recruitment of CCR4–NOT by 
W-motifs present in CED and NED regions is independent of PABP and 
represents either a complementary or alternative mechanism for repres-
sion. The critical observation in our study was that deletion of PAM2 
or its mutation that disrupts CED-PABP interaction did not affect the 
CED association with CCR4–NOT and mRNA repression, whereas the 
CED 7W mutant, which still interacted with PABP but not with CCR4–
NOT, was inactive in repression (Fig. 2). Moreover, the dGW182 NED 
region, which is repressive in both S2 and HEK293T cells, interacted 
with the CCR4–NOT complex components but not with PABP (Fig. 3b). 
Similarly, the repressive yeast Sic1p fragment associated with the 
CCR4–NOT proteins but not PABP (Fig. 3d). The association between 
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Figure 6  Repression of poly(A)– RNA by tethering 
dGW182 or its fragments depends on NOT1, but 
repression by tethered CCR4–NOT components 
is dGW182-independent. (a) Repression of FL-
5BoxB-HSL reporter by tethering dGW182 or 
its fragments is alleviated in S2 cells depleted 
of NOT1. S2 cells treated with dsRNA targeting 
GFP or NOT1 were co-transfected with plasmids 
expressing either NHA fusions of dGW182 and 
its fragments or the PIN domain (either WT or 
a catalytic mutant thereof) of the endonuclease 
SMG6, and also reporter plasmids FL-5BoxB-
HSL and RL-Con. Normalized firefly luciferase 
activity is indicated as percentage of the activity 
in cells expressing NHA-lacZ or SMG6-PINmut, 
set as 100%. The NOT1 depletion affected the 
repression by dGW182 and its fragments but 
had no effect on repression by SMG6-PIN that 
targets mRNA for endonucleolytic degradation35, 
supporting the specificity of the effect.  
(b) Repression of FL-5BoxB and FL-5BoxB- 
HSL reporters by tethered dCAF1 and human 
CNOT1 is unaffected in S2 cells depleted of 
dGW182. Normalized firefly luciferase activity 
is indicated as the percentage of activity in cells 
expressing HA-dCAF1 or HA-CNOT1, or cells 
transfected with pAC5.1 (empty vector), each  
set as 100%. The efficiency of GW182 depletion 
was analyzed by western blotting (lower panel). 
Lanes 1–5, dilutions of the extract from S2 cells 
treated with GFP-specific (control) dsRNA.  
(c) Scheme illustrating a possible mode of 
action of GW182 proteins in miRNA-mediated 
repression. GW182 proteins are recruited to mRNA through direct interaction with the miRNA–AGO complex. The GW182 NED and CED regions both recruit, 
through the W-motifs, the CCR4–NOT complex that represses translation and leads to mRNA deadenylation. Interaction of the GW182 PAM2 motif with 
PABP may interfere with the PABP-eIF4G association, thus contributing to translational inhibition and mRNA deadenylation. The PABP interaction with the 
CED M2/C-term regions (broken line) may be mediated by the CCR4–NOT complex (see text).
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(see model in Fig. 6c). We find it interesting that in yeast and in fly, the 
CCR4–NOT complex is known to interact with the translational repres-
sor Dhh1/Me31b30,31, whose orthologs in other organisms are known to 
be required for miRNA-mediated repression32–34, suggesting a possible 
mechanism by which the CCR4–NOT complex could repress translation.
metHoDs
Methods and any associated references are available in the online version 
of the paper at http://www.nature.com/nsmb/.
Note: Supplementary information is available on the Nature Structural & Molecular 
Biology website.
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The mutants in the dGW182 CED are designated as follows: 2W stands for 
W1107 W1114; 3W, W1107 W1114 W1118; 4W, W1092 W1107 W1114 W1118; 
5W, W1051 W1092 W1107 W1114 W1118; 6W, W1037 W1051 W1092 W1107 
W1114 W1118; 7Wa, W1024 W1037 W1051 W1092 W1107 W1114 W1118; 
8W, W942 W1024 W1037 W1051 W1092 W1107 W1114 W1118A; 8Wa, W942 
W1024 W1037 W1051 W1092 W1107 W1114 W1350; 7W, W942 W1024 W1037 
W1051 W1092 W1107 W1114; and 5Wa, W942 W1024 W1037 W1051 W1092.
The 8W mutant of the TNRC6A contains the following mutations: W1420A 
W1450A W1494A W1505A W1518A W1619A W1666A W1676A (see 
Supplementary Fig. 1).
Pull-down assays and western blotting. For GST pull-down assays, HEK293T 
cells grown in a 10-cm dish were transfected with 5 mg plasmid expressing GST-
TNRC6C CED, GST-dGW182(1–490) (or mutants thereof), GST-Sic or GST-
Sic7xW. Cells were lysed 24 h after transfection and GST-fusions were pulled 
down as described40. In short, cells were lysed in buffer A (50 mM Tris-HCl, 
pH 7.5, 150 mM KCl, 0.5% (v/v) Triton X-100, 1× complete EDTA-free prote-
ase inhibitor mix (Roche)), and cleared lysates were treated with micrococcal 
nuclease (10 ng ml–1) for 25 min at 20 °C. We have verified that this treatment 
eliminates RNA-dependent interactions (see, for example, Fig. 6c in ref. 40). The 
lysates were incubated with glutathione (GSH)-Sepharose beads (GE Healthcare) 
for 2 h at 4 °C; beads were washed 3× with buffer A containing 0.1% (v/v) Triton 
X-100, and GST-fusions were eluted with 50 mM GSH. For anti-TNRC6A immu-
noprecipitations, HeLa cells were lysed in buffer B (50 mM Tris-HCl, pH 7.5, 
150 mM NaCl, 0.5 mM DTT, 0.5% (v/v) NP40, 1× complete EDTA-free protease 
inhibitor (Roche)), treated with micrococcal nuclease as described above and 
incubated with anti-TNRC6A antibody (Bethyl A302-330A) or, as a negative 
control, with rabbit IgG (Sigma) bound to Dynabeads Protein G (Invitrogen) 
overnight at 4 °C. Beads were washed 3× with buffer B containing 0.1% (v/v) 
NP-40 and boiled in Laemmli SDS-PAGE buffer.
The following primary antibodies were used for western blotting: anti-TNRC6A, 
1:5000 (Bethyl A302-329A); anti-CNOT1, 1:250 dilution (provided by M. Collart); 
anti-CAF1 (Abnova), 1:1,000; anti-PABP (Cell Signaling Technology), 1:5,000; anti-
PAN2, 1:1,000 and anti-PAN3, 1:500 (both provided by A.-B. Shyu); anti-dGW182, 
1:2,000 (provided by E. Izaurralde); anti-GST (GE Healthcare), 1:10,000; anti- 
a-tubulin (Sigma T5168), 1:10,000; anti-HA tag (Roche 3F10), 1:5,000; anti-HA 
tag (Santa Cruz sc-7392), 1:2,000; and anti-LexA (Santa Cruz sc-7544), 1:2,000.
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enhances oncogenic transformation. Science 315, 1576–1579 (2007).
39. Chekulaeva, M., Filipowicz, W. & Parker, R. Multiple independent domains of dGW182 
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40. Fabian, M.R. et al. Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-
dependent deadenylation. Mol. Cell 35, 868–880 (2009).
online metHoDs
Cell culture, transfections, RNAi and luciferase assays. Human HEK293T cells 
were grown in DMEM (GIBCO BRL) supplemented with 2 mM l-glutamine and 
10% (v/v) FCS buffer. Transfections were done in 6-, 12-, 24- and 96-well plates with 
nanofectin (PAA Laboratories), according to manufacturer’s instructions. In tether-
ing experiments, cells were transfected with 1 ng RL-5BoxB, 20 ng FL-Con and 20– 
30 ng HA- or NHA-fusion constructs per well in a 96-well plate. For other formats, the 
amount of plasmids was adjusted proportionally. Cells were lysed 24 h after transfec-
tion. For TNRC6 rescue experiments, HeLa cells stably expressing Tet-On machin-
ery36 were transfected using attractene reagent (Qiagen). Per well of the 96-well 
plate, transfection mixtures contained 10 ng of the let-7 reporter plasmid, increasing 
amounts of NHA-TNRC6A or its point mutants (20, 60 and 180 ng), and either 
siRNAs specific to TNRC6A, B and C (5ʹ-GCCUAAUCUCCGUGCUCAATT-3ʹ, 
5ʹ-GGCCUUGUAUUGCCAGCAATT-3ʹ and 5ʹ-GCAUUAAGUGCUAAACAA-
ATT-3ʹ (Microsynth; sequences represent sense strands), 0.53 pmol each; or 
1.6 pmol AllStars siRNA negative control (Qiagen). TNRC6A plasmids were made 
resistant to siRNA by introducing silent point mutations. Let-7 reporter plasmids 
(kindly provided by J. Béthune) encoded Renilla luciferase fused to the human 
HMGA2 3ʹ UTR, either WT with sites recognized by let-7 (RL-hmga2), or mutant 
in which let-7 sites were mutated (RL-hmga2 mut)37,38, as well as FL-Con, both 
under control of the tetracycline-responsive element. Expression of reporters was 
induced with 1 mg ml–1 doxycycline 2 d after transfection and cells were lysed 
4 h after induction. D. melanogaster S2 cells were transfected in 96-well plates with 
Cellfectin II and PLUS reagents (Invitrogen). In tethering experiments, we trans-
fected 5 ng FL-5BoxB plasmid, 30 ng RL-Con, and 20–30 ng plasmid encoding HA- 
or NHA-fusion protein per well. Cells were lysed 3 d after transfection. In rescue 
experiments, transfection mixtures contained 5 ng FL-nerfin reporter plasmid, 
30 ng RL-Con and 5 ng of either an empty vector or a plasmid encoding miR-9b 
or miR-12 per well of a 96-well plate; plasmids encoding dGW182, TNRC6C and 
their mutants were added in increasing amounts from 3–30 ng. RNAi experiments 
were conducted as described39 using dsRNA targeting the dGW182 3ʹ UTR or the 
coding region of NOT1. S2 cells were treated with dsRNA twice, on days 1 and 4, 
transfected on day 6 and lysed on day 9.
Luciferase activities were measured with the Dual-Luciferase Reporter Assay 
System (Promega). In all luciferase assays, values represent means ± s.e.m. from 
three to six independent experiments.
CED mutants containing mutations in W-motifs. Positions of single tryptophan 
mutations are as indicated in Figure 2a,c. Other mutants in the TNRC6C CED 
are designated as follows: 2W stands for W1445 W1487; 3W, W1445 W1487 
W1494; 4W, W1445 W1487 W1494 W1659; 5W, W1445 W1487 W1494 W1648 
W1659; 6W, W1445 W1487 W1494 W1605 W1648 W1659; 7W, W1445 W1487 
W1494 W1504 W1605 W1648 W1659; 8W, W1445 W1487 W1494 W1504 
W1515 W1605 W1648 W1659; all GW, W1487 W1494 W1648 W1659; most 
conserved, W1504 W1515; and less conserved, W1487 W1605 W1648 W1659.
For selecting most conserved and less conserved W-motifs mutated in the last 
two mutants, the protein alignment included sequences of more GW182 proteins 
than the one shown in Supplementary Figure 1 (data not shown).
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